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PREFACE
This thesis reports the first of a  two-stage project for the development of 
an  integrated microcomputer-based ’clinic automation system’ for which the 
author has recruited the help of the Electrical and Electronic Department of 
Strathclyde University. The potential of the application and adaptation of com­
puting techniques in solving clinical problems related to ophthalmic diagnosis 
and management are investigated.
This thesis is intended to broaden the perspective of clinicians who are 
interested in Graves’ ophthalmopathy, and computer scientists interested in 
medical computing. The author has endeavoured throughout the thesis to pres­
ent information related to different disciplines in a m anner readily under­
standable to the reader not well versed in that discipline.
Chapter 1 is written primarily for clinicians who may not be familiar with 
computers. It provides a simplified introduction to computers and their medical 
applications.
Chapters 2 and 3 furnish the background knowledge concerning the 
clinical problem of dysthyroid eye disease.
In Chapter 4 the need for further research in both thyroid ophthalmo­
pathy and medical computing was identified and the objectives of the present 
study were defined.
The reader will find a detailed account of a long-term study of a  series of 
thyroid ophthalmopathy patients in Chapter 5. Statistical analyses were em­
ployed on the collected data appertaining to ’patients’ rather than  ’orbits’ except 
when comparing the initial and ’final’ values of the parameters related to each 
individual eye (e.g., lid retraction, exophthalmos, visual acuity, intraocular press­
ure). For such parameters, analysis was applied separately on right and left eye 
data (no significant statistical difference was found between right and  left eyes 
for those parameters). With regard to clinical parameters such as exophthal- 
mometric reading, expert statistician advice confirmed that, in the context of com-
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paring the initial and ’final’ values, obtaining control values would not add to the 
validity of the statistical results and therefore was not required. It is worth not­
ing tha t Graves’ ophthalmopathy, dysthyroid eye disease, thyroid opthalmo- 
pathy, Graves’ orbitopathy, and thyroid orbitopathy are used interchangeably 
throughout this thesis.
Detailed descriptions of the development of computer-based systems for 
testing ’temporal visual acuity’ and for automatically digitising and interpreting 
ophthalmic charts are found in chapters 6 and 7 respectively.
Details of the design and development of a thyroid eye disease expert sys­
tem are provided in Chapter 8. Testing and validation of this prototype showed 
tha t it gives consistent inferences and highly accurate conclusions. This high de­
gree of accuracy resulted from using historical patient data in the evaluation of 
the performance of the system. This is valid as an  indication of the integrity of 
the programme. However, it is expected that the accuracy will be less on using 
the system for a different group of patients. This w arrants a separate study.
It is hoped that this work will be of interest to ophthalmologists, endo­
crinologists, and computer scientists.
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SUMMARY
The fundam ental cause of Graves’ ophthalmopathy remains unknown 
and the optimum management protocol is controversial. This disorder is taken 
as an  example to study some aspects of the use of microcomputer techniques in 
ophthalmic diagnosis and management.
A simplified introduction on computers and their applications in me­
dicine and a  literature review of the pathology, clinical presentations, classifica­
tions, patient assessment, and various treatm ent modalities are presented. The 
various problem areas and the need for further research to study the long-term 
effects of thyroid ophthalmopathy were identified. A protocol for the study of 
examples of the use of microcomputers in assessm ent of patients, in interpreta­
tion of clinical data and in medical decision support systems was devised.
The results of a prospective review of the long-term (mean follow-up time 
10 years) effects of thyroid ophthalmopathy in 224 patients, the largest propor­
tion of whom were hyperthyroid a t presentation, are presented. Fewer males de­
veloped severe ophthalmopathy, bu t when they did, this tended to occur more 
rapidly than  in females. Patients were grouped into ’mild’ and ’severe’ categories.
The sensitivity, specificity and predictive value of 25 param eters (at pres­
entation) in making the diagnosis of ophthalmopathy, and in predicting its course 
were calculated. Risk factors were identified and two linear discriminant analysis 
equations, based on the combined effect of sets of independent variables, were 
computed to predict the severity of the disease and the requirement for orbital 
decompression. The exophthalmometric reading was found to be the m ost im­
portant predictor followed by ’thyroid s ta tu s’, then the magnitude of ocular mo­
tility disorder and finally, the time from the onset of thyroid dysfunction to the 
onset of ophthalmopathy. Based on those four parameters the model gives a  74% 
correct classification of patients into ’mild’ or ’severe’ subgroups. The second 
model, based on 17 parameters, achieves an 81% correct prediction of the 
necessity for surgical decompression. The results reported emphasise the poten­
tial sight threatening nature of thyroid ophthalmopathy and indicate tha t cor­
neal ulceration can be as serious as optic nerve compression and may w arrant 
orbital decompression especially in the presence of marked proptosis.
xxx
Three computer systems were developed. TEMPRAC, a microcomputer- 
based system for clinical assessm ent of ’temporal visual acuity’ based on Snel­
len optotypes is described. The most accurately repeatable optotype for normal 
individuals was 6 /9 . The test is sensitive in detecting small uncorrected errors 
of refraction which may not affect the Snellen acuity. Temporal acuity’ was found 
to be affected in eyes with retrobulbar neuritis compared with the fellow unaf­
fected eye although each eye can achieve the same Snellen visual acuity. A univer­
sal autom ated chart reading microcomputer system which extracts the plotted 
information from a range of ophthalmic charts for subsequent scoring and quan­
tification and a  novel combination of graphics and image processing algorithms 
is described.
A disease-specific expert system prototype called TEDEX, which gives ad­
vice on the diagnosis and m anagement of thyroid ophthalmopathy, has been de­
veloped. The results obtained from the long-term study of dysthyroid eye disease 
constituted the foundations of the knowledge base for TEDEX.
An overview of the application of artificial intelligence techniques in me­
dicine and representative examples of various approaches of computer-based 
medical decision aids is provided. A detailed account of building and testing 
TEDEX prototype is presented to characterise a methodology which led to the 
achievement of the desired goals in the time available. No standard methodology 
for designing and building medical expert systems is currently available. T here­
fore, the methodology presented could be followed in the development of similar 
systems in other domains. The thesis concludes with successes and limitations 
of the techniques employed, and an  outline of suggestions for future research.
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ABBREVIATIONS
AMP Adenosine monophosphate
CGA Colour graphics adaptor
Ci Curies
cm centimetres
CSR Central serous retinopathy
EGA Enhanced graphics adapter
EPS Exophthalmos-producing substance
KB Kilobytes
Kg Kilograms
LATS Long-acting thyroid stimulator
MB Megabytes
MHz Mega Hertz
mm millimeter
mm. Hg. millimeters of mercury
msec milliseconds
PBI Protein-bound iodine
Rad Rads
T3 Triiodothyronine
T4 Tetraiodothyronine (Thyroxine)
TBG Thyroxine-binding globulin
TBPA Thyroid-binding prealbumin
TEDEX Thyroid eye disease expert system
TEMPRAC Temporal visual acuity’ testing system
TRH Thyrotropine-releasing hormone
TSH Thyroid-stimulating hormone
STD Standard deviation
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GLOSSARY OF COMPUTER TERMINOLOGY
Algorithm
A step-by-step procedure tha t guarantees a correct outcome. To de­
velop a  conventional computer programme, the programmer specifies 
the algorithm which the programme will follow.
Artificial intelligence
A sub-field of computer science concerned with the concepts and 
methods of symbolic inference by a computer and the symbolic repre­
sentation of the knowledge to be used in making inferences. A field 
aimed at pursuing the possibility that a computer can be made to ’be­
have’ in ways which hum ans recognise as ’intelligent’ behaviour in 
each other. Artificial intelligence is an  academic discipline, not a  pro­
duct, its research aims a t improving what computer techniques can 
offer.
Backtracking
The process of backing up through a sequence of inferences in order 
to try a different path. Planning problems typically require backtrack­
ing strategies which allow a system to try one plan after another until 
the system finds a path  tha t has no unacceptable outcome.
Breadth-first search
A control strategy that examines all of the rules or objects on the sam e 
level of the hierarchy before examining any of the rules or objects a t 
the next lower level.
Certainty
The degree of confidence one has in a fact or relationship. As used in 
artificial intelligence, this contrasts with probability, which is the li­
kelihood tha t an event will occur. There are two types of certainty: the 
certainty that the expert has in a relationship expressed in a  particu­
lar rule, and the certainty that the user has when he provides infor­
m ation during a consultation.
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Confidence factor
A numerical weight given to a  fact or relationship to indicate the con­
fidence one has in the fact or relationship. Most rule-based systems 
use confidence factors rather than  probabilities.
Control strategy
The method used by the inference engine to determine the order in 
which reasoning occurs.
Domain
A subject m atter area or problem-solving task. Existing systems only 
provide ’good’ advice when they are used to assist users in solving 
problems which lie within very narrowly defined domains.
Experiential knowledge
Knowledge gained from hands-on experience. This typically consists 
of specific facts and rules-of-thumb (surface knowledge). This is in 
contrast with ’deep knowledge’ of formal principles or theories.
Frame
A knowledge representation scheme which associates an  object with 
a  collection of features (e.g., facts, rules, values). Eachfeature is stored 
in a  slot. A frame is the set of slots related to a specific object.
Inference
The process by which new facts are derived from established facts. 
Inference engine
Is the portion of an  expert system which contains the inference and 
control strategies. When an  inference engine is separated from a 
knowledge base, it is, in effect, an  expert system building tool.
Interface
The link between a computer programme and the outside world. A 
single programme m ay have several interfaces.
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Knowledge
An integrated collection of facts and relationships which, when exer­
cised, produces competent performance.
Knowledge acquisition
The process of locating, collecting, and refining knowledge. The per­
son undertaking the knowledge acquisition m ust convert the acquired 
knowledge into a form which can be used by a computer programme.
Knowledge representation
The method used to encode and store facts and relationships in  a 
knowledge base. Semantic networks, facts, rules, objects, and frames 
are all methods of knowledge representation.
LISP machines
Are 32-bit computer systems which are used by expert systems devel­
opers. They are currently very expensive machines.
Maintenance of an expert system
Unlike conventional computer software which is only infrequently up­
dated, expert systems by their nature are very easy to modify. Most 
expert systems which are currently in use are constantly being im­
proved by the addition of new rules.
Semantic
Refers to the meaning of an  expression. It is often contrasted with syn­
tactic, which refers to the formal pattern of the expression. Compu­
ters are good at establishing tha t the correct syntax is being used; 
programmers have a great deal of trouble programming them  to estab­
lish the semantic content of an  expression.
Semantic networks
A type of knowledge representation tha t formalises objects and values 
as nodes, and connects the nodes with links which indicate the rela­
tionship between the various nodes.
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Tools
As used in this thesis, tools are computer software packages tha t sim­
plify the effort involved in building an expert system.
Uncertainty
In the context of expert systems, uncertainty refers to a  value which 
cannot be determined during consultation. Most expert systems allow 
the user to indicate that he does not know the answer. In this case the 
system uses its other rules to try to establish the value by other means 
or relies on default values.
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PARTI. 
GENERAL INTRODUCTION
CHAPTER 1. 
THE COMPUTER
1.1. INTRODUCTION:
Computers and microprocessors are used in virtually every aspect of 
m odem  medicine. In General Practice, computerisation of patients’ notes 
promises to revolutionise the delivery of health care, especially with regard to 
preventive medicine. By applying computer techniques to medical decision m ak­
ing it is possible to improve diagnostic and therapeutic accuracy, with improved 
cost efficiency as an added advantage. The development of expert systems has 
also advanced our understanding of the nature of medical knowledge and of the 
decision-making process itself. A wide range of medical databases is now ac­
cessible to any doctor equipped with a personal computer and a  modem link to 
the telephone network. Powerful new non-invasive diagnostic instrum ents, in­
cluding CT scanners, MRI, and ultrasonic imaging, are based on computers. 
Computers are used widely in medical research, both for the acquisition and ana­
lysis of data. Computerisation has greatly increased the efficiency and the scope 
of clinical laboratory procedures and advanced analytical instrum ents. The in­
terpretation of diagnostic tests like the ECG, and monitoring of patients in  in­
tensive care have also been improved by careful application of computer 
technology.
Detailed discussions of certain areas of medicine, where computers have 
either been shown to be of value in the past or promise as such for the future, 
are found in the comprehensive reviews by Norris et aL (1985), Ellis (1987) and 
Chard (1988).
1.2. COMPUTER TECHNOLOGY:
The foundations of modem computing were established by the work of 
Allan Turing in the 1930s, and John  von Neumann in the 1940s. Turing 
presented an  abstract design of a  computer that could solve any problem pro­
vided that it was presented in the form of a  series of symbols on an  infinite strip 
of paper tape. Von Neumann on the other hand, suggested a more practical way 
of constructing a computer, and proposed the idea of an electronic com puter con­
trolled by a  series of instructions, the ’programme’. This im portant identification 
of two separate components - the computer ( the ’hardware’) and the programme 
(the ’software’) - currently forms the fundamental basis of computer design.
Early computers were room-sized, expensive to operate, and generated a 
large am ount of heat because their logic circuits were constructed exclusively 
from thermionic valves. In 1948 a further practical step in the development of 
m odem  computers was taken by the invention of the transistor. The transistor 
is small, reliable, and uses comparatively little power (Garetz, 1985).
In 1959, a  further advance was made when it became possible to pu t 
more than  one transistor on the same substrate material (i.e. an  integrated cir­
cuit, or IC). By 1980, 100,000 transistors occupied the same area previously 
taken up by one transistor. Since computing power is largely determined by the 
num ber of logical operations performed in a given time span, the more transis­
tors available to act as logic components the greater the intrinsic computing 
power of a  chip (Meindl et oL, 1981).
Chip technology progressed to the development of IC in which transis­
tors and other components were combined in a single package. Such chips be­
came the backbone of most logic circuits in the large mainframe computers 
produced in the 1960s. In 1971, the Intel 4004 chip, measuring a few centime­
ters square was introduced into the semiconductor market. The 4004 chip 
changed the tradition, by providing 1,900 transistors-worth of data processing 
capability in  a  single chip (Garetz, 1985).
Since the early 1970s, the development of microprocessors and related 
chips has rapidly progressed. The capacity of microprocessors to perform calcu­
lations quickly, accurately and cheaply has led to their incorporation in a  host 
of equipment designed where some degree of data processing is required for con­
sum er use. The sam e qualities of the microprocessor have led to its increasing­
ly diverse application in medicine. Indeed, developments in chip technology have 
largely determined the growth of certain diagnostic areas. For example, without 
the computing power of advanced microprocessors the CT scanner would take 
far too long to perform the mathematical calculations needed to reconstruct to­
mographic images.
1.2.1. Limitations:
There are limits to the num ber of transistors that can be packed into a 
given space in order to produce greater computing power. Close packing also 
leads to increased heat production.
Von Neumann’s system of computing based on a series of programmed 
instructions is impractical for multiple calculations. For example a single fourth 
generation CT image requires 109 calculations . A single programme would take 
many hours. Parallel processing in which multiple portions of a complex pro­
gramme are simultaneously handled has therefore been developed, thus dramati­
cally shortened the processing time to m inutes or seconds.
At present microprocessor technology is more than  adequate for the m a­
jority of tasks in  medicine, whether this be non-specialist applications like word 
processing and accounting, or in the specialised areas such as general practice 
computing systems for diagnosis and patient management.
1.3. THEHARDWARE:
Current microcomputers are characterised by their flexibility and wide 
range of input and output. Sources of data can be as diverse as the electrical sig­
nal coming from ECG leads, the characters typed on a keyboard, the probabilities 
from a disease database, the intensity levels from a digitised X-ray film or the 
signals from a  foetal monitor. The output of data processing can be equally var­
ied (e.g. the display of a  text on a monitor screen, the adjustm ent of a valve to 
alter a  drug infusion rate, or the sounding of an  alarm to warn staff of a patient 
in asystole).
The microprocessor comprises digital logic circuits which operate on the 
basis of binary arithmetic. The digits 0 and 1 are termed binary digits or ’bits’. 
Data is communicated in ’bytes’ which consist of eight h its ’ each.
The first affordable personal computer which appeared in the 1970s re­
quired the user to both enter data and read results in terms of these row binary
values, b u t m arket pressures soon led to the development of more user friendly 
machines with keyboard entry systems.
A programme is a sequential list of instructions. This list has to be sorted 
in a  form which is readily accessible to the processor. This element of computer 
hardware is called ’memory’. Memory ICs are capable of storing m any thousands 
of bytes of data in a complex array of microscopic, bit-sized memory ’cells’ where 
an  empty cells denotes the value ’0’ and a  full cell equals *1’. Memory is also re­
quired for storing the data received from inputs until the processor is ready to 
make use of it. Similarly, data from the processor is often stored in memory be­
fore being sent to a display device.
1.3.1. Microprocessors:
Microprocessors play the m ain role in any computer. Their specifications 
provide important points of comparison between different machines. Two par­
ticular attributes are taken as indications of performance: First the width (in bits) 
of processing data handling; and second, the speed by which the processor car­
ries out instructions on these data (the so-called clock rate). This last feature 
derives from a quartz crystal clock which is built into each computer to provide 
a time-base for its activities.
From the early beginning of the 4004 processor to the latest parallel pro­
cessing chips, the goal of processor design has been to achieve fast rates of hand­
ling data. In computationally intensive areas like medical image processing the 
advantages of increased speed are obvious. The rapid MRI and CT reconstruc­
tion times possible with the new 32-bit processors make such equipment more 
economically viable.
1.3.2. Memory:
Different types of memory have been produced to serve particular pur­
poses. The two principal varieties are the Read Only Memory (ROM) and R an­
dom Access Memory (RAM). ROM is so termed because the processor can ’read’ 
the data stored in its memory cells bu t cannot ’write’ data into it. Traditionally, 
ROM has been used to store programmes that are fundamental to the operation 
of the computer rather than  being specific to a particular task.
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The floppy disk
RAM differs from ROM in two important aspects. Firstly, the processor 
is able to use RAM as work space for programme storage and data manipulation 
because it can be written to as well as read from. Secondly, RAM needs a con­
stan t power source in order to retain the contents of its memory cells. Switching 
the computer off destroys any stored programme or data.
1.3.3. Storage:
The first form of storage which became widely available to the general 
microcomputer user was the cassette tape. This method suffers from a num ber 
of disadvantages. First, it is difficult to locate the start of a programme in the 
middle of a  data cassette. Second, the combination of the slow cassette speed 
and the slow conversion rate of binary data seriously limits the speed a t which 
the data can be transferred to and from the cassette. From the point of view of 
medical computing, therefore, such systems would be inappropriate.
The floppy disk became generally available for use with microcomputers 
in the late 1970s. As with cassette tape, the basic medium is magnetic. However, 
unlike tapes, the magnetic material is coated onto a plastic disc enclosed in a 
protective envelope (Figure 1.1). The floppy disk is inserted into a  suitable disk 
drive and rotated a t high speed. A head scans across the surface of the disk to 
perform the read or write functions. When a programme or data is stored on a 
disk, various coordinates are also stored in a ’directory’ on the outermost edge. 
The next time the computer is instructed to retrieve the data, the directory auto­
matically provides the computer with the necessary information about the loca­
tion of the data on the disk. As a result, the process of finding a programme and 
loading it into the computer may be as m uch as one hundred times faster than 
the equivalent operation performed with cassette storage.
An alternative to the floppy disk is th e ’hard disk’. Although the principle 
of data storage is the same as its counterpart, the hard disk is designed with the 
disk as an  inseparable and permanently sealed part of the drive mechanism. The 
hard disk is also a good way of storing data that has to be accessed quickly or 
updated at frequent intervals as well as providing space for the storage of a  large 
num ber of programmes. The chief medical use of the hard disk is for storing pa­
tient records.
Other forms of storage are under intensive development. The finite size 
of magnetic particles and the limitations of magnetic recording techniques places 
an  upper limit on the storage density that can be achieved. New forms of storage 
are making use of the precision of the laser to read and write data. One version 
of the technology which appeared a t the time of writing is the so-called WORM 
disk (Write Once Read Many). The WORM disk stores data as a series of micro­
scopic pits burned into a surface of a  tellurium-coated disk by a small laser. Once 
stored in this manner, the data can be read by the laser, b u t it cannot be erased. 
Given a storage capacity of a t least 200 Mega bytes such disks may have a role 
in medical archiving.
A more perm anent form of high-capacity storage is the CD-ROM. Physi­
cally identical to the audio Compact Disk, the CD-ROM is a 12 cm plastic disk 
read by laser in a special CD player that outputs data rather than  audio signals. 
Since each CD can store as m uch as 550 Mega bytes of data, the medium offers 
the possibility of cheap archives for medical data that can be accessed by anyone 
with a  personal computer. The drawback with a CD-ROM is that, like conven­
tional ROMs, data can only be read from the CD not written onto it. However, a 
num ber of companies are developing optical storage media with both read and 
write capabilities. The m ain use of the CD-ROM is likely to be in the field of large 
databases.
1.3.4. Inputs and outputs:
The inputs and outputs of the computer have a  major part to play in 
determining its flexibility. All computers have some form of video output for dis­
playing text and graphics on a screen.
One limitation of video technology is the cathode ray tube. An obvious 
disadvantage of the conventional tube is its length. A second drawback is its con­
siderable power consumption. One solution which has found increasing support 
and development is Liquid Crystal Display (LCD). An increasing num ber of port­
able computers are being produced with displays in a  ’flip-top-lid’. Other display 
technologies are also under active development, including plasma displays and 
electro-luminescent panels. Although both these alternatives improve on the 
LCD’s visibility, power consumption is a  problem, making battery power imprac­
tical.
The computer keyboard is the m ost commonly used input device on any 
microcomputer. Standard computer codes have been developed to represent each 
keyboard character, since there is no direct binary equivalent of a letter or a  num ­
ber. The most popular of these is the American Standard Code for Information 
Interchange or ’ASCII’. This assigns a decimal num ber to each character which 
the computer then converts to its binary equivalent, thereby interpreting a  par­
ticular command (RETURN for instance) or character entered from the keyboard.
The keyboard is not an  ideal input device and remains the major barrier 
tha t prevents many users with poor keyboard skills from using computers in the 
m ost effective way. This is particularly true if, for example, a  paramedical expert 
system or a waiting room advice programme is being used by someone who has 
never touched a  keyboard before.
Substitutes for the keyboard have been developed. One idea is the touch­
screen whereby the user simply points to areas on the screen, an  infrared beam 
detects the relevant spot and acts accordingly to register the choice with what­
ever programme is being run  by the computer. Its disadvantages include the rela­
tively high cost and the limited resolution of finger pointing. The m ost popular 
data input technique a t the time of writing is known by the acronym WIMPs’ 
standing for Windows, Icons, Mice, and Pointers, like the touch-screen the basic 
intention of WIMPs is to simplify computer use for the average user. The tech­
nique is based on the use of a  hand-operated input device ’the mouse’ to select 
from various options displayed on the screen as pictures ’the icons’. Thus, one 
picture might be of the eye for the visual system examination, another of the heart 
to indicate cardiovascular system findings. The mouse is simply an  interface for 
turning movements of the hand on the desktop into x, y coordinates tha t are used 
to move an on-screen pointer between the various icon options.
1.3.5. Printers:
The printer is probably the most useful of all microcomputer peripherals. 
The modem printer has no direct connection with a  keyboard, bu t receives data 
from the computer. These data are usually presented as a  series of ASCII codes, 
which are turned into their corresponding printed characters.
The most popular form of printer is the ’dot-matrix’ printer. For high 
quality printing, the choice lies between a daisywheel printer or laser printing 
technology. The daisywheel printer is slower than  the dot-matrix printer b u t is 
of high quality. Laser printers are essentially an  adaptation of photocopier tech­
nology. The laser ’writes’ text and graphics onto the surface of a photosensitive 
drum, which attracts pigment ’toner’ to the exposed areas and then deposits this 
onto paper. It has the advantages of high speed and quality with low noise, bu t 
it is relatively expensive. Laser printing is an obvious candidate for general prac­
tice or clinic and ward use.
1.3.6. Communications:
One of the major features of the microcomputer is its facility to integrate 
data from a variety of sources. It can be linked to additional computers in the 
sam e building or to distant databases. The simplest link that can be made be­
tween one computer and another a t a  distance is to use an  ’acoustic coupler’. 
This item of hardware converts data into audible tones. The m ain drawbacks of 
this method are its very limited speed (30 characters per second) and the lack of 
reliability when competing with noise on the line.
A more satisfactory way of sending data down telephone lines is to use a 
device called a ’Modem’. The term  modem comes from the fact tha t the device 
first modulates data with a tone to transm it it, and then reverses the process a t 
the receiving end, and thus demodulates the data.
Although the m anner in which data is transmitted is essentially similar 
to an  acoustic coupler, the major difference is that the modem is connected di­
rectly to the telephone system, and is therefore both more reliable than  the acous­
tic coupler and has an  increased transm ission rate.
Some form of local communication system can be provided wherever data 
have to be shared amongst a num ber of users so that the individual computers 
can access the central hard disk, or output data to a  single printer.
Two short distance communication systems have been developed. The 
’m ulti-user’ system was developed in the 1960s mainly for business u s e /a n d
comprises a  num ber of terminals connected to a central processing unit and stor­
age facilities. This sort of system is common in business as well as in hospitals 
with computerised administration facilities. The main problem with this ap­
proach is tha t users may have to wait their tu rn  in the processing queue when 
there are m any processing requests from the terminals.
A more recent development is the Local Area Network (LAN) system. This 
uses conventional microcomputers as ’intelligent terminals’, with interconnected 
cables providing high speed transfer of data between one computer and another 
with a  central data store. Special LAN controller chips have been developed which 
enable even different microcomputers to be coupled together in a  network. Com­
puters in a  LAN operate a t virtually the speed they would on their own because 
each terminal retains its own processing functions. An apparent decrease in 
speed may be observed only when two or more computers are being used to ac­
cess a  hard disk at the same time. Since each computer has its own floppy disk 
drive, users also have the option of running their own computers outside the net­
work, this is impossible with the m ulti-user system.
1.4. THE SOFTWARE:
Software refers to the instructions required to apply the technology of the 
hardware to a  particular purpose. ’Good’ software should provide an  efficient in­
terface between the user, the computer, and the application.
Pioneer computer programmers in the early 1970’s used to programme 
with the computer’s own language by using the so-called ’machine code’ which 
comprises the basic instructions that the processor requires to cany  out a par­
ticular data manipulation. A special programmers aid called ’assembly language’ 
was devised to enable the programmer to construct a programme in a mnemonic 
shorthand which was then assembled automatically into a  final sequence o f’low 
level’ machine code for use by the processor. An assembly language programme 
was easier to write and to eradicate errors (debug) than  its pure machine code 
equivalent. One of the advantages of programming in either machine code or as­
sembly language is that programmes run  very fast. In situations where speed is 
critical, for example updating the screen display of an  ECG monitor or the re­
sponse to a  change in blood pressure, the fact th a t the programme is written in 
machine code or assembly language (low level language) may be important. On
the other hand, as the processors have themselves become faster and more 
powerful, shortening the last cycle of a programme has become less important, 
and m any time-critical programmes for modem 16-bit microcomputers may in 
fact be written in other (high level) languages.
1.4.1. Programming languages:
A large num ber o f’high level’ languages are now available. This is the re­
sult of differences in programmers attitudes over several decades of developments 
in computing.
’BASIC’ is the computer equivalent of English language which stands for 
’Beginners All-purpose Symbolic Instruction Code’. Although ’BASIC’ is easy to 
learn, it is relatively slow and lacks a feature called ’structure’, so that it is diffi­
cult for someone reading the programme to understand its operation. This makes 
debugging more difficult.
Many high level languages have been designed for particular programm­
ing environments and application. FORTRAN (FORmula TRANslation) is one of 
the old programming languages and was designed primarily for engineering and 
scientific applications.
A num ber of high level languages have been developed for application in 
artificial intelligence, and therefore find use in the construction of medical expert 
systems. Examples include PROLOG (PROgraming in LOGic) and LISP (LISt Pro­
cessing language). Other important languages are PASCAL, C, LOGO and ADA.
1.4.2. Operating systems:
An essential piece of computer software is a programme called the oper­
ating system. This programme brings the electronics of the computer into useful 
function. It allows a  user to type at the keyboard, store and recall data from disk, 
and create programmes. Often this programme is totally ’transparent’ to the user. 
A very popular operating system for microcomputers is the Disk Operating Sys­
tem ’DOS’ (Appendix A). Some particular software packages run  only under a  
specific operating system. The standard operating systems, like DOS, have large 
libraries of commercially available software that will run  under them.
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1.5. MACHINE SELECTION:
Computers are described as ’mainframe’, ’superm inis’, and ’minis’ 
amongst other names. No absolute definition of these term s exists. All these 
names indicate some sort of size relating both to the physical volume of the m a­
chine and the am ount of computational power it can generate. The terminology 
is further complicated by advances in the design technology which reduce the 
power of a mainframe into the volume of a  minicomputer (Norris et oL, 1985).
One of the most noticeable characteristics of different sized computers is 
the num ber of users tha t can use the machine simultaneously. A mainframe can 
support about 200 users, a  mini, 4-40, and a micro, usually only one.
Moreover, the volume of data which each of them can store may differ. A 
mainframe can typically store vastly more than a mini which in tu rn  can store 
more than  a  micro. Roughly one to twenty megabytes for a  micro, five to two hun ­
dred megabytes for a  mini and many thousands megabytes for a mainframe. Each 
of the machine types can be used profitably in health care, but only within the 
limits of their design.
A fourth consideration before a  machine type is selected might be called 
the special features of the machine. Mainframes, especially if sited a t the local 
university, have a wealth of software available within them. Minis and some 
micros are very flexible in their hardware configuration making the solution of 
certain problems m uch simpler. A special feature, unique to the micro, is the 
ability to produce complex graphical pictures on the screen often in colour, chea­
ply and easily. This feature is veiy valuable for patient testing and interviewing, 
and for computer aided education.
1.6. ADVANTAGES AND DISADVANTAGES OF MICROCOMPUTERS:
There is a  move away from large computer installations to small desk­
sized systems. This partly reflects technical developments which have perm itted 
the reduction in the size of the computer. It also reflects changes in attitudes 
whereby the computer has become a tool used directly by the consumer. Advant­
ages and disadvantages of microcomputers were discussed by Norris etoL,[1985) 
and Table 1.1 summarises the main points.
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Advantages and disadvantages of microcomputers:
Advantages:
Physical size, small
Information storage 
Low running cost 
Reliability 
Flexibility
Confidentiality and security 
Improving assessm ent 
Saving time 
E ase of operation 
Wide range of applications 
Increased scope 
Good backup provision 
Liaison with other departments 
Low software costs 
Large storage volume
Disadvantages
Devising programmes, not easy
Limitations of disks
Patient comprehension, might be difficult 
Extra work and staff is needed 
Testing of programmes, time consuming 
Effect on staff and managem ent
Table 1.1
The physical size of a computer can be important. Also the portability 
and the ease by which the device can be moved. Size is also relevant with regard 
to information storage. A large quantity of paper can be reduced to a small num ­
ber of floppy disks only 5.25 or 3.5 inches across. Both patient records and re ­
search data can accumulate and occupy a  great deal of space. When translated 
into magnetic patterns on disk their physical volume is very m uch reduced.
The capital cost of equipment, the running expenses and the recurring 
cost is another aspect. Small machines based on modem electronics are reason­
ably priced, highly reliable and the cost of machine breakdown and m aintenance 
is greatly reduced.
Microcomputers are flexible instrum ents, the user can determine exact­
ly w hat the computer will do, when it will do it and where the computer will be 
located. They present no problems of privacy. Confidential information can be 
kept in a safe place, the use of passwords is also available in  some programmes.
Microcomputers are straightforward to operate and are not easily dam­
aged. A wide range of applications is available. Liaison with other departments 
and clinics, reduces software cost and large storage volume.
On the other hand, there are also some disadvantages. Microcomputers 
need a  software programme to ru n  any particular application; this programme 
might be available commercially or m ust be written especially for a  specific pur­
pose. Devising and writing programmes requires considerable training and 
usually these take a  long time to be operational.
Microcomputer memory and storage devices have their limitations. They 
can be appreciably slower than  bigger machines when searching through thou­
sands of records.
In conclusion, most microcomputers are small, portable, cheap and re­
liable. They are inherently flexible and offer security and privacy. They have utility 
for patient assessm ent and interviewing. Their speed of operation and memory 
capacity are adequate for m any clinical applications. However, their limitations 
m ust be recognised.
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Medical applications of computers - Administration.
Financial management of health-care
Billing systems.
Payroll.
Accounts.
Patient registers and indices 
Stores and supplies 
Pharmacy
Providing a  data base of drug information.
Calculation of dosage.
Writing prescriptions.
Providing a  data base of poison information. 
Printing labels and instructions.
Pricing and charging of prescriptions. 
Provision of a  complete record of each  task. 
Monitoring of patient compliance.
Monitoring of prescribing practice.
Patient appointment system.
Staff time table.
Scheduling of facilities.
Ambulance scheduling.
Manpower information.
Management forecasting.
Table 1.2
Examples of administrative health-care functions which are suitable for 
computer system applications.
1.7. THE USE OF COMPUTERS IN MEDICAL ADMINISTRATION:
Administration comprises taking resources (manpower, equipment, 
building, money, etc.) and transforming them into patient care. The challenge of 
management is to assemble individual simple steps into vast and complex struc­
tures. The inherent facility of computers to provide a total picture a t any given 
time is one of the features of computing which is essential to the management 
process. Table 1.2 shows a summary of the areas in which computerisation is 
taking place.
1.8. COMPUTERS AS PART OF MEDICAL EQUIPMENT:
Computers form an integral part of a  wide variety of electronic equipment 
used in both clinical diagnosis and therapy. These applications can be grouped 
on the basis of the type of signal which is processed by various equipment (Chard, 
1988) (Table 1.3).
Medical imaging is one of the areas where computer-based machines 
uses digitised images in the most effective way (Table 1.4). Computers can im­
prove the basic quality of a digitised image in a  num ber of ways (e.g. enhance­
ment, noise reduction, restoration and image compression). Storage and 
distribution of computerised images, three dimensional imaging and automatic 
interpretation of images are growing and promising fields of application.
1.9. COMPUTERS FOR CLINICAL DATA COLLECTION:
The use of computers for the collection, storage and retrieval of patient 
data has so many advantages over traditional systems tha t it is likely they will 
substantially replace written records and represent one of the most rapidly grow­
ing activities in clinical medicine. This approach has many advantages (Table 1.5) 
and, of course, some disadvantages (Table 1.6). However, most of the disadvant­
ages are generally theoretical.
1.10. MEDICAL EDUCATION:
The most significant advantage of the use of computers in education is 
that they go some way towards converting passive into active systems. This is
Medical applications of computers - Signal analysis.
Temperature
Thermometers.
Thermocouples.
Liquid crystals.
Thermography.
Displacement
Strain gauges.
Induction coils.
Ultrasound.
Doppler ultrasound.
Forces.
Pressure
Occlusive cuffs.
Tonometry.
Catheter-tip transducer.
Flow
Electromagnetic flowmeters.
Ultrasound.
Electrochemical forces
Ion-specific.
PH and dissolved gas electrodes.
Light
Photon detectors.
Bioelectric potentials
Electrocardiographs.
Electroencephalographs
Electromyographs
Electrooculographs
Electroretinographs.
Table 1.3
Some forms of energy which provide input signals to computerised medical
equipment.
Medical applications of computers - Imaging.
Classical radiology.
CT scans.
Nuclear medicine. 
Contrast radiology. 
MRI.
Ultrasound. 
Thermography. 
Cytology and histology.
Table 1.4
Examples of imaging system s which may use digital techniques.
Medical applications of computers - Data collection.
Legibility and organisation of clinical records
Standardisation
No omissions
Saving on skilled staff
W idespread availability of information
No loss of information
Ancillary checks
Direct input of data by patient
Convenient document preparation
Medicolegal aspect
Table 1.5
Advantages of computerised data collection.
Medical applications of computers - data collection.
Loss of doctor-patient relationship 
Loss of confidentiality 
Hardware and software breakdown 
Limitations of access 
High cost
Problems of system design 
Conversion of existing records
Table 1.6
Disadvantages of computerised data collection
achieved by providing ’intelligent interaction’ between the pupil and the machine. 
’Active’ education is delivered by a hum an teacher to a single student or a small 
group. On the other hand ’passive’ education is delivered by a teacher presen­
ting a  formal lecture to a  large group of students or by ’inanimate’ media such 
as a  book. ’Interaction’ is the key contribution which a  computer can bring to 
education.
There are two further contributions. Firstly, the facility of the computer 
to hold vast am ounts of indexed information. Therefore, the machine can move 
far more rapidly and effectively between various aspects of a subject. Secondly, 
the facility to provide a simulation of a  physiological or pathological situation, 
and then to modify the model according to the action taken by the student.
CHAPTER 2.
THYROID DYSFUNCTION AND OPHTHALMOPATHY
2.1. INTRODUCTION:
Graves’ disease is defined by McKenzie (1968) as:
"a multisystem disorder of unknown aetiology, characterised by 
one or more of three clinical entities (1) hyperthyroidism 
associated with diffuse hyperplasia of thyroid gland, (2) 
infiltrative ophthalmopathy, and (3) infiltrative dermopathy 
(localised pretibial myxcedema). ”
Not all patients with Graves’ disease exhibit the full spectrum  of mani­
festations. Hyperthyroidism is by far the most common overt manifestation. Pre­
tibial dermopathy is rarely seen in the absence of overt ophthalmopathy. Thyroid 
acropachy, the rarest expression of Graves’ disease, is found only in patients who 
also have thyroid, eye, and skin manifestations of Graves’ disease (Gorman, 
1984).
The fundamental cause of Graves’ disease remains unknown. However, 
there is general agreement that the hyperthyroidism of Graves’ disease is caused 
by a  family of thyroid-stimulating immunoglobulins which are stimulatory anti­
bodies directed toward theTSH receptors (Volpe, 1981). W hat evokes the produc­
tion of antibodies remains an  enigma.
Although m any patients with ’dysthyroid’ eye disease are clinically eu­
thyroid m ost demonstrate subtle disturbance of thyroid regulation or function 
(Werner, 1955). Moreover, hyperthyroidism and thyroid ophthalmopathy com­
monly occur in close succession (Gorman, 1983). These diseases may therefore 
have a  common aetiology, however, the occurrence of one disease in the absence 
of the other is suggestive of either varying tissue susceptibility or a  less direct 
pathogenetic linkage.
Current treatm ent of hyperthyroidism comprises the reduction or elimi­
nation of thyroid bulk or activity by surgery, radioiodine or antithyroid drugs. 
None of these regimes, however, is directed against the presumed pathogenesis 
of autoim m une stimulation (Gorman, 1983).
Synthesis of thyroid hormones:
n  Iodide is trapped by the thyroid giand and oxidised - becom es iodine.
□ One or two molecules of Iodine are incorporated into Tyrosine to form Monoiodotyrosine or Diiodotyrosine. 
a  One molecule each of Monoiodotyrosine and Diiodotyrosine couple to form Triiodothyronine (T3).
or
a  Two molecules of Diiodothyronine couple to form Tetraiodothyronine (Thyroxine or T4). 
a  Thyroxine is then stored a s  part of a  molecule of Thyroglobulin (contained as  colloid in thyroid follicles) until re­
leased by proteolysis.
Table 2.1
THYROGLOBULIN 
IN COLLOID
IODIDE AND TYROSINE T3, T4
VEIN
ARTERY
TISSUECELLS
F igure  2.1
Iodine tra p p e d  by th e  thyro id  is in co rp o ra te d  in to  ty ro s in e  in th y ro g lobu lin  a t 
th e  luminal su r fa c e  of th e  follicu lar cell.
2.2. THYROID PHYSIOLOGY AND REGULATION:
2.2.1. Thyroid physiology:
The thyroid gland concentrates dietaiy iodine which is absorbed 
throughout the intestinal tract. In the gland the iodine is concentrated 30-fold, 
oxidised, and attached to tyrosine molecules on thyroglobulin in the thyroid fol­
licle (Figure 2.1). The coupling of monoiodotyrosine with diiodotyrosine produces 
triiodothyronine (T3) (Table 2.1). When two diiodotyrosine molecules couple, the 
product is tetraiodothyronine (thyroxine; T4) (Figure 2.2). Antithyroid drugs, for 
example methimazole and propylthiouracil, act by inhibiting the oxidation, iodi- 
nation and coupling steps. In addition propylthiouracil acts peripherally to im­
pair T4 to T3 conversion (Brennan and Gorman, 1984).
2.2.2. Thyroid Hormone metabolism:
T3 and T4 in the circulation are almost entirely bound to transport pro­
teins (TBG, TBPA and Albumin), which serve to control the volume of distribu­
tion. TBG has a  high affinity and is the major T4 and T3 binding protein. Despite 
a  m uch larger capacity of albumin for T4 and T3, very low affinity results in little 
T4 and T3 being bound to this protein (Lutz et oL, 1972; Refetoff, 1979).
Protein bound thyroid hormone is functionally inactive, whilst free hor­
mone, which comprises less than  0.1% of the total (Sterling and Brenner, 1966), 
mediates its effect by intra-cellular activity in peripheral tissues (Spaulding and 
Utiger, 1981). Large variations in protein bound thyroid hormone may then  occur 
without change in metabolic status.
In the peripheral tissues, m uch of the T4 secreted by the thyroid is mono- 
deaminated to T3 (Schimmel, 1977), which is the more physiologically active form 
of the hormone. Thyroid hormone effects are brought about, at least in part, by 
binding of T3 to nuclear receptors in a tissue cells. The systemic m anifestations 
of excessive free T4 and free T3 levels are also illustrated in Figure 2.3.
IODINE + TYROSINE
3 MONOIODOTYROSINE ] c 3,5 DIIODOTYROSINE
i
3,5,3 TRIIODOTHYRONINE 3,5,3’,5’ TETRAIODOTH YRON'INE
Figure 2.2
Iodine coupling and synthesis of thyroid hormones
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Effects of Increased production of T4 and T4
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Figure 2.4
Pathways of thyroid gland function regulation
2.2.3. Thyroid giand regulation:
Figure 2.4 summarises the pathways of thyroid gland regulation which 
ostensibly comprise two negative feedback loops which modulate the output of 
the hypothalam us and the pituitary.
2.3. THYROID REGULATION IN DISEASE:
2.3.1. Regulation in Graves’ disease:
In Graves’ disease and other autoimmune thyroid diseases a variety of 
autoantibodies has been identified. They are directed against membrane and col­
loid thyroid antigens (Volpe, 1984). Among these, are a group of autoantibodies 
term ed thyroid-stim ulating immunoglobulins which have in common the 
property of binding to or near the TSH receptors. These immunoglobulins initiate 
a  series of stimulatory steps, otherwise normally set in action by TSH production 
which is tightly regulated by the level of thyroid hormones in the circulation 
(Figure 2.4). In thyrotoxic Graves’ disease, the unregulated continuing produc­
tion of a  potent thyroid stimulator results in inappropriately high levels of T4 and 
T3 in blood and peripheral tissues, causing the consequences delineated in 
Figure 2.3. Serum  TSH levels are usually undetectable because of negative feed­
back by T4 and T3. The normal gland, faced with high serum  concentrations of 
T3, inhibits iodine uptake into the gland completely. By contrast, in  Graves’ dis­
ease the thyroid, acting independently of TSH, continues to trap iodine and to 
release T4 and T3 into the circulation. This principle underlies the T3 suppress­
ion test (Werner and Spooner, 1955).
2.3.2. Lymphocytic thyroiditis:
Both Graves’ disease and lymphocytic thyroiditis are considered autoim­
m une thyroid diseases. The m ain distinction between them  may be the popula­
tion of antibodies directed towards the thyroid. If the family of antibodies 
produced is predominantly stimulatory, hyperthyroidism may result, whereas if 
the antibodies are mainly inhibitory or cytotoxic in type Hashimoto’s lymphocytic 
thyroiditis may result (Davies and De Bernardo, 1983). Some patients have both 
stimulatory and inhibitory antibodies, and the thyroid function may be hypothy­
roid or balanced in the normal range b u t is characteristically nonsuppressible
(Wyse et al, 1968). Such patients may histologically exhibit lymphocytic (Hashi- 
moto’s) thyroiditis, whereas their eye findings are characteristic of Graves’ dis­
ease.
2.3.3. Thyroid-stimulating immunoglobulins:
There is no direct immunoassay for thyroid-stimulating immunoglobu­
lins in blood. Their presence can be inferred from the results of the TRH stim u­
lation test or the T3 suppression test (both of which are not specific) and the 
temporary positive therapeutic effect of plasmapheresis. No direct assay of thy­
roid-stimulating immunoglobulins has yet been developed. Assays which are 
based on the ability of thyroid stimulating immunoglobulins to displace 1 ^ - l a ­
belled TSH from its receptors on thyroid cells (TSH displacement assay), or those 
which assess the am ount of cyclic AMP generated in thyroid cell monolayers of 
thyroid slices when they are exposed to serum  containing thyroid-stimulating 
immunoglobulins (cyclic AMP generation assays) provide indices of thyroid 
stimulating immunoglobulin antibody levels (Brennan and Gorman, 1984).
2.4. DYSTHYROID EYE DISEASE AND THYROID DYSFUNCTION:
About 80% of patients with dysthyroid ophthalmopathy have associated 
hyperthyroidism, 10% have Hashimoto’s thyroiditis or primaiy hypothyroidism 
and the other 10% have no demonstrable thyroid disease. Their ophthalmopathy 
is called euthyroid Graves’ disease or ophthalmic Graves’ disease (Wall, 1984). 
On the other hand, the true prevalence of ophthalmopathy in dysthyroid patients 
is unknown. It depends on the diagnostic criteria when examining the patients 
(Gorman, 1984). Clinically obvious infiltrative ophthalmopathy is seen in 3-5 % 
of the hyperthyroid group (Hamilton, et ol, 1960), but, by careful study, evidence 
of subtle ophthalmopathy has been found in most if not all patients with diffuse 
toxic goitre (Amino, et aL, 1980; Tamai et oL, 1980; Gamblin, et al, 1983).
CHAPTER 3. 
DYSTHYROID EYE DISEASE
Plate 3.1
Clinical manifestations of dysthyroid ophthalmopathy.
(Photograph of a wax model from the historical collection of the Tennent Institute of
Ophthalmology, Glasgow.)
Courtesy Professor W. S. Foulds
3.1. INTRODUCTION:
One of the most enigmatic syndromes in ophthalmology is the variable 
exophthalmos associated with dysthyroid eye disease. Despite m any years of in­
vestigation the pathogenesis of this disorder remains obscure and treatm ent em­
pirical.
Thyroid ophthalmopathy commonly presents as bilateral eye disease 
characterised by signs of conjunctival, episcleral and eyelid inflammation and 
vascular congestion, associated with eyelid retraction, proptosis, and extraocu­
lar muscle dysfunction (Plate 3.1). These features may be present in varying com­
binations and may change during the course of the disease. Remissions and 
exacerbations characterise the disease process. Such signs, when coupled with 
abnormalities of thyroid function or regulation, leave little question concerning 
the clinical diagnosis. Not all patients present with the full constellation of symp­
toms and signs. The eye signs may be subtle or unilateral, or may present with­
out a clearly demonstrable abnormality of thyroid function. Furthermore, a  
num ber of vascular, inflammatory, and neoplastic disorders may closely mimic 
dysthyroid eye disease (Hay, 1984).
Although no single eye finding is pathognomonic, certain patterns can 
be considered diagnostic of Graves’ disease and ostensibly exclude other disor­
ders in the differential diagnosis.
3.2. HISTORY:
Table 3.1 provides a brief historical review of dysthyroid eye disease. The 
association of eye disease and goitre has been recognised since the twelfth cen­
tury (Parry, 1825). In the 1780s a  physician from Bath, Dr. Caleb Parry, recorded 
a comprehensive description of exophthalmos associated with goitre. The work 
of Parry, Robert Graves (1835) and Carl von Basedow (1840, 1848) provides the 
focus on the triad of hyperthyroidism, diffuse nodular goiter, and ophthalmo­
pathy.
Graves’ name is predominantly associated with the syndrome, and has 
been generally accepted throughout the English-speaking world. The condition 
is frequently termed Basedow’s disease in German literature. Parry’s observa-
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HISTORY
AUTHORS yeAr CONTRIBUTION
Flajani 1802 Described three cases of goitre and cardiac palpitation 
without assodating the two in a symptom complex.
Parry 1825 Gave a detailed clinical description of 13 cases of goitre 
associated with tachycardia, in one of which, seen in 
1786, protrusion of the eyes was described.
Graves 1835 Described a case of an enlargement of the thyroid, 
palpitation and protrusion of the eyes.
Basedow 1840-1848 Wrote two notable papers describing exophthalmos as 
due to hypertrophy of the orbital tissues caused by 
disordered circulation. Discussed exophthalmos, goitre, 
and tachycardia.
Cooper 1849 Gave a detailed clinical account describing the staring 
appearance and associating it with exophthalmos, 
goitre, palpitation and anaemia.
Neumann; Warner; Bristowe 1853;1883; 1886 Were first to remark that extraocular muscle paresis is 
an early and prominent feature in patients with normal 
or subnormal thyroid activity.
Rehn;Moebius 1884;1887 Were the first to point out to hyperthyroid as an 
essential cause of the exophthalmos.
Moebius 1891 Reported weakness of skeletal as well as extraocular 
muscles in patients with hyperthyroidism.
Zimmermann 1929 Recognised a group of patients with hypo- or 
euthyroidism associated with exophthalmos.
Rosenbaum; Ruedemann 1937;1937 Introduced the term "malignant exophthalmos" for the 
group of patients with exophthalmos associated with 
hypo-or euthyroidism.
Burch; Thomas and Woods; 
Naffziger
1929;1936;1938 Showed the enormous hypertrophy of extraocular 
muscles seen during orbital decompression for 
dysthyroid eye disease.
Rundle and Pochin 1944 Considered that all aspects of dysthyroid eye disease 
varied only in degree following a definitive cycle 
depending on pituitary activity and more of less 
independent of thyroid function.
Leob and Friedman; Smelser 1932;1936 Found that pituitary extracts, particularly that containing 
the TSH fraction produced exophthalmos in 
experimental animals.
Means 1945 Classified Graves’ disease into three main types. 
Thyrotoxicosis with ophthalmopathy, without 
ophthalmopathy and a "hyperophthalmopathic" type 
associated with hyper-, normal, or hypothyroid function.
Jefferies; Dobyns and Steelman 1949;1953 Isolated the "exophthalmos-producing substance" (EPS) 
from extracts of the anterior pituitary.
Adams and Purves; McKenzie 1956;1960 Identified the association of exophthalmos with the 
"long-acting thyroid stimulator* (LATS) in the sera of 
thyroid eye disease patients who have undergone 
pituitary ablation.
Lemarchand-Buraud et al. 1967 Showed that TSH in plasma, estimated by 
radio-immuno-assay, is not increased in dysthyroid 
exophthalmos but is usually decreased.
Table 3.1
Summary of historical review
tions had been published posthumously by his son and von Basedow’s were pub­
lished a few years after those of Graves.
The first observers to suggest hyperthyroidism as an  essential cause of 
the exophthalmos were Rehn (1884) and Moebius (1887).
Since the time of these early writings, exophthalmos has been generally 
accepted as a  significant feature of diffuse toxic goitre. However, for many years 
the incomplete association between the two conditions has been recognised. A 
group of cases called ’paradoxical exophthalmos’ by Zimmerman (1929), in which 
the exophthalmos tends to be more pronounced and intractable than  the rela­
tively mild displacement which is characteristic of thyrotoxicosis, were not asso­
ciated with thyrotoxicosis. This justified the introduction of the term ’malignant 
exophthalmos’ (Rosenbaum, 1937; Ruedemann, 1937). The phenomenon of 
extraocular muscle paresis was documented by Moebius (1891) as being u n ­
usual. Exophthalmic ophthalmoplegia was reported first by Nuemann (1853) and 
later by W arner (1883) and Bristowe (1886) as an  early and prominent symptom 
of Graves’ disease. Burch (1929), Thomas and Woods (1936), and Nafiziger (1933) 
demonstrated both pathologically and neurosurgically' the enormous hyper­
trophy of extraocular muscles.
Rundle and Pochin (1944) and Means (1945) divided Graves’ disease into 
three m ain types. Thyrotoxicosis with ophthalmopathy, without ophthalmopathy 
and a "hyperophthalmopathic" type. The differences in the clinical picture and 
in pathology suggested to others tha t there are two main divisions representing 
two separate clinical entities. The first type has been termed ’thyrotoxic’ (Brain, 
1943), ’dysthyroid non-congestive’ (Chandler, 1950) or ’non-progressive exoph­
thalmos’ (Cordes, 1954) and the second ’thyrotropic’ (Brain, 1943), ’dysthyroid 
congestive’ (Chandler, 1950) or ’progressive exophthalmos (Cordes, 1954).
This diversity of nomenclature, which is partly due to ignorance of the 
aetiology of the condition, remained until the past decade when the concept of 
hyperthyroidism being an  autoimmune response was proposed (Section 3.4.1).
The control of the secretion of the thyroid gland by the anterior lobe of 
the pituitary gland and the negative feedback mechanism were discovered early
in the 20th century. The theory tha t Graves’ disease is caused by oversecretion 
of thyroid stimulating (thyrotropic) hormone (TSH) was immediately suggested 
(Leob and Friedman, 1932). This theory became more appealing after it has been 
found th a t pituitary extracts produced exophthalmos in experimental animals 
(Smelser, 1936). The isolation o f’exophthalmos producing substance (EPS)’ fur­
ther drew attention to the pituitary (Jefferies, 1949; Dobyns and Steelman, 1953). 
Some investigators found good correlation between exophthalmos and EPS while 
others did not. Moreover, in 1967 it was shown that TSH in plasma, estimated 
by radio-immuno-assay, is not increased in dysthyroid exophthalmos and is 
usually decreased (Lemarchand-Beraud, Vannotti and Scazziga, 1967).
Adams and Purves (1956) and Adam (1958) were able to show an asso­
ciation between exophthalmos and a  protein found in the sera of dysthyroid eye 
disease patients who had undergone pituitary ablation. This led to the identifi­
cation of a  Long-Acting Thyroid Stimulator (LATS) (McKenzie, 1960) which was 
subsequently found to be an immunoglobulin (Kriss, Pleshakovand Chien, 1964) .
3.3. PATHOLOGY:
3.3.1. Introduction:
The pathological changes which occur in Graves’ disease may be wide­
spread, and the changes that occur within the orbit are merely part of a  gener­
alised pathological process that also affects the thyroid, thymus, heart, skeletal 
m uscles and subcutaneous tissues. Within these structures pathological 
changes are similar with respect to cellular infiltrate and oedema b u t differ in de­
gree from patient to patient. These changes have been reviewed by Kroll and Ku- 
wabara (1966), Riley (1972) and Campbell (1984).
3.3.2. Nature of orbital changes:
Authors have debated over the years and presented conflicting evidence 
as to the precise nature of the increased volume of tissue within the orbit above 
its average volume of 26 ml.
Von Basedow (1840) described w hat he called "hypertrophy of the orbi­
tal tissue," especially orbital fat. Many others have also emphasised the increased
am ount of fibrofatty tissue. Smelser (1937) considered both water and fat to be 
responsible for the increased am ount of retrobulbar tissue in experimental ani­
mals. An increase in the fat content of the orbit was demonstrated in the animals 
treated with thyrotropic hormone. Other authors emphasised the muscle changes 
and reported enlargement up to 8 or 10 times normal (Naffziger, 1933; Bouzas, 
1980), computed tomography scanning and pathology (Deicker, 1979; Trokel and 
Jakobiec, 1981), and ultrasound (Werner, Coleman and Franzen, 1974; Hodes 
and Shoch, 1979) studies have shown that the extraocular muscles primarily 
contribute to the proptosis and are the primary focus of the disease process.
Rundle and Pochin (1944) performed quantitative analysis studies of the 
orbital contents of 17 autopsy cases with thyrotoxicosis, with and without eye 
signs, and found an  increase in the am ount of "muscle fat". The contents of fat 
within the muscles was more than  double that of tissues in control subjects. This 
increase in fat was found to be proportional to the volumes of the muscles; tha t 
is, the levator palpebrae supeiioris muscle showed the greatest increase in  fat, 
and the medial rectus muscle showed the least. In a  normal control patient, fat 
formed approximately half the total weight of the tissue. This finding suggests an 
abnormal deposition of fat because the fat content of muscle is not increased in 
obesity.
In dysthyroid eye disease the orbital contents appear to the surgeon as 
glistening and cedematous. The muscles are tan  in colour and firm or rubbery in 
consistency. The microscopic picture of the tissues is a  combination of oedema, 
accumulation of mucin, cellular infiltration, and fibrosis of various degrees. These 
changes are seen predominantly within the extraocular muscles and the lacri­
mal gland. They are present to a  lesser degree in the fibrofatty tissues.
In the normal person, the eye fills 30% of the orbital volume with the re­
mainder of the orbital contents occupied by retrobulbar and peribulbar struc­
tures and is composed chiefly of muscles, fat, nerves, and vessels. The vessels 
include arterial and venous channels as well as lymphatics. The eye is an  exten­
sion of the central nervous system and is without lymphatics, b u t it is import­
ant to recognise that lymphatic channels are present within the fat and muscle 
of orbital tissue (Rusznyak, Foldi and Szabo, 1967). Because fibrofatty tissue 
elsewhere in the body contains lymphatic channels, there is no reason to pres­
ume that the fibrofatty tissue within the orbit should differ. The popular miscon­
ception that lymphatic channels do not exist within the orbit was encouraged in 
part by the experiments of Patek and Bemicks (1960), who failed to demonstrate 
the channels. Other investigators have ligated the lymphatic ducts within the 
necks of dogs and cats as well as the subm andibular and deep cervical lymph 
glands. At autopsy they demonstrated both grossly and microscopically, the 
presence of oedema of the superficial and deep orbital fascia, fibrofatty tissue, 
extraocular muscles, and lacrimal gland. Some of the animals had exophthalmos 
due to orbital oedema (Foldi et aL, 1963). Kozma and Gellert (1958) were able to 
demonstrate experimentally the presence of lymphatic pathways within the 
extraocular muscles. The fact that lymphangiomas occur in the orbit also sup­
ports the concept that lymphatic channels are present within th a t site (Jones, 
1961). Thus a  body of evidence supports the presence of orbital lymphatic chan­
nels hence providing a  pathway for the development of orbital oedema and the 
infiltration of mononuclear cells in Graves’ disease.
3.3.3. Pathological tissue changes:
Five pathological changes within the orbital tissue have been described 
by Wybar (1957): Increase in fat content, increase in m ucin content, increase in 
water content, fibrosis, and lymphocytic infiltration. The extent to which any or 
all of these factors contribute to the production of exophthalmos has been de­
bated over the years, b u t many studies have shown that extraocular muscles are 
predominantly affected. The seven extraocular muscles are not equally affected 
by the pathological process, although all of the muscles show histopathological 
changes to some degree. These changes are most marked in the inferior and me­
dial rectus muscles. In specimens obtained during decompression procedures, 
the inferior rectus muscle shows the earliest exudate and the earliest fibroblas­
tic proliferation.
In Graves’ disease the interstitium  of the extraocular muscles shows an  
infiltration with mononuclear cells and fibroblasts with an  admixture of oedema 
fluid and an  accumulation of mucin. These changes are present in the endomy- 
sium  and perimysium and to a  lesser extent in the epimysium. The fibrofatty 
tissue th a t surrounds the muscle is involved to a  lesser extent, and the tendon 
is not involved a t all.
The cellular infiltrate is composed predominantly of m ature lymphocytes 
with some plasma cells and a few macrophages. The histological picture depends 
on the stage of the disease. In the early stages the cellular infiltrate is scanty and 
is both focal and diffuse within the endomysium. Mast cells may be present but 
are few in number; they are found in a  perivascular distribution. As the lympho­
cytes and plasma cells increase in number, the fibroblasts in the interstitium  en­
large and proliferate, and in so doing produce collagen and mucopolysaccharide 
material. Ludwig, Boas and Soffer (1950), linked the orbital changes to those of 
localised myxoedema occurring in the skin and demonstrated an  increased 
am ount of hexosamine content in the orbits of guinea pigs treated with thyroid 
stimulating hormone. In hum ans the localised myxoedema of Graves’ disease con­
tains 16 times the normal skin concentration of acid mucopolysaccharides. Ac­
cumulation of glycosaminoglycans is a  characteristic feature of orbital tissue in 
hum ans and most experimental animals with exophthalmos. Normal hum an 
retrobulbar connective tissue contains hexosamine in the glycoprotein fraction, 
with one third in the glycosaminoglycan fraction. These substances were former­
ly considered to be produced by m ast cells, bu t morphological and experimental 
evidence shows that they are the product of fibroblasts (Tengroth, 1964; Sisson, 
1968). Fibroblasts are stimulated to proliferate and to secrete hyaluronic acid by 
lymphocytes and lymphocytic products. Sisson (1977) demonstrated the en­
hanced synthesis of hyaluronic acid by the retrobulbar fibroblasts in response 
to exposure to lymphocytes and their products. Cell cultures of hum an fibro­
blasts also show secretion of hyaluronic acid after exposure to lymphocytes and 
lymphocytic products. The increased mucin content of the tissues causes in­
creased water-holding property and hence oedema.
As fibroblasts proliferate within the perimysium, bundles of fibers are 
compressed and atrophy. Fibrous strands within the epimysium may extend into 
the adjacent sector of the orbital fat. This orbital scarring characterises end stage 
disease and is associated with severe muscle atrophy and loss of function (Camp­
bell, 1984).
The histological changes described above are also observed within the 
connective tissue of the lacrimal gland. Fibrosis occurs to a lesser degree than  
in the extraocular muscles and results in only a  mild atrophy of the glandular 
elements (Wybar, 1957; Campbell, 1984).
3.3.4. Pathological changes of the globe:
The pathological changes that may afflict the globe are secondary and 
are not specific to Graves’ disease. The two important complications are keratitis 
and disc oedema. The keratitis is caused by exposure and is secondary to prop­
tosis and inadequate protection of the cornea by the eyelids. The tear film quick­
ly evaporates, the cornea dries, and in the most severe cases of proptosis the 
comeal epithelium changes from the normal five-layered epithelium to one which 
is keratinised, stratified, and squamous. Ulceration may occur. Inflammatory 
cells are present within the comeal stroma and may be acute or chronic. New 
vessels may grow into the comeal stroma from the limbal area. According to 
Ogura, Wessler and Avioli (1971), if the patient is not treated, panophthalmitis 
may occur in about 1-2 % of patients, and orbital cellulitis may result.
Disc oedema may result from compression of the vessels to and within 
the optic nerve. On histological examination the disc head varies in its degree of 
swelling and shows separation of nerve fibres by oedema fluid. Subretinal fluid 
may accumulate and is first seen adjacent to the optic disc. The histopathologi- 
cal appearance of the optic disc in Graves’ disease is identical to that of pa- 
pilloedema produced by other causes (Hayreh, 1977; Campbell, 1984).
3.4. PATHOGENESIS:
3.4.1. Autoimmunity and Graves’ ophthalmopathy:
Much of the research into the pathogenesis of Graves’ ophthalmopathy 
has focused on its association with hyperthyroidism and the possible role of long- 
acting thyroid stimulator (IATS) (Mckenzie, 1965; Kriss et oL, 1967; Lipman 
etaL, 1967; 1968; Mckenzie and McCullagh, 1968). LATS is an immunoglobulin 
G (IgG) of lymphoid origin which acts like an  antibody directed against some com­
ponents of the thyroid cell plasma membrane receptors for thyroid-stimulating 
hormone (TSH). There is no direct evidence for an  effect of thyroid hormones or 
TSH on orbital tissues in Graves’ ophthalmopathy.
Present evidence suggests that in Graves’ ophthalmopathy autoim m une 
responses are directed against orbital tissue antigens and do not cross-react with
thyroid antigens. Clinical studies suggest that all patients with ophthalmopathy 
have some abnormality of eye muscles, whereas not all patients with ophthalmo­
pathy have evidence of thyroid disease. It is not possible a t the present time to 
be certain whether Graves’ ophthalmopathy is an  integral part of Graves’ disease 
or a separate entity (Kendall-Taylor, Atkinson and Holcombe, 1984).
The eye changes of Graves’ disease have been classified by the American 
Thyroid Association (Section 3.5.2) according to the severity of the changes and 
the extent of the orbital tissue involvement. There are two main subdivisions: (a) 
mild ophthalmopathy (lid lag and stare), thought to be due to increased sensitiv­
ity of the sympathetic nervous system to catecholamines and attributed to hyper­
thyroidism per se; and (b) severe ophthalmopathy, a distinct autoimmune 
disorder.
Currently, the diagnosis of Graves’ ophthalmopathy is mainly clinical 
and in difficult cases the diagnosis can be helped by advanced imaging tech­
niques. In their well controlled studies, Zappia, Winkelman and Gay (1971) and 
Gamblin et aL (1983), using raised intraocular pressure on upward gaze as a  par­
ameter for eye muscle involvement showed that most patients with Graves’ dis­
ease have eye muscle disease, and almost all patients with ophthalmopathy have 
eye muscle involvement. Patients with Hashimoto’s thyroiditis also showed a  high 
prevalence of extraocular muscle involvement (Gamblin etoL, 1985). Although 
these findings certainly suggest a close relationship between ophthalmopathy 
and Graves’ disease, they also can be interpreted as providing strong evidence 
tha t Graves’ hyperthyroidism, Hashimoto’s thyroiditis and ophthalmopathy are 
three separate autoimmune disorders. Clearly the controversy concerning the re­
lationship between ophthalmopathy and thyroid disorders will not be resolved 
for sometime, particularly as the param eters for ophthalmopathy are not well es­
tablished. Thus one needs not only a  very sensitive and specific clinical test for 
eye muscle disease, bu t also specific biochemical test to confirm the diagnosis 
(Donaldson, Bagshaw and Kriss, 1973).
Wall (1984) has reviewed the theories concerning the pathogenesis of 
Graves’ ophthalmopathy in relation to the recently identified eye muscle auto­
antigens and their corresponding circulating antibodies. He concluded th a t al­
though it is becoming clear tha t Graves’ ophthalmopathy is an organ-specific 
autoim m une disorder with target autoantigen and corresponding circulating
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Abridged classification of eye changes in Graves* disease:
C la ss Definition
0 No physical signs or symptoms
1 Only signs, no symptoms (signs limited to upper
Lid retraction, stare and lid lag)
2 Soft tissue involvement (symptoms and signs)
3 Proptosis
4 Extraocular muscle movement
5 Corneal involvement
6 Sight loss (optic nerve involvement)
Table 3.2
From Warner (1969)
antibodies, more work is necessary to clarify the nature of the antigens and the 
clinical and pathogenetic significance of the antibodies. Moreover, the likelihood 
that orbital tissue damage is mediated by T or K cell reactions needs to be stu ­
died. The m echanism for the association with thyroid disease is still unexplained. 
Research is currently being directed towards the identification of cross reacting 
antibodies and whether they demonstrate cytotoxicity or stimulatory activity.
3.5. CLINICAL PRESENTATIONS:
3.5.1. Introduction:
In this section the current classifications of orbital changes of dysthyroid 
eye disease are considered and the wide variety of eye and orbital signs which 
may be seen in  this disorder is described. The principles underlying the formu­
lation of a  clinical diagnosis and the ophthalmic diseases which may be confused 
with dysthyroid eye disease are also reviewed.
3.5.2. Classification of orbital changes:
The formal classification of the eye changes of Graves’ disease was de­
vised in 1969 by a special committee of the American Thyroid Association. The 
classification was initially presented in both an abridged and a detailed form. The 
abridged form sum m arises the six classes which had been devised, the first let­
ter of the definition of each class constituting the acronym NO SPECS (Table 3.2). 
The detailed classification (Table 3.3) provides specific criteria for grading the 
signs within each class and identifies the activity of the orbital process as "ac­
tive, static, or inactive" (Werner, 1969).
In 1977, the Committee of the American Thyroid Association, published 
several modifications of the original classification (Werner, 1977). As before, the 
classification had  two forms: The abridged and the detailed. Although the orig­
inal six classes were retained, changes were made in the criteria for class I and 
III. It was emphasised that progression of disease need not be sequential between 
each of the classes. Also, it was noted that the am ount of myopia and racial dif­
ferences should influence the measured normal upper limit of proptosis.
Detailed classification of eye changes of Graves’ disease:
G rade S ug gestion  for grading
C lass  0 No physical signs or symptoms
C lass  1 Only signs (signs limited to upper lid retraction,
stare with or without lid lag and proptosis). 
Proptosis associated with C lass 1 only (specify 
difference of 3mm or more between eyes; or 
progression under observation of 3mm or more, 
Grade 0 included)
0 Absent (2 mm or less - normal)
a  Minimal (21 - 23 mm)
b Moderate (24 - 27 mm)
c Marked (28 mm or more)
C lass  2  Soft tissue involvement (symptoms of excessive
lacrimation, sandy sensation, retrobulbar 
discomfort and photophobia, but not diplopia; 
objective signs a s  follows:
0 Absent
a Minimal (oedema of conjunctivae and lids,
conjunctival injection, and fullness of lids, often 
with orbital fat extrusion, palpable lacrimal 
glands, or swollen extraocular muscle palpable 
laterally beneath lower lids)
b  Moderate (Above plus chemosis,
lagophthalmos, lid fullness)
c  Marked
C lass  3 Proptosis associated with C lasses 2-6 only
(specify if inequality of 3mm or more between 
eyes, of if progression of 3mm or more under 
observation)
0 Absent (20 mm or less)
a  Minimal (21 - 23 mm)
b . Moderate (24 - 27 mm)
c  Marked (28 mm or more)
C lass  4 Extrocular muscle involvement (usually with
diplopia)
0 Absent
a  Minimal (limitation of motion evident a t extreme
gaze in one or more directions)
b Moderate (evident restriction of motion without
fixation of position)
c  Marked (fixation of position of a  globe or globes)
C la ss  5 Corneal involvement (primarily due to
lagophthalmos)
■5
0 Absent
a  Minimal (stippling of cornea)
b Moderate (ulceration)
c  Marked (clouding, necrosis, perforation)
C la ss  6 Sight loss (dure to optic nerve involvement)
0 Absent
a  Minimal (disc pallor or choking, or visual field
defect; vision 20/20-20/60)
b Moderate (disc pallor or choking or visual field
defect; vision 20/70-20/200)
c  Marked (blindness, i.e., failure to perceive light;
vision less than 20/200)
Table 3.3
Werner (1969)
Van Dyk (1981) suggested a  further modification to the American Thy­
roid Association classification which, he hoped, would permit "greater clinical 
specificity" in the description of patients with dysthyroid eye disease. He advised 
the return  of criteria for grading patients in class II soft tissue involvement and 
argued that symptoms be excluded from the definition. His proposed modifica­
tion to the detailed classification of class n  orbital changes comprised six soft 
tissue signs, the first letter of each forming the acronym RELIEF (Section 3.5.4.).
Resistance to retrodisplacement of eye
CEdema of conjunctiva/caruncle
Lacrimal gland enlargement
Injection of conjunctiva, focal or diffuse
CEdema of the eyelids
Fullness of the eyelids
Feldon and Unsold (1982) described a simple classification of Graves’ 
ophthalmopathy based entirely on evaluation of seven clinical signs: Proptosis, 
lid retraction, lid lag, horizontal oculomotor dysfunction, optic nerve involvement, 
and periorbital oedema. These signs were judged as mild, moderate, or severe 
based on "strict semi-quantitative clinical criteria", and the patients in their 
studies were said to be "categorised easily" into three classes on the bases of over­
all clinical severity of disease.
The ophthalmopathy index suggested by Donaldson et oL (1973) is cal­
culated by adding total points for each of four ocular signs: proptosis, motility 
restriction, keratitis and soft-tissue swelling and injection (Table 3.4).
The Werner classification of the American Thyroid Association falls short 
of clinical usefulness in ophthalmic practice. It is complicated and does not rep-
Method for calculating the ophthalmopathy index:
C lass Involvem ent category
2 Soft tissue
3 Proptosist
4 Extraocular muscle
5 Cornea
6 Sight loss
Minimal = 1
Moderate = 2
Marked = 3
t  For proptosis, Hertel exophthalmometer readings were scored as follows:
minimal (20-23mm) = 1
moderate (>23-27mm) = 2
marked (<27mm) = 3
Table 3.4
Adapted from Donaldson et al. (1973)
resent a  progressive continuum  form the class 0 to class 6. The ophthalmopathy 
index suggested by Donaldson et oL (1973) proved to be useful for classifying pa­
tients with optic neuropathy and forms the basis of patient evaluation in several 
recent studies (Grauthoff, Wuttke and Frommhold, 1980; Pinchera et oL 1984; 
Glinoer etoL, 1986).
3.5.3. Involvement of the eyelids:
In class I of the American Thyroid Association classification, patients with 
Graves’ ophthalmopathy have eye signs limited to upper lid retraction, stare, and 
lid lag. These signs, although considered little more than  a  cosmetic blemish by 
W erner (1978) may provide a major source of concern and anxiety to the affected 
patient. In class I involvement the patient has a characteristic ’startled’ or ’star­
ing’ appearance because the upper Qrelid on one or both sides is elevated, there­
by exposing the superior corneoscleral limbus. When the eyes pursue a  slowly 
downward-moving target, the lid lags behind. The presence of both lid retraction 
and lid lag, even when subtle, is considered highly suggestive of Graves’ ophthal­
mopathy, b u t is by no means pathognomonic. Retraction of the upper lids has 
been described as the most characteristic ocular sign of Graves’ disease (Day, 
1978), and is said to occur in a t least 50% of cases with ophthalmopathy.
For years, excessive sympathetic nervous system activity was uncritically 
accepted as the m echanism responsible for lid retraction in Graves’ disease. Re­
traction was attributed principally to overstimulation of Muller’s muscle. Evi­
dence for sym pathetic overactivity was inferred from the knowledge that 
propranolol, when used systemically, could produce a ptotic effect on the upper 
lid, and that the topical administration of postganglionic blocker guanethidine 
resulted in a  significant lowering of the retracted eyelid in the majority of thyro­
toxic patients with eyelid retraction (Hodes, Frazee and Szmyd, 1979).
However, recently it has been clinically observed tha t there are many in­
stances of eyelid retraction for which the sympathetic overactivity theory is an 
inadequate explanation. These include: (a) the retraction is not abolished by cer­
vical sympathectomy; (b) many retracted eyelids fail to drop to normal with guane­
thidine; (c) eyelid retraction may be present in the euthyroid or hyporthyroid 
patients; and tha t the retraction persists with sleep, general anaethesia, and 
retrobulbar anaethesia (Hay, 1984). The fact that unilateral lid retraction is so
common makes sympathetic overactivity extremely unlikely. Also, if the lashes 
or lid margin are grasped and an  attem pt is made to draw the retracted lid down­
ward, resistance is often encountered, another observation suggesting a  mech­
anical restriction of the levator muscle rather than  excess sympathetic tone.
On the bases of the results of high-resolution ultrasonic (Shammas, 
Minckler, and Ogden, 1980) and computed tomographic scans (Trokel and Jako- 
biec, 1981) of the orbit, it is being increasingly recognised that dysthyroid eye 
disease is a diffuse process resulting in a panmyositis affecting all muscles of the 
orbit. From these findings it can be inferred that the same process of inflamma­
tion, thickening, and ultimate fibrosis which affects the recti and oblique m us­
cles in class IV, involves also the levator and Muller’s muscle in the upper eyelid. 
This causes restricted movement and contracture which result in a pharmaco­
logically irreversible elevation of the upper eyelid (Hodes etaL, 1979). Such a 
mechanism would provide a more acceptable explanation than  sympathetic over­
activity for the fairly frequent finding of eyelid retraction in those euthyroid pa­
tients who present with no thyrotoxic history or those who develop eye signs many 
years after successful ablation therapy for hyperthyroidism.
3.5.4. Soft tissue involvement:
Classes II-VI of the American Thyroid Association classification represent 
the severe eye changes with a potentially serious prognosis, formerly called ’in­
filtrative’, ’progressive’ or ’malignant’ (Werner, 1969). Patients who fall within this 
overall category, are characterised by consistent enlargement of the extraocular 
muscles, resulting in an  increase in orbital contents, and an  increase in orbital 
pressure.
The oedema resulting from the swollen extraocular muscles and their in­
creased water-holding property due to the higher concentration of glycoseami- 
noglycans (Section 3.3.3), coupled with the increased orbital pressure, probably 
causes a slowing down of removal of the fluid in the interstitial space. Venous 
stasis, resulting from compression of apical veins by enlarged muscles, also prob­
ably contributes to this process (Trokel and Jakobiec, 1981).
Class II symptoms were described as excessive lacrimation, a  ’sandy’ sen­
sation, retrobulbar discomfort, and photophobia. Relevant signs include oedema
of the conjunctiva and lids, conjunctival injection, fullness of the eyelids often 
with orbital fat extrusion, palpable lacrimal glands, and swollen extraocular m us­
cles palpable laterally beneath the lower lid. In Van Dyk’s opinion, the inclusion 
of symptoms in  class n  was a  mistake (van Dyk, 1981). In his proposed modifi­
cation (Section 3.5.2), criteria for inclusion were limited to six signs remembered 
by the acronym RELIEF. These are described in detail below:
Resistance to retrodisplacement of the eyes into the orbit results because 
the orbit is infiltrated and oedematous. In contrast to the normal orbit, which 
allows about 5 millimeters of backward displacement of the eye, the orbit involved 
by Graves’ disease process provides variable resistance to retrodisplacement of 
the globe.
CEdema of the conjunctiva and the caruncle, may be represented only by 
a new fold of redundant conjunctiva hanging over the mucocutaneous junction 
of the lower lid. However, with more marked involvement, there may be frank 
prolapse of the conjunctiva across the lower lid, a  prolapse in which the caruncle 
usually participates.
Lacrimal gland enlargement may rarely be palpable, bu t more often is 
seen as a contrast-enhancing supero-lateral m ass on orbital CT scan. Infiltra­
tion of the gland causes enlargement, which is made more prominent by the 
gland’s involvement in the generalised anterior movement of the orbital struc­
tures.
Injection of the conjunctiva may occur in the presence or absence of che- 
mosis. When conjunctival oedema is minimal, an intense focal hyperaemia may 
be seen outlining and overlying the swollen horizontal rectus muscles, sometimes 
extending anterior to the insertion of the tendon towards the limbus. When gross 
chemosis is present the conjunctivae are diffusely hyperaemic and the presence 
at the lateral canthus of large, tortuous, purplish vascular loops with overlying 
chemosis is considered highly characteristic of dysthyroid ophthalmopathy (Gor­
man, 1978).
CEdema and Fullness of lids may occur separately, bu t sometimes the 
signs are not precisely separable. It is probable that eyelid fullness is caused by
oedema, infiltration or fat extrusion behind the orbital septum, whereas lid 
oedema reflects fluid anterior to the septum, ju s t under the skin and orbicularis 
muscle (Van Dyk, 1981).
3.5.5. Proptosis:
In Graves’ disease swelling, infiltration, and later fibrosis and eventual 
muscle contracture within the unyielding confines of the bony orbit tend to push 
the eye forward (Gorman, 1983).
In the 1977 modification of American Thyroid Association classification, 
patients with exophthalmometiy reading up to 22 mm (2 mm above Caucasian 
normal) were placed in class I; those with readings in excess of 22 mm, even with­
out symptoms, were placed in class in. It was recognised tha t for Japanese and 
black Americans the upper normal values for exophthalmometry reading were, 
respectively, 18 and 22 mm. Because of these ethnic variations in the proptosis 
baseline, the grading (a, b, or c) for class ID has been changed from being based 
on the actual millimeters of forward protrusion of the eye to a grade based on the 
extent to which the proptosis reading exceeds normal (Werner, 1969; 1977).
It has been estimated that about 20 - 25% of patients with Graves’ dis­
ease develop proptosis. Eye findings are typically bilateral, although the severity 
of involvement may differ significantly between the two eyes (Duke-Elder and 
MacFaul, 1974; De Santo, 1980). Occasionally patients present with unilateral 
signs and symptoms. However, in Graves’ disease an  asymmetry in exophthal­
mos rarely exceeds 6 mm (Hall et oL, 1970).
Graves’ ophthalmopathy can account for 15-28% of all cases of unilat­
eral exophthalmos (Gorman, 1978). In spite of what may seem to be a unilateral 
process, pathological involvement of the intraorbital contents does occur bilat­
erally, and this can be confirmed by ultrasonography or computed tomography 
(Sections 3.4.1 and 3.5.3). It is this bilateral involvement that provides an  im­
portant clinical clue for differentiating apparent unilateral Graves’ ophthalmo­
pathy from an  orbital m ass lesion.
3.5.6. Extraocular muscle involvement:
Based on a study in which over 200 orbits of patients of Graves’s disease 
were scanned by high-resolution CT, Trokel and Jakobiec (1981) concluded that 
the extraocular muscles comprised the most consistently involved focus of dis­
ease in Graves’ orbitopathy, an  observation which has been substantiated by his- 
topathological evaluation of both biopsy and autopsy tissue.
Clinically and radiologically, the range of abnormality varies from mini­
mal enlargement of a few muscles in patients with class I disease to enormous 
enlargement of multiple muscles in class IV disease. In the initial stages of dis­
ease the enlarged muscles m aintain the ability to contract and relax, bu t later 
they become fibrotic and are unable to relax. These fibrotic extraocular muscles 
restrict mobility by a ’tethering’ action and give rise to an  apparent underaction 
of the antagonist muscle. In severe and massive involvement of muscles, the 
ability to contract may be lost and the resultant restriction in motion may event­
ually result in class IVc changes with fixation of the position of the globe (Trokel 
and Jakobiec, 1981).
Patients with clinically significant extraocular muscle involvement 
usually complain of interm ittent or slowly progressive vertical or oblique diplo­
pia. Occasionally, especially during acutely active inflammatory phases, they may 
complain of a  mild painful ’pulling’ sensation on attempted upgaze. As inflam­
mation subsides, the ophthalmoplegia is usually not accompanied by pain, ex­
cept perhaps for a  foreign body sensation. Proptosis a t this stage is variable, and 
minimal am ounts of proptosis (class II) may coexist with marked limitation of 
ocular motility. A middle-aged patient presenting with diplopia of gradual onset 
or double vision on waking, which gradually becomes controlled after a  period of 
m inutes bu t then returns again during the day if the patient becomes tired, or 
sometimes following a  single alcohol drink, is typical of dysthyroid ophthalmo­
pathy (Fells et aL, 1988).
The four recti muscles are particularly involved in the restrictive process. 
Clinical involvement is most common in the inferior rectus (60-70%), less fre­
quent in the medial rectus (25%), and uncommon (10%) in the superior rectus. 
The lateral recti are seldom involved (Dyer, 1976). Quantification of extraocular
muscle enlargement by CT scanning has recently allowed the demonstration of 
a regular increase in total muscle volume with increasing ophthalmopathy. Al­
though in a  study of 8 patients with variably severe Graves’ ophthalmopathy in­
ferior rectus enlargement was apparent in all patients; only medial and lateral 
rectus muscle volumes increased in proportion to the severity of the clinical dis­
ease. Feldon and Weiner (1982) found a linear relationship between worsening 
ophthalmopathy (judged by multiple clinical signs) and both horizontal and total 
extraocular muscle volumes.
It is generally agreed tha t inferior extraocular muscles suffer more severe 
involvement than  the others. Hodes et oL (1979) suggested three possible expla­
nations for the observed inferior muscle dominance in the restrictive process. 
First, they suggested that because twice as many muscles, with far more com­
plex actions, are involved in vertical eye movements than  in horizontal eye move­
m ents, one might anticipate, based on num bers alone, a  predominance of vertical 
muscle symptomatology. Second, unlike the horizontal muscles, the vertical 
muscles are paired and cross one another in the orbit. The inferior crossing is 
possibly more prone to reactive adhesions because unlike the superior crossing 
which occurs between a  muscle and a  tendon, the inferior one occurs between 
two muscles with a consequent large area of surface contact. Finally, they pointed 
out th a t horizontal fusional versions are considerably greater than  vertical fu- 
sional versions, thereby allowing an individual to compensate for larger deficits 
in horizontal eye movements.
The restrictive extraocular muscle involvement of Graves’ ophthalmo­
pathy should be differentiated from other neurological entities, e.g., neurogenic 
palsy and myasthenia gravis, which may complicate thyrotoxicosis. The forced 
duction test is indispensable. The presence of a positive test implying restrictive 
phenomena, is almost diagnostic of orbital disease and usually excludes neur­
ogenic disease except in those cases of long-standing ocular deviation where there 
may be secondary m uscular contracture.
When a  patient with extraocular muscle involvement turns his eyes up­
ward, restrictive tethering of the enlarged extraocular muscles, especially the in­
ferior recti, pressing against the globe raises the intraocular pressure. Thus, the 
m easurem ent of intraocular pressure by applanation tonometry m ay be helpful 
clinically in establishing bilateral orbital involvement in those patients who pres-
ent initially with unilateral proptosis, a  concept which is further discussed in 
Section 3.8.7.
3.5.7. Corneal involvement:
Comeal exposure has been ascribed to upper lid retraction, exophthal­
mos, lagophthalmos, inability to elevate the eyes and a decreased blink rate (Day, 
1978; Werner, 1978). Different factors, potentially associated with comeal expo­
sure in  Graves’ disease, were evaluated to determine which ones were associated 
with ocular surface damage. Analysis revealed that only increased palpebral fis­
sure width and  increased blink rate were significant predictors of ocular surface 
damage, as demonstrated by rose Bengal. None of the other factors generally con­
sidered im portant in comeal exposure (exophthalmos, lid lag and lagophthalmos) 
was significantly correlated with ocular surface damage. It is therefore possible 
that increased palpebral fissure width accelerates tear film evaporation, allow­
ing an  increase in tear film osmolarity with resultant ocular surface damage. A 
secondary increase in blink rate may occur (Gilbard and Farris, 1983).
Patients with comeal involvement and ocular surface symptoms may 
complain of excess tearing, a  gritty or sandy sensation, burning, or a foreign body 
sensation. In the American Thyroid Association classification, minimal involve­
m ent is characterised as mild by superficial punctate keratopathy, moderate by 
comeal ulceration, and marked by clouding, necrosis, or perforation. When ul­
cers occur, they are usually located in the central cornea, and if they become sec­
ondarily infected, globe perforation may occur with resultant loss of the eye (Day, 
1978).
3.5.8. Optic nerve Involvement:
Visual loss due to optic neuropathy is infrequent in Graves’ ophthalmo­
pathy (Day, 1978; Kennerdel et oL, 1981). When present in one or both eyes, it 
may result in  a  progressive decrease in visual acuity, impairment in colour vi­
sion, an  afferent pupillary defect, optic disc congestion or atrophy, and visual 
field defects (Kennerdel etaL, 1981).
In 1933, Naffziger first suggested that optic neuropathy in Graves’ dis­
ease could be caused by compression of the optic nerve a t the orbital apex, where
the swollen muscle bellies of extraocular muscles converge a t the annulus of 
Zinn. Recently the ability of high-resolution CT scanners to resolve structures at 
the orbital apex has confirmed that dysthyroid optic neuropathy is consistently 
associated with substantially enlarged extraocular muscles a t the apex of the 
orbit in tight juxtaposition to the optic nerve (Trokel and Jakobiec, 1981). The 
consequent apical compression may result in optic neuropathy by direct press­
ure on the nerve or its blood supply (Kennerdel et oL, 1981). The results of fluo­
rescein angiography and orbital venography in 20 patients with optic nerve 
compression suggest tha t increased intraorbital pressure exerts a  profound ef­
fect on visual function through interference with first the orbital and then, later, 
the ocular circulation (Cant and Wilson, 1974).
In m ost patients with optic nerve compression the involvement is bilat­
eral, although the two eyes may not necessarily be affected simultaneously or to 
the same degree. In 24-31% of cases the presentation is limited to one eye (Day 
and CaiToll, 1962; Kennerdel et dL, 1981). Congestive signs and symptoms al­
most always precede visual loss, which may be gradual or rapidly progressive. 
On ophthalmoscopic examination the optic discs appear normal in 40% where­
as in about one third hyperaemia or frank papilloedema may be seen. In neglected 
cases with irreversible visual loss, optic atrophy with pallor may be present (Ken­
nerdel et oL, 1981). Chorioretinal folds may be an  additional fundoscopic find­
ing. The appearance of the optic disc, unless optic atrophy is severe, does not 
correlate with visual acuity nor does it predict the potential for recovery of vision 
with treatm ent.
Visual symptoms of dysthyroid optic neuropathy are often variable and 
inconsistent, ranging from a normal corrected visual acuity of 6 /6  (class Via) to 
a sharp decrease to an  acuity of 6 /6 0  (class Vic). Colour vision as tested with 
Ishihara pseudoisochromatic plates or Famsworth-Munsell 100-Hue test, may 
be normal, b u t in the majority of patients is affected to a  variable extent. The 
axial position of the globe as measured by Hertel exophthalmometer, can vary 
from a minimum of 18 mm (class I) to a  maximum of 30 mm (class III). Afferent 
pupillary responses are found to be defective in most cases of dysthyroid optic 
neuropathy, b u t in a  minority they are retained. The most consistent finding in 
dysthyroid optic neuropathy patients is a  change in the visual field (Werner, 1969; 
Kennerdel etaLt 1981).
In a  large series of patients with dysthyroid optic neuropathy, Trobe 
found central scotomata in 94%, arcuate or ultitudenal defects in the inferior or 
superior field in 72%, and a generalised constriction of the field in 25% of pa­
tients. The most common perimetric finding was a  combination of a  central sco­
toma (with reduced acuity) and an  inferior arcuate nerve fibre bundle defect 
(Trobe, 1981; Sergott and Glaser, 1981).
3.6. ASSESSMENT OF SYSTEMIC CONDITION:
Assessm ent of thyroid sta tus and the overall clinical evaluation of the 
patient is essential for confirmation of the diagnosis, detection of associated con­
ditions and planning of future management especially if surgery or systemic ste­
roids are needed.
3.6.1. Systemic diseases with orbital involvement:
A variety of systemic diseases, including lymphoma, sarcoidosis, amyloi­
dosis, and vasculitis, may involve the orbit and present with symptoms and signs 
similar to those of dysthyroid eye disease. Certain clinical clues are helpful in 
distinguishing these diseases from Graves’ ophthalmopathy. Lymphoma has a 
predilection for the trochlear area and should be suspected when palpation of 
the supero-nasal aspect of the orbit reveals nodular areas. The presence of para- 
orbital disease involving the lacrimal excretory system, upper eyelid, and fore­
head should also raise the suspicion of lymphoma. Bilateral involvement with 
lymphoma does occur. When lymphoma is suspected, a  biopsy is indicated for 
confirmation and histological classification (Henderson, 1980).
Sarcoidosis and amyloidosis may involve the orbit and may resemble dys­
thyroid eye disease because of their variable manifestations. Sarcoid nodules and 
amyloid deposits can produce proptosis and may result in extraocular muscle 
enlargement which becomes apparent on CT scanning. Involvement of the eyelids 
may also occur. Sarcoidosis and amyloidosis are suspected when typical invol­
vement of other organ systems is present. A biopsy gives the definitive diagnosis 
(Waller and Jacobson, 1984).
Wegener’s granulomatosis should be strongly suspected in any patient 
with bilateral orbital inflammation, nasolacrimal duct obstruction, or a saddle
Thyroid function tests commonly used to a sse ss  ophthalmopathy:
T e st M ethod C om m ent
Serum total thyroxine (T4) Radioimmunoassay Preferred screening te s t  Results are influenced 
by altered thyroxine binding, and it is sometim es 
increased after radiographic contrast 
administration or during therapy with thyroxine. 
The test should not be used for patients receiving 
estrogens, androgens, diphenylhydantoin of 
salicylates.
Serum free thyroxine (T4) Radioimmunoassay Usually reliable indicator of thyroid function when 
total thyroxine results are modified due to altered 
thyroxine binding.
Total serum triiodothy­
ronine (T3)
Radioimmunoassay This test is abnormal in ~5% of thyrotoxic patients 
in whom total T4 is normal T 3  thyrotoxicosis’.
Thyroid Binding Globulin 
(TBG) binding capacity
Electrophoresis .A direct check on the normality of 
thyroxine-binding proteins. This test is used if the 
results of total thyroxine are modified by oedema, 
androgen, salicylate, pregnancy or 
diphenylhydantoin.
TRH stimulation test Intravenous injection 
of 200-400 micro­
gram s TRH
The test is used when serum total T4 and T3 are 
in the normal range but subtle hyperthyroidism is 
suspected e .g .,’euthyroid G raves’ 
ophthalmopathy*. No TSH response is consistent 
with early hyperthyroidism.
Radioiodine uptake 131l 3mCi orally; 
m easure percent of 
dose in thyroid at 24 
hours
This test distinguishes Graves’ hyperthyroidism 
from other causes of increased serum thyroxine.
T3 suppression test Baseline radioiodine 
uptake (24 hours), 
T3 25 micrograms 
t.Ld. for 7 days, re­
peat radioiodine up­
take
This test can be thought of a s  a  bioassay for 
circulating non-TSH stimulators of thyroid 
function. Because of the T3 dose, it is 
contraindicated in elderly or cardiac patients.
Thyroid Stimulating immu­
noglobulins
Various methods This test is positive in 90% of patients with 
thyrotoxic Graves’ d isease and in a  smaller 
percentage of those who have ’euthyroid Graves’ 
d isease’.
Table 3.5
(Summarised from Brennan and Gorman, 1984)
nose deformity in the presence of systemic findings which include epistaxis, 
haemoptysis, haematuria, or arthralgia. The diagnosis may be confirmed by a  bio­
psy of the nasal mucosa (Waller and Jacobson, 1984).
3.6.2. Pathogen related orbital inflammatory processes:
In addition to infective sinus disease which can produce signs of orbital 
vascular congestion and inflammation along with proptosis and painful ophthal­
moplegia, a  wide variety of viral, bacterial, fungal, and parasitic infections can 
involve the orbit and may, especially early in their course, be difficult to distin­
guish from dysthyroid eye disease. The most lethal of these is mucormycosis, 
which most commonly occurs in diabetics with ketoacidosis or patients who are 
immunosuppressed. Survival of the patient depends on early diagnosis and ag­
gressive treatment. Infectious mononucleosis, syphilis, trypanosomiasis, schis­
tosomiasis, systicercosis, and echinococcal disease have all been associated with 
orbital inflammation producing lid oedema, conjunctivitis, proptosis, and eye 
muscle dysfunction (Waller and Jacobson, 1984).
3.7. ASSESSMENT OF THYROID FUNCTION:
Guidelines for the selection of thyroid tests from the wide variety avail­
able are delineated in Table 3.5, each of which is specific to a  given purpose. As­
suming that the ophthalmologist will be working with an endocrinologist, the 
first-line tests to order are measurements of serum  T4 and T3, a  check of abnor­
mal binding (e.g., serum  TBG or T3 resin test), and a radioiodine uptake test. 
Radiographic contrast material and Amiodarone invalidate the uptake test (Burgi 
et al, 1976). If thyroid hormone levels and 131I uptake are high, the problem is 
solved. If one or both are normal, thyroid-stimulating immunoglobulins assays, 
T3 suppression testing, or TRH stimulation testing may be selected before the di­
agnosis of Graves’ disease is excluded. A few patients who have normal levels of 
thyroid hormone in their blood and histologic changes of lymphocytic thyroiditis 
in their thyroid gland may show the typical eye findings of Graves’ ophthalmo­
pathy (Brennan and Gorman, 1984).
3.8. TECHNIQUES OF EYE EXAMINATION:
Eye examination includes the m easurement of best corrected visual 
acuity, pupillary reactions, ocular motility, confrontation fields, flash light in­
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spection of the external eye and adnexae, biomicroscopy of the external eye and 
the anterior segment, ophthalmoscopic examination and measurements of the 
intraocular pressure. Special observations which pertain to the Graves’ disease 
patients are described below as reviewed by McCrary III (1983) and Younge 
(1984).
3.8.1. Visual acuity and pupils:
Hypermetropia may be induced by pressure of swollen orbital tissues on 
the back of the globe (Cant and Wilson, 1974), often hinted a t by relatively poor 
near vision. Pinhole acuity may help improve the vision in the presence of tear 
film or comeal abnormalities not corrected by refraction.
Before the pupils are dilated, a  relative afferent pupillary defect may be 
found with careful testing indicating asymmetrical optic nerve compromise. Such 
a finding m ay be lacking if both eyes have similar optic neuropathy. Thus, any 
cause of reduced vision m ust be determined including refractive errors, abnor­
mal tear film or comeal drying, retinal distortion by choroidal folds, or optic neur­
opathy.
3.8.2. Ocular motility:
Double vision, which is commonly vertical, need not necessarily be ac­
companied by proptosis. The limited ocular movements are not due to ocular 
muscle paresis, bu t to a  restriction of free rotation of the globe by tight rectus 
muscles. Poor elevation which is least in the abducted position, improves slight­
ly as the eye moves towards elevation in adduction. Increasing difficulty in elev­
ation in this condition is shown by diplopia, maximal in the abducted position, 
increasing intraocular pressure on attempted up gaze, and in the most severe 
cases actual retraction of the globe into the orbit on attem pted upward move­
ment. Limited abduction due to a tight medial rectus and reduced depression 
from superior rectus fibrosis are the next most commonly impaired rotations. Or­
thoptic m easurem ents of the field of binocular fixation and the Hess chart show­
ing the relative ocular movements are taken a t regular intervals (Fells et oL, 
1988).
Eponyms for external eye signs
Eponym Definition
Ballet’s  s ig n Complete immobility of globe without internal 
ophthalmoplegia
B o sto n ’s  sig n Staring appearance
E nroth’s  s ig n Fullness of lids due to oedema
Gifford’s  s ig n Difficulty in everting upper lid
Griffith’s  sig n Laging of lower lid on upward gaze
Joffroy ’s s ig n Absence of forehead creases on upward gaze
K ocher’s  s ig n Spasmodic increase in lid retraction with 
intense fixation
M eans’ g lo be lag More rapid movement of lid in upward gaze 
compared to globe movement
MObius’ s ig n Difficulty converging
R o sen b ac h ’s  s ig n Trembling of lids on gentle closure
S ain to n ’s  s ig n s Contraction of frontalis after levatoc has ceased
Stellw ag’s s ig n Infrequent, incomplete blinking
S uk er’s  s ig n s Inability to hold fixation in extreme lateral gaze
von  G raefe’s  s ig n Lid lag
Table 3.6
Summarised from Younge (1984).
A forced duction test may be useful to assess limitation of eye movements, 
bu t this is stressful to a patient with red eyes, swollen lids, and tearing. An al­
ternative is to m easure the intraocular pressure in slight downward gaze and 
then in extreme upward and outward gaze (Section 3.8.7).
3.8.3. Exophthalmometry:
The orbits should be palpated for the resistance to retropulsion of the 
globe. This m aybe asymmetrical, depending on the stage of the disorder. Failure 
of the globe to recede a t least 1 mm into the orbit on m easurem ent with exoph­
thalmometer on the patient in a reclining position is also a sign of expanded and 
incompliant orbital soft tissue. Although exophthalmometry is not an  accurate 
m eans of m easuring exophthalmos, it is a  useful procedure when performed with 
care, especially if repeated on subsequent visits by the same examiner under 
similar circumstances with the same instrument.
The Hertel exophthalmometer is the preferred instrum ent because the 
optics of the mirror system prevent significant error produced by parallax. It is 
im portant to fit the reference pieces comfortably and correctly against the lateral 
orbital rims so that the same horizontal base m easurem ent is used for sub­
sequent recordings.
3.8.4. Eyelids:
One needs to note the width of the palpebral fissure, the position of the 
upper lid relative to the superior limbus (e.g., 2 mm above), and the presence of 
lid lag as the patient follows a target into downward gaze.
One occasionally sees ptosis as a manifestation of Graves’ disease and 
myasthenia can accompany this disorder, producing anomalous eye findings. 
Many eponyms are used for the external eye signs which are varied and often 
confusing (Table 3.6).
3.8.5. Ophthalmoscopy:
Disc oedema identical in appearance to that of papilloedema secondary 
to increased intracranial pressure can occur, and this can seriously compromise
vision if left untreated too long. Choroidal folds may result from increased orbi­
tal pressure. After reversal of the underlying disorder, these may persist as pig­
m ented lines even though the folds themselves resolve. Such folds are associated 
with distortion of vision and decreased visual acuity. The clarity of the media may 
be impaired because of exposure keratopathy. Indirect ophthalmoscopy is indi­
cated in such cases.
3.8.6. Visual fields:
Perimetry is often difficult in patients with thyroid ophthalmopathy, be­
cause of the problem of m aintaining comfortable straight-ahead gaze and be­
cause of the chronic irritation of the exposed globe.
The m ost common effect of severe dysthyroid eye disease on the visual 
fields is generalised depression. There may be arcuate defects or, more rarely, 
paracentral, central scotomata, or an  irregular contraction of the field. Enlarge­
m ent of the blind spot occurs in cases with disc oedema (Kennerdel etoL, 1981).
True glaucomatous defects are rare and occur with a similar frequency 
as the general population (Ching and Perkins, 1967). Nonetheless, it is common 
to see patients being treated with anti-glaucoma medications largely because the 
intraocular pressure may be increased even in the straight-ahead position. In 
slight downward gaze the pressure is more likely to be normal (Section 3.8.7).
Visual field defects are usually seen in conjunction with impaired colour 
vision, decreased central visual acuity, prolongation in latency of visual evoked 
potential and, in asymmetrical involvement, a relative afferent pupillaiy defect. 
These findings indicate compromise of optic nerve function. Such defects are 
often reversible after medical or surgical orbital decompression (Ravin, Sisson 
and Knapp, 1975; Marcocci et aL, 1978; Gasser and Flammer, 1986).
Static perimetry may reveal th a t the whole of the field is depressed. Cen­
tral values may be depressed in the presence of normal acuity, as they are in  all 
other mild optic neuropathies, e.g., the optic neuritis of multiple sclerosis. As ex­
perience with the automated static perimeters develops, these defects m ay be 
seen earlier than  with a  standard kinetic perimetry (Younge, 1984).
3.8.7. Intraocular pressure:
Applanation tonometry using the Perkins or Draeger hand-held ton­
ometer, allows for accurate central applanation when positional changes are 
being m easured (Manor, Kurz and Lewitus, 1974). By careful head positioning, 
the slit-lamp m ounted Goldmann applanation tonometer can be used to m easure 
the intraocular pressure in straight, up and down directions of gaze whilst still 
applanating the central area of the cornea.
Braily and Eyre (1901) were the first to report cases with hyperthyroid­
ism and exophthalmos who had evidence of glaucoma by palpation. The studies 
during the first half of the twentieth century were reviewed by Pohjanpelto (1968), 
who emphasised the lack of agreement on the question of the link between in­
traocular pressure and thyroid dysfunction and that tonometry had been poor­
ly developed during tha t period.
Interest in the relation between thyroid function and intraocular press­
ure was renewed during the 1960’s by the study of Mclenachan and Davis (1965) 
and Beker, Kolker and Ballin (1966).
Other investigators, paying close attention to eye position when perfor­
ming tonometry, have failed to confirm previously reported findings. Ching and 
Perkins (1967) , found only two cases of glaucoma in a group of 155 patients with 
thyroid disease. This prevalence is the same for all individuals over 40 years of 
age (2.0 to 2.4%).
Lyons (1971), Zappia, Winkelman and Gay (1971) and Gamblin et oL 
(1983), have suggested tha t the m easurement of positional intraocular pressure 
changes may be clinically useful in the detection of orbital involvement in Graves’ 
disease as well as in monitoring the progression of ophthalmopathy.
The presence of intraocular pressure abnormalities in  m ost patients 
without clinical eye disease is consistent with orbital ultrasonographic (Werner 
et aL, 1974) and CT studies (Enznann, Donaldson and Kriss, 1979) which also 
indicate fi*equent subclinical ophthalmopathy. Pressure changes on eye move­
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m ents correlate well with the severity of ophthalmopathy as suggested by Draeger 
and Schneider (1975).
It should be recognised that the presence of positional intraocular press­
ure changes is not specific for Graves’ ophthalmopathy. Both orbital myositis and 
orbital fracture with inferior rectus entrapment have been shown to cause in­
traocular pressure changes on upgaze (Zappia etaL, 1971).
3.9. IMAGING TECHNIQUES FOR THE DIAGNOSIS AND 
MANAGEMENT OF DYSTHYROID EYE DISEASE:
3.9.1. Ultrasonography of the orbit:
One of the most important uses of diagnostic ultrasonography in the orbit 
is the demonstration of fat and extraocular muscles changes accompanying ac­
tive stages of dysthyroid eye disease. The space between the retrobulbar fat and 
the orbital wall shows generalised widening. The usually echo-free area occupied 
by the muscles acquires internal tissue echoes from the histological disorganiz­
ation within the muscles. Additionally, muscles are compressed against the bony 
orbital wall, thus producing a better reflecting surface and a more defined outer 
margin of the muscle and orbital walls. The four rectus muscles may be visualised 
ultrasonographically by scanning both the horizontal and sagittal meridia. Su­
periorly, where the orbital roof slopes down towards the apex, one often can dis­
tinguish  the levator muscle from the superior rectus muscle by the tissue plane 
separating them  (Ossoinig, 1984).
The degree of muscle enlargement varies from being subtle to pro­
nounced, depending on the am ount of soft tissue oedema from the disease pro­
cess. Bilateral changes are often evident ultrasonographically, even when the 
exophthalmos appears clinically to be unilateral. Quantitative m easurem ents of 
muscle enlargement are of questionable accuracy, depending on which portion 
of the muscle is measured and whether the beam is perpendicular or oblique to 
the muscle. Expansion of the retrobulbar fat volume and a  slight enlargement of 
the optic nerve profile frequently accompany the enlarged extraocular muscle 
seen ultrasonographically in dysthyroid eye disease.
Although ultrasonic findings are highly suggestive of dysthyroid eye dis­
ease, they are not pathognomonic for it. Passive congestion of the orbit second­
ary to arterio-venous anomalies or active inflammation from cellulitis or 
pseudotum our may produce similar ultrasonographic findings. Enlargement of a 
single extraocular muscle, with the other appearing nearly normal in size, is char­
acteristic of myositis or pseudotum our involving one muscle (Dallow, 1986)
3.9.2. Computed tomography of the orbit:
Orbital CT is outstanding in identifying the typical myopathy, often in 
the contralateral unsuspected eye as well (Leib, 1986).
With CT scanning it is possible to define the type and extent of change 
in the retrobulbar space, to differentiate it from neoplastic, vascular, and inflam­
matory lesions, to plan and control orbital radiotherapy in active cases, and to 
plan surgical orbital decompression.
Computation of extraocular muscle volume on CT identifies the popula­
tion a t risk for developing optic neuropathy (Feldon and Weiner, 1982; Feldon, 
M uram atsu and Weiner, 1984; Feldon et oL, 1985). Doubling of the total 
extraocular muscle volume is correlated with the development of optic neuro­
pathy, and affected muscles may undergo as m uch as an  eightfold increase in 
volume in severe cases (Haik, Saint-Louis and Smith, 1986).
Recently, one hundred and fifty-two orbits were studied by Hallin and 
Feldon (1988). Analysis of CT scans was performed, consisting of a quantitative 
estimation of extraocular muscle volume, mid-orbital extraocular muscle area, 
mid-orbital medial rectus muscle area and width. They showed tha t medial rec­
tus muscle width on a mid-orbital slice of CT scan, which can be obtained m a­
nually, was found to reliably distinguish between the group that would develop 
optic neuropathy and the group tha t would not.
3.9.3. Magnetic Resonance Imaging (MRI):
MRI produces an  image based on hydrogen protons (both density and re­
laxation, T l, T2). Although in this instance the image is derived from both  the 
tissue density of hydrogen protons and its T l or T2 value, it is possible to derive
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images based on fluoride or sodium or other atomic nuclei with odd num bers of 
protons or neutrons. Thus, it is potentially possible to obtain high-resolution, 
anatomically correct images of the orbit and to image different biochemical sub­
strates of the orbital tissues. Nuclei other than hydrogen result in images that 
have a relatively poor signal to noise ratio because of their low abundance in vivo 
and lower magnetic moment than  hydrogen (Isherwood, Pullan and Ritching, 
1970; Bottomley et aL, 1984).
Imaging of the orbit by MRI has been available only for the last few years. 
The initial experience has been either that the MRI offers no advantage over CT 
scanning (Han et aL, 1984), or that results are competitive with those of CT im­
ages (Mosely, Brant-Zawadzki and Mills, 1983; Hawkes etaL, 1983). In these 
studies a  slice thickness of 7-12 mm was imaged. At present, CT is capable of 
1.5 mm slice thickness and a resolution of 0.75 by 0.75 mm. For MRI to be equally 
sensitive, the spatial resolution of the images m ust be improved by decreasing 
both pixel size and their slice thickness. The limitation of the low-magnetic field 
MRI systems is tha t their inherent signal to noise ratio do not permit thinner sec­
tions and finer spatial resolutions without degrading the image quality. To im­
prove the signal to noise ratio, the scan time m ust be increased to an  
unacceptable duration.
Zimmerman et aL (1985) used a surface coil with a  large diameter as a 
transm itter to produce relatively uniform excitation throughout the image plane. 
A surface coil with a  smaller diameter placed over the orbit acted as the receiver. 
Using a  surface coil increases the signal to noise ratio permitting the use of m uch 
smaller pixels. The improvement in signal to noise ratio is a function of bringing 
the receiver coil closer to the anatomy being scanned, so that MRI signals are 
derived from tissues within the area of interest whereas only minimal noise is 
derived from tissues outside this area.
3.9.4. Advantages and limitations of different imaging techniques:
Standardised A-scan ultrasound can often determine the nature  of in­
traocular or intraorbital disease based on microscopic anatomical differences in 
tissue texture which result in alterations in tissue acoustic reflectivity. CT can 
often aid in diagnosis based on differences in Roentgen density and anatomical
localisation (Mosely et aL, 1983). Both of these techniques, however have signi­
ficant limitations.
Many disease processes give similar ultrasound appearances, e.g., lym­
phoma and pseudotumour. CT can be hampered by overlying bone and cannot 
distinguish between soft-tissue masses, which are radiologically isodense. In ad­
dition, CT exposes the patient to substantial doses ofx-radiation (Chan and Chu­
kovsky, 1976; Harris and Levene, 1976; Isherwood et aL, 1970). However, some 
surgeons consider that the delineation of bone is an  advantage which makes CT 
more helpful than  other imaging techniques in planning surgical orbital decom­
pression.
Magnetic resonance imaging techniques are not hampered by bone since 
it is a  solid structure with low molecular mobility tha t renders it relatively in­
visible on MRI images (Zimmerman et aL, 1985). Therefore, soft tissues are seen 
in an  unobstructed fashion.
Computer tomography has scan times in the order of 5-10 seconds where 
surface-coil MRI has scan times of 3-8 m inutes with a potential for shorter times. 
For the present, CT is faster than  MRI (Hawkes et aL, 1983; Sassani and Osbak- 
ken, 1984; Han etaL, 1984).
MRI does not expose the patient to ionizing radiation and is safe as em­
ployed clinically (Wolff et aL, 1980), provided the patient is free from foreign m et­
al and has no cardiac pacemaker, which might inadvertently be turned on or off 
(Finn et aL, 1985). Furthermore, MRI techniques promise not only to distinguish 
between lesions based on location and tissue structure bu t also on the basis of 
metabolic profile (Isherwood et aL, 1970; Crooks et aL, 1980; Bottomley et aL, 
1984; Zimmerman et aL, 1985). Although these techniques are in their clinical 
infancy, recent developments indicate th a t MRI techniques will offer m uch 
needed information for improvement of clinical diagnosis and management of pa­
tients with thyroid ophthalmopathy (Weiss, Haik and Smith 1986).
3.10. TREATMENT OF DYSTHYROID EYE DISEASE:
A num ber of medical treatm ents and surgical procedures have been ad­
vocated for dysthyroid eye disease. Although none has proved to be ideal, some 
do have a definite place in the treatm ent of certain types of ophthalmopathy. In 
this section these modalities are presented and discussed to see how they fit into 
the therapeutic picture.
3.10.1. Guanethidine:
It has been shown tha t mild to moderate degrees of lid retraction can be 
ameliorated by local instillation of the adrenergic blocking agent Guanethidine. 
Cant, Lewis and Harrison (1969) treated 81 patients with upper lid retraction for 
an  average of 54 weeks with either 10, 5, or 2% Guanethidine eye drops. They 
found the treatm ent to be effective in almost all cases. Two percent drops were 
m uch less effective, and 10% caused eye pain and punctate keratitis. They ad­
vised the use of 5% drops instilled into the eyes three times a day. They also 
found tha t when treatm ent was stopped the eyelids of most of the patients re­
turned to their former position. Crombie and Lowson (1967) and Bowden and 
Rose (1969) reported th a t in addition to decreasing the lid retraction, instillation 
of 5% Guanethidine eye drops decreased the proptosis, although others (Gay and 
Wolkstein, 1966; Cant et aL, 1969; Haddad, 1973) have not found any effect on 
proptosis. A decrease in intraocular pressure in patients so treated has been 
noted by Crombie and Lawson (1967) and Cartlidge et aL (1969).
3.10.2. Oral corticosteroids;
The m ost frequently used medical treatm ent for severe thyroid ophthal­
mopathy is the oral administration of corticosteroids. In 1953, Kinsell, Partridge 
and Foreman reported improvement in 9 such patients who received large doses 
of both cortisone and ACIH. In 1955 Brain reported moderate to marked im­
provement in 8 of 28 patients treated with either cortisone or ACTH, usually in 
relatively small doses.
In 1966 Werner reported remarkable immediate improvement following 
the sustained administration of unusually large doses of prednisone (120- 
140 m g/ day) of two patients with advanced changes of Graves’ disease. However,
Systemic steroids:
Hoffenberg 1958
Brown et al. 1963
Day 1967
Riley 1972
Mulherin, Temple And Cundey 1972
Aper etaL 1975
Freiwald and Gonzalez 1986
Nagayama etal. 1987
Table 3.7
Reports which document the immediate beneficial effects of giving large doses  
of corticosteroids to patients with severe Graves’ ophthalmopathy.
he pointed out that this treatm ent could not be relied on to induce a  permanent 
remission.
Many reports have now appeared which document the immediate benefi­
cial effects of giving large doses of corticosteroids to patients who have severe 
ophthalmopathy either alone or combined with orbital radiotherapy or immuno­
suppressive agents. Some of such reports are listed in Table 3.7.
3.10.3. Subconjunctival and intraorbital injection of 
corticosteroids:
Several workers have reported the beneficial effect of subconjunctival or 
retrobulbar injection of corticosteroids for the treatm ent of Graves’ ophthalmo­
pathy. Garber (1966) treated 15 patients with such injections using 10-15 mg of 
methylprednisolone acetate and reported that all patients obtained relief from 
the symptoms of ocular discomfort, ranging from ’moderate’ to ’dramatic’, after 
the first injections. The num ber of injection varied from two to 18 over time peri­
ods ranging from 2 to 24 months. The intervals between injections were leng­
thened progressively as indicated. The aim of treatm ent was to m aintain 
improvement until a  spontaneous remission of the disease occurred.
Riley (1972) treated 27 patients and reported minor improvements in 
most patients. Trobe, Glaser and Laflamme (1978) saw no perceptible change in 
five eyes treated with repeated injections of 60mg of triamcinolone acetonide. 
They cautioned that such subconjunctival or retrobulbar injections should not 
be used for a  prolonged period because of the risk of causing glaucoma.
On the other hand Haddad (1973) has advocated the inj ection of steroids 
into the retrobulbar or subtenon space as a test for the effectiveness of oral ste­
roid therapy.
3.10.4. Plasmapheresis:
The successful use of intensive plasma exchange in the treatm ent of one 
patient with severe thyroid ophthalmopathy was originally reported by Dandona 
et aL (1979). Later, the same investigators reported on a total of 7 patients with 
Graves’ ophthalmopathy treated with plasmapheresis: Four were in an  acute
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stage and responded favourably, while 3 presented with chronic disease and did 
not respond to treatm ent (Dandona et aL, 1980). Because of possible relapses 
after plasma exchange, treatm ent was combined with subsequent adm inistra­
tion of immunosuppressive drugs.
Sawers et aL (1981) reported improvement in the ophthalmopathy of two 
patients treated with plasma exchange, prednisolone and cyclophosphamide, 
and one patient treated with plasma exchange and pednisolone.
Confirmation of the beneficial effects of intensive plasma exchange in 
severe thyroid ophthalmopathy was shown in a preliminaiy study by Glinoer 
et al (1981) and in 1986 the same investigators treated nine patients with severe 
Graves’ ophthalmopathy by intensive plasma exchange, followed by im m unosup­
pression. Each patient was submitted to 4 plasmapheresis sessions over a  peri­
od of 5 to 8 days. A total of 8.5-10 liters of plasma was removed and replaced by 
frozen plasma, concentrated albumin solution or stable solutions of plasma pro­
teins. Immunosuppressive therapy with prednisolone (40mg/day) and azatho- 
prine (lOOmg/day) was administered to all patients from the day following the 
last plasmapheresis session. The severity of ocular involvement and response to 
therapy were evaluated clinically by numerical scoring based on the ophthalmo­
pathy index of Donaldson et a l (1973). Serum thyroid stimulating immunoglo­
bulin and urinary excretion of glucosaminoglycans were m easured immediately 
before and immediately after plasmapheresis. Plasma exchange was rapidly ac­
companied by marked clinical improvement in 8 patients. The most marked ef­
fects were on soft tissue involvement, proptosis, intraocular pressure, and visual 
acuity. The ophthalmopathy index decreased from 9.7 (+/- 4.1) to 5.7 (+/- 2.2) 
(pcO.OOl) after plasmapheresis. Serum thyroid stimulating immunoglobulin le­
vels were initially elevated in 6 patients and remained positive in 3 patients after 
treatment. Urinary glucosaminoglycans excretion was initially 2 to 12 fold nor­
mal levels and was decreased by 60%. After plasmapheresis, patients received 
immunosuppressive drugs for three to six month. The follow-up period, after 
withdrawal of drugs, ranged from 5 to 38 months with a  median of 17 m onths. 
The ocular condition remained stable in 6 patients. Three patients had relapse 
one year after plasmapheresis; they were treated a  second time by plasm a ex­
change with subsequent improvement.
In conclusion, intensive plasma exchange provided prompt and effective 
improvement in patients with severe progressive Graves’ ophthalmopathy. Re­
lapses were responsive to further plasmapheresis therapy. This therapeutic pro­
cedure followed by immunosuppression, gives long lasting results.
3.10.5. Immunosuppression:
Because of the suggested autoimmune pathogenesis of the ophthalmo­
pathy of Graves’ disease, treatm ent with immunosuppressive agents has been 
tried. Burrow et aL (1970) treated five patients with azathioprine 2m g/kg/day for 
periods of 8 to 11 weeks for three patients and for more than  36 weeks for one 
patient with no improvement in ophthalmopathy.
In 1979 Bigos et aL reported some success with the use of cyclophospha­
mide in three patients. They did not report any side effects from the drug.
Ten patients with severe Graves’ ophthalmopathy, resistent to other ther­
apeutic regimens were treated with cyclosporin A over a  period of six m onths. 
Clinically, nine patients improved, two of them  only after addition of corticoste­
roids. Intraocular pressure on upward gaze decreased in all of these nine pa­
tients. In six patients there was a  significant decrease in eye muscle thickness 
under the treatm ent as determined by computerised tomography. Side effects 
(e.g., paraesthesia and proteinuria) which were observed under high doses of cy­
closporin A disappeared after lowering the dose. It was concluded th a t this drug 
appears to be valuable for treatm ent of severe Graves’ ophthalmopathy when pre­
vious therapeutic regiments turned out to be unsuccessful (Utech et aL, 1985).
Witte et aL, (1985) treated 13 patients with severe Graves’ ophthalmo­
pathy with cyclosporin A. They concluded that cyclosporin A was not able to stop 
acute progression of ophthalmopathy in one patient and did not obviate surgical 
decompression of the orbits in two more patients. There was no m easurable ef­
fect of treatm ent on underlying immunological process with regard to thyroid dis­
ease. Kvetny et aL (1986) studied six patients and also concluded tha t cyclosporin 
A has no effect in the treatm ent of Graves’ ophthalmopathy, bu t ra ther exerts 
serious renal effects.
On the other hand, three recent studies showed that cyclosporin A is ef­
fective both in  term s of improvement of the acute signs and symptoms and in re­
lapse prophylaxis of Graves’ ophthalmopathy (Kahaly et aL, 1986; Glinoer and 
Schrooyen, 1987; Utech et aL, 1988).
It can be concluded tha t treatm ent of thyroid ophthalmopathy with a low 
dose of cyclosporin A combined with plasmapheresis (Sawers et aL, 1981; Gli­
noer et aL, 1986) or orbital radiation (Teoh and Woo, 1987) needs further inves­
tigation.
3.10.6. Radiotherapy:
Pituitary irradiation:
External orbital irradiation has been employed sporadically for more than  
50 years. The earliest reports (Thomas and Woods, 1936; Mann, 1946) comprised 
those of isolated cases and were poorly documented. In later series attention was 
focused on pituitary irradiation when effective therapeutic responses were occa­
sionally noted m onths after radiotherapy (Dobyns, 1950; Hermann, 1952; Beier- 
waltes, 1953).
Orbital irradiation:
In 1951 Jones indicated tha t orbital irradiation was more successful in 
the treatm ent of thyroid ophthalmopathy than  pituitary irradiation; a  finding fur­
ther supported by Gedda and Lindgren (1954) and Horst, Sautter, and Ulerich 
(1960). However, in all these early reports documentation of the eye and orbital 
changes was not standardised. The m ain doses were delivered using low energy 
x-ray beam s with poor collimation, different field sizes were employed, and the 
results were disappointing except in those cases in which the posterior portion 
of the orbit was either deliberately or inadvertently included in the radiation field 
(Beierwaltes, 1950; 1953; Blahut, Beierwaltes and Lampe, 1963).
In 1973, Donaldson et aL reported significant improvement in patients 
with severe Graves’ ophthalm opathy after supervoltage orbital radiotherapy. They 
reported the use of a  well collimated high energy x-ray beam generated by a li­
near accelerator. Their patients received a  total orbital dose of 2000 Rad which 
was usually calculated a t the midline and was given in 10 fractions over a 2 week
period. The beam  was angled 5 degrees posteriorly to avoid the lens of the con­
tralateral eye. They reported a good to excellent response in 15 (65%) of 23 pa­
tients treated and no serious complications were observed.
In 1975, Ravin et aL treated a series of 37 patients. They found that pa­
tients with optic nerve involvement have the best response to radiation treatm ent 
and suggested this as a  primary treatm ent modality for dysthyroid optic neuro­
pathy. They also concluded tha t patients with only proptosis probably should not 
be treated with radiotherapy. Trobe et aL (1978) also reported beneficial effects 
of radiation treatm ent for dysthyroid optic neuropathy.
Teng etaL (1980), studied 20 patients with ’moderately severe’ ophthal­
mopathy due to Graves’ disease. Their results were disappointing, about half of 
the patients showed some improvement, bu t the benefit was ’not impressive’, and 
in fact were minor and mainly in soft tissues which could not be assessed objec­
tively. Proptosis improved in only 25% of patients and by 2 mm a t most. Patients 
with long-standing ophthalmoplegia, presum ably associated with fibrotic 
extraocular muscles rarely responded. Their overall results were not as good as 
Donaldson et aL (1973), or Covington, Lobes and Saudarsanam  (1977), who 
found good to excellent results in about 65% of their patients. The difference 
might partly be explained by the fact that their patients had had a  longer dura­
tion of involvement (the m ean duration was more than  3 years), which was also 
less severe; and none of their patients were suffering from optic neuropathy.
Thus, orbital irradiation may be beneficial in acute ophthalmopathy 
where there is lymphocytic infiltration of the muscles and orbital tissues, but, it 
is unlikely to have any effect when this infiltration has been replaced by fat or fi­
brous tissue. Indeed, as it is clear from the literature, and as one might expect, 
unsuccessful cases were treated late or as a last resort after failure of other treat­
m ent modalities.
Previous reported complications of the orbital irradiation for Graves’ oph­
thalmopathy included: Periorbital and conjunctival oedema, hair loss, erythema, 
headaches, increased proptosis, diplopia, nausea, and vomiting. These compli­
cations had been transient and mild and no perm anent sequelae were reported 
(Ravin etaL, 1975; Trobe etaL, 1978).
Radiation retinopathy is well known to occur after total dose exceeding 
3500 Rad which generally is considered to be the upper limit to safe dosage. Other 
important variables tha t need to be considered to avoid complications of radia­
tion include the total elapsed time during the course of the irradiation, and the 
size and num ber of radiation fractions (Duke-Elder and MacFaul, 1972).
Sporadic reports of radiation retinopathy after reportedly safe doses of 
radiotherapy have appeared in the literature. Bagan and Hollenhorst (1979), re­
ported retinal microaneurysms in an  eye after only 2000 Rad delivered to a  pi­
tuitary tumour, and Perrers-Taylor (1965), reported radiation retinopathy after 
a retinal dose of approximately 1700 Rad. In addition, Tomsak and Smith (1980), 
reported a case of radiation retinopathy after irradiation of the whole head with 
3300 Rad for palliative treatm ent of metastatic carcinoma.
Mewis, Tang and Salmonsen (1982) described three patients with radia­
tion retinopathy after 2500-3000 Rad for choroidal metastases. These three pa­
tients, however, were treated also with chemotherapy for systemic effects, which 
is known to be associated with an  increased risk of ocular damage due to irradi­
ation (Chan and Shukovsky, 1976). Other risk factors include hypertension, 
diabetes mellitus, collagen vascular disease and large fraction size (Harris and 
Levene, 1976).
Bagan and Hollenhorst (1979), reported radiation retinopathy and optic 
atrophy secondary to irradiation after treatm ent of Graves’ ophthalmopathy with 
high doses of irradiation, bu t the doses were not stated. The clinical similarities 
between irradiation and dysthyroid optic neuropathy make it difficult if not im­
possible to determine which diagnosis is correct in patients with Graves’ oph­
thalm opathy who have had prior orbital irradiation, particularly if the CT scan 
is equivocal for optic nerve compression a t the orbital apex.
Recently, a  group of 62 patients treated with orbital irradiation has been 
reported by Hurbli et aL (1985), almost all patients had been on treatm ent with 
high doses (60- 120mg/day oral prednisone). Those who had no response, incom­
plete response or transient improvement were treated with radiation. Different 
radiation sources were used during the course of this study. Most patients re­
ceived 20 Gy a t 2.5 to 3 cm depths (or in the case of bilateral treatm ents to the 
mid-plane) in ten daily fractions over 12 to 14 day period. In all b u t two cases
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corticosteroids were decreased and stopped within two weeks of radiation. Four 
patients required surgical decompression, they did not appear to be significant­
ly different from those who responded favorably to radiation in term s of length of 
the disease, am ount of visual disability, or medication usage. Unfortunately there 
were no comments on the histopathology of the orbital tissues of these four pa­
tients. The first objective sign of response to radiation occurred between two days 
to two m onths after the sta rt of the treatm ent (mean 14 days). The maximum 
benefit was observed a t one to 14 months (mean 5.6 months). External beam ir­
radiation reduced or eliminated signs and symptoms of thyroid ophthalmopathy 
in approximately 56% of patients. In 74% of those with non-chronic myopathy 
(34 of 46 cases), motility disturbances were alleviated. As others have noted, radi­
ation was m ost effective in patient with relatively recent thyroid eye disease with 
marked soft tissue signs (Kriss et al, 1983; Bartalena et al, 1983). No morbidity 
with radiation delivered to the orbits in the m anner described was observed.
At 20 Gy given in 10 fractions, patients are unlikely to develop signifi­
cant ocular complications. Vascular retinopathy occurs with significantly higher 
doses or in  patients whose ocular vasculature is compromised from diabetes, 
other vascular disorders or systemic chemotherapy (Chan and Shukovsky, 1976; 
Harris and Levene, 1976).
Radiation therapy is useful in the management of some patients of dys­
thyroid eye disease, particularly those with recent onset of marked tissue signs, 
proptosis, optic neuropathy or myositis. Radiotherapy may play a role in cases 
of acute congestive ophthalmopathy, as an  alternative to steroid therapy or be­
fore contemplating orbital decompression. Radiation therapy was found not to 
be useful in patients with mild and long-standing noninflammatory thyroid oph­
thalmopathy (Konishi etaL, 1986; Pigeon etaL , 1987; Marcocci etaL, 1987). 
More recently the treatm ent field was limited to the orbit based on the rationale 
tha t this disease is a cellular immune-reaction in the extraocular muscles and 
is not hormonal in origin. Radiation therapy as described above has less mor­
bidity than  long-term corticosteroids and does not make subsequent surgical de­
compression more difficult if this becomes necessary (Hurbli et aL, 1985).
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Figure 3.1
Showing the right orbital walls forming a four sided pyramid.
3.10.7. Orbital decompression:
Whenever the pathophysiology of a disease is incompletely understood, 
treatm ent tends to be multifaceted and directed toward alleviation of symptoms 
rather than  resolution of the disease. This is true for dysthyroid eye disease.
The ideal treatm ent would be to identify the process which leads to 
massive enlargement of the extraocular muscles and periorbital fat, stop the pro­
cess, and then  reverse it. Unfortunately this is not possible a t this time. Systemic 
steroids and radiation therapy do have effects on the process. Surgical decom­
pression of the orbit is usually recommended when the control of thyroid disease, 
local ophthalmic therapy, and systemic steroids fail.
Orbital decompression is not an  ideal treatment. It does nothing to alter 
the basic process. In feet, the orbital contents are merely displaced rather than  
reduced. There is consistent alleviation of certain problems, bu t other problems 
are created i.e., extraocular muscle imbalance. The concept of decompression is 
relatively simple. There is too m uch tissue in a limited space, and either the tissue 
m ust be removed or the space enlarged.
The bony orbit can be thought of as a  four sided pyramid, in which the 
apex represents the optic canal and the base the orbital rim. This leaves four 
walls designated as superior, inferior, medial, and lateral. The superior wall com­
prises primarily the orbital process of the frontal bone. The lesser and the greater 
wings of the sphenoid and the zygomatic bone forms the lateral wall. Inferiorly 
is the maxilla. The medial wall comprises the ethmoid and lacrimal bones 
(Figure 3.1). Orbital decompression procedures involve the removal of one or 
more of these walls. This alleviates pressure and creates space to accommodate 
excess orbital tissue (Hamer, 1984).
Indications for decompression fall into three categories: Decreasing vis­
ual acuity, deterioration of colour vision, disc oedema and increasing visual field 
defects. These emergency situations are the unquestioned indications for orbital 
decompression.
Keratitis, chemosis, diplopia and lid oedema are relative indications for 
surgery. Early reports dealing with dysthyroid eye disease were not concerned 
with cosmetic appearance as an  indication for surgery. This is an  important fact 
to remember when evaluating results. A series tha t includes patients operated 
for cosmetic reasons requires better results and fewer complications.
The operative procedures can be placed into one of three groups: lateral 
approach, superior approach and inferior approach
The lateral approach:
Lateral approach has been used primarily by ophthalmologists. It is the 
same surgical approach which Kronlein described in 1888 to remove tum ours in 
the infratemporal fossa and retrobulbar area. The lateral approach requires a 
skin incision somewhere in the region of the lateral canthus or over the zygo­
matic arch. Usually a significant portion of the temporalis muscle is removed. 
The lateral rim and wall of the orbit are removed from anterior to posterior. The 
bony walls can be removed superiorly across the midline nearly to the ethmoid 
complex. The inferior wall and approximately half of the medial wall can also be 
removed by this approach. Generally the decompression is considered to be less 
than  th a t achieved with the inferior approach even when combined with tha t of 
the superior approach. The four wall dissection of Kennerdel and Maroon (1980; 
1982) is reported to yield 10-17 mm of recession. Although results are satisfac­
tory, there are some negative aspects of this approach.
Generally, only one side is operated on at a  time and some type of exter­
nal incision is necessary in order to expose the lateral orbital rim. This, combined 
with the removal of a  segment of the lateral orbital rim and temporalis muscle 
creates a  subsequent noticeable change in  facial appearance.
The space available with the lateral approach is limited. There are the 
problems of bleeding, paralysis of the frontalis muscle, and post operative weak­
ness of the lateral rectus muscle.
The superior approach:
The first example is the frontal craniotomy approach described and popu­
larised by a neurosurgeon, Naffziger and Jones (1932) and the second is the pte-
rion approach described by Welti and OfTert (1943) and used by a num ber of su r­
geons (Rowbotham and Clarke, 1956; Hamby, 1964; Backlund, 1968).
Initially, Nafiziger and Jones described the removal of only the superior 
roof on one side. Later they recognised that the lateral orbital wall should also 
be removed and that both sides could be decompressed in one procedure. It is 
im portant to recognise th a t this procedure is intracranial bu t extradural.
The results of this approach are good, vision is stabilised or improved, 
ocular motility is improved, and the appearance is satisfactory in most cases. 
The degree of recession varies, bu t the average (from series in the literature) seems 
to be around 3 mm (Hamer, 1984).
Frontal lobe injury, intracranial haemorrhage, cerebrospinal fluid rhinor- 
rhea and meningitis are potential problems bu t in fact are very uncommon. The 
limited space available for decompression is a  m uch more significant criticism of 
this procedure. The external incision and deformity secondary to the bone flap 
can also be distressing.
Another criticism has been post-operative pulsating exophthalmos. How­
ever, this did not seem to be a problem from the patient’s point of view (MacCarty 
etaL, 1970).
The pterion approach has the same goals as the trans-cranial, i.e., remo­
val of the superior and lateral orbital walls (Welti and Offert, 1943). As in the 
transfrontal approach, the lateral rim of the orbit is preserved. The scar created 
by the procedure is inconspicuous and the bony defect well covered by tempo­
ralis muscle. The basic results and potential complications are otherwise the 
same as with the transfrontal procedure, bu t generally the two sides are oper­
ated on a t different sessions.
The inferior approach:
Currently the inferior approach is the most widely used and accepted de­
compression technique. This procedure can be carried out either by a transan-
tral or a transorbital approach. The greatest num ber of decompressions have 
been done by otolaryngologists using the transantral rout.
The inferior approach has tremendous appeal because it provides the 
greatest space for transorbital contents. The concept of transantral orbital de­
compression is to remove the bony wall between the orbit and the ethmoid and 
the maxillary sinuses. The technique is described by DeSanto (1984). The ability 
to preserve or restore vision, improve ocular motility, and enhance appearance 
is excellent. Potential complications include blindness, cerebrospinal fluid leak­
age, orbital cellulitis, sinusitis, nasolacrimal duct obstruction and persistent 
num bness of the face. The advantages are that there is no external incision, no 
facial deformity, and morbidity is minimal.
The most consistent criticism of the transantral approach has been the 
relatively high incidence of extraocular muscle imbalance, ptosis of the globe, the 
need for secondary eye muscle surgery and persistent diplopia.
Transorbital decompression has been criticised first because it utilises a 
transcutaneous lid incision with scarring and some degree of deformity. Expo­
sure through the inferior fornix combined with lateral canthotomy results in an  
inconspicuous incision. The medial, inferior, and lateral walls can be approached.
As with all the various approaches the results are quite good. The aver­
age recession achieved approaches 6 mm, which is slightly higher th an  most re­
ports of the transantral procedures. The complications, morbidity, and mortality 
of this procedure should be the same as with the transantral procedure.
Until 1970, nearly every patient who was surgically decompressed had 
’malignant exophthalmos’. By definition they had failing vision, comeal ulcers, 
ophthalmoplegia, and severe proptosis. Multiple treatm ent options had been 
utilised and failed. The goal in these patients was prevention of blindness or 
possible death. Over the past 10-15 years the success of orbital decompression 
has lead to significant changes in  indications for surgery. This m eans greater 
num bers of patients with milder degrees of disease, better results, and fewer com­
plications.
Lateral and superior approaches can achieve reasonable results in the 
preservation of vision and prevention of comeal ulcers. However, in the milder 
cases, the cosmetic defects of these procedures are unacceptable. The transan­
tral inferior approach achieves excellent results. It has the logical appeal of 
greater space for orbital contents, no cosmetic defects, short hospitalisation, and 
acceptable morbidity and mortality. Even the incidence of diplopia has decreased 
as the milder cases are treated surgically. Furthermore, the incidence of inade­
quate decompression via the anterior approach is higher than  with the transan­
tral approach. Transantral decompression allows for complete removal of the 
posterior ethmoidal air cells and successful decompression of the orbital apex 
(Gorman, Waller and Dyer, 1984). However, many ophthalmologists prefer the 
anterior approach because the anatomy is more familiar.
It is obvious that consistently successful surgical decompression re­
quires the removal of two walls of the orbit. It now seems tha t three or more walls 
can be safely removed when indicated (DeSanto, 1984).
If decompression is indicated it still represents only one stage in the over­
all rehabilitation of a patient with dysthyroid eye disease. Control of thyroid func­
tion, correction of extraocular muscle imbalance, and relief of residual lid retrac­
tion require coordinated efforts by several medical and surgical disciplines.
PART II. 
EXPERIMENTAL STUDIES
CHAPTER 4. 
OBJECTIVES OF THE PRESENT STUDY
4.1. INTRODUCTION:
Microcomputers:
Microcomputers are powerful, flexible, portable and relatively cheap 
tools. They are easy to operate and have excellent graphics capabilities. There­
fore, they can be adapted to solve a wide range of clinical problems.
In the present study, some aspects of the use of microcomputer tech­
niques in ophthalmic diagnosis and management will be investigated. Thyroid 
ophthalmopathy will be taken as an  example in order to demonstrate the appli­
cation of these techniques.
The clinical problem of thyroid ophthalmopathy:
It is now generally agreed that dysthyroid eye disease is most probably 
an  autoim m une disease affecting primarily the extraocular muscles, with 
possible roles of pituitary or thyroid hormones in modifying the course of the dis­
ease. However, the aetiology and the exact pathophysiology of the immune dis­
turbance are yet to be known.
4.2. THE NEED FOR FURTHER RESEARCH:
The following problem areas had been identified after reviewing thyroid 
eye disease literature.
(a) Immunology:
The following problems require further research in clinical immunology.
1- There is no direct immunoassay for thyroid-stimulating immunoglobu­
lins. The availability of such test will help in making the diagnosis as well 
as in following up the patients.
2- A biochemical or immunological test which is specific to thyroid oph­
thalm opathy is needed.
3- Identification of the aetiological factors and the pathophysiological pro­
cesses is required.
4- A specific treatm ent which prevents the immune disturbance or 
modifies the reaction of the body is required.
(b) Patient management:
The following problems require further research to optimise the tech­
niques which are currently used for making the diagnosis and planning the m an­
agement of patients. These techniques are empirical in m ost cases.
The diagnostic problem:
No single clinical or laboratory test is currently available which is suffi­
ciently sensitive or specific to make or confirm the diagnosis of dysthyroid eye 
disease.
n The natural history of this disorder is not clearly known.
□ Current classifications and scoring systems are either complicated and 
therefore impractical or inadequate. No system is available which helps 
to predict the prognosis and the disease course.
o Many of the currently used clinical tests are subjective and the majority 
of them  are interpreted qualitatively.
The management problem:
n The num ber of cases is small.
a  The course is variable, 
n The follow-up is long.
o No clear guidelines are available regarding the choice of treatm ent.
n Treatment is nonspecific and directed to the effects rather than  the 
cause of the disease.
Therefore, thyroid ophthalmopathy is an  appropriate area for studying 
the application of microcomputer techniques.
(c) Computing techniques:
The facilities offered by microcomputers have not been fully exploited in 
the field of clinical ophthalmology. Further research is required which involves
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clinicians and computer scientists working closely in solving clinical problems. 
Three areas were identified which need further investigations:
1- The use of the graphics capabilities of microcomputers in devising new 
tests and refining existent equipment for patient assessm ent.
2- The application of image processing techniques in quantifying charted 
clinical information automatically.
3- The application of artificial intelligence approaches in the diagnosis and 
m anagem ent of ophthalmic patients.
4.3. AIMS OF THE PRESENT STUDY:
4.3.1. The long term effects of dysthyroid eye disease:
1- To study the long term effects of thyroid ophthalmopathy.
2- To investigate the relative importance of various clinical signs and symp­
toms of the disease as well as the investigations for making the diagnosis 
and planning the management of patients.
3- To identify the risk factors and to devise a technique for predicting the out­
come in term s of severity of the course of the disease.
4.3.2. The use of microcomputers in patient assessment:
To provide an  example of the uses of microcomputers in assessm ent of 
patients which involves:
(1) To devise a  microcomputer-based clinical test for the assessm ent o f’tem­
poral visual acuity’ using Snellen optotypes.
(2) To present an  account of the process of development of the system and its 
evaluation.
(3) To provide guidelines regarding the potential clinical applications of this 
test.
4.3.3. The use of microcomputers in data interpretation:
To provide an  example of the use of microcomputers in the interpreta­
tion of patient data by devising a  universal chart reader which automatically di-
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gitises the images of various ophthalmic charts and extracts the charted infor­
mation and applies various calculations and formulae to score and quantify this 
information.
4.3.4. Expert system for the diagnosis and management of 
dysthyroid eye disease:
1- To discuss the various approaches to computer aided medical deci­
sion making systems.
2- To provide an  example of the use of microcomputers as medical deci­
sion support systems by building a  ’disease-specific’ expert system model which 
gives advice on the diagnosis and management of dysthyroid eye disease.
3- To provide an  account of the methodology followed in the development 
of the prototype expert system so developed.
4- To investigate the difficulties which may be encountered in building 
expert system models.
5- To investigate the potential use of expert systems designed to run  on 
microcomputers in clinical ophthalmology.
6- To study the proposed expert system with a  view to understanding 
and investigating the value of expert system programmes in  achieving the follow­
ing aims:
n To investigate the issues involved in designing consultation programmes. 
Q To investigate the nature of expertise to be formalised, 
a  To improve the accuracy and reliability of clinical decisions, 
a  To improve the cost efficiency of tests and therapies, 
n To improve understanding of the structure of medical decision making, 
a  To disseminate rare and costly expertise.
n To integrate the various sources of knowledge.
This thesis reports the first stage of a project to develop a model of an 
ophthalmic clinic automation system. This project is running jointly with, Mr. 
A. Wail, who is currently a  research fellow at the Signal Processing Division of 
the Electronic and Electrical Department of Strathclyde University. Achieving the 
above delineated aims will conclude the first stage and establish the foundations 
for the second stage of the project in which further refinement of the prototype 
computer systems will take place. These systems will then be integrated so that 
they will be operated using one universal user interface.
CHAPTERS.
LONG TERM EFFECTS OF DYSTHYROID EYE DISEASE
5.1. INTRODUCTION:
Current knowledge concerning the long-term outcome of dysthyroid eye 
disease is limited. Hales and Rundle (1960) carried out a  retrospective review of 
104 patients with an approximately 15 year follow-up. They presented their re­
sults in term s of lid retraction, ophthalmoplegia and exophthalmos and con­
cluded tha t lid retraction disappears in a  large num ber (60%) of patients so 
affected. Ophthalmoplegia remained unchanged in approximately two thirds of 
patients and exophthalmos reaches its peak early in the course of the disease 
and becomes static near its maximum. The study described in this chapter was 
carried out in  order to gain greater insight into the natural evolution of dysthy­
roid eye disease and to determine which features at presentation constitute the 
principal risk  factors for the development of adverse complications.
In the early 1960s a  prospective review of patients with dysthyroid oph­
thalm opathy was started in the Tennent Institute of Ophthalmology, Glasgow. A 
wide range of investigations was carried out upon these patients who have since 
been followed up  in detail over an  average of 10 years. The assessm ent of the 
long- term  effects of this disorder on systemic and ocular structure and function 
of those patients forms the ba6is of the information presented in this chapter.
The overall amount of data available comprises 140 pieces of informa­
tion concerning each of 224 patients. Eight thousand contingency tables have 
been derived from this information and subsequently evaluated. The accent of 
this thesis is towards the utilization of computers in ophthalmology and to that 
end the results presented in this chapter comprise a  small proportion of the data 
available, bu t they have been carefully selected as those which provide the knowl­
edge base for the computer expert system (subsequently described in Chapter 8).
5.2. PATIENTS AND METHODS:
5.2.1. Patient identification:
All patients who had been entered into the prospective study of dysthy­
roid eye disease between 1961 and 1983 were identified and traced (Sec­
tion 5.2.4).
5.2.2. Inclusion criteria:
Patients were included in this study if they met with the following crite­
ria:
(1) Adequate clinical data recorded at the onset of the eye disease (Sec­
tion 5.2.5).
(2) Comprehensive follow-up data for four or more years.
(3) Evidence of disturbed thyroid function either a t presentation or during fol­
low-up.
5.2.3. Patient assessment:
All the case records were examined and data collected (Section 5.2.4). 
Those patients for whom a comprehensive clinical examination was carried out 
four or more years after the onset of the disease and who demonstrated no de­
tectable change were deemed to have sufficient data for demonstration of a  ’final* 
outcome. The patients for whom these data were not available were traced and 
underwent detailed assessm ent of the features described in Section 5.2.5. The 
last available clinical data of patients who were deceased was considered ’final’. 
Those patients who could not be traced and for whom adequate ’final’ data was 
not available were not included in the study.
5.2.4. Data collection:
A list of patient names an d /o r hospital num bers was prepared from the 
following sources:
Q Ophthalmic photography department: The information available be­
tween 1963 and 1987 was used.
Q Operating theatre books: These were available for between 1975 and 
1987.
a  Orthoptic department records: For which data was available between 
1969 and 1987.
Plate 5.1
Photocopied Patient information.
The collection of data was carried out during five-hour sessions, five times 
per week for 12 months. Case records from the following Glasgow hospitals were 
scrutinised.
□ The Western Infirmary,
Q Gartnavel General Hospital, 
a The Eye Infinnaiy.
Patient identification was completed using the record office microfilm 
’m aster index’ and by examination of microfilm reels and case notes.
Photocopies of the relevant pages of the case notes and the microfilms 
were made to include the following information:
n Administrative and personal information, 
n Relevant clinical notes and letters, 
n Visual field charts, 
a  100-Hue colour vision test charts, 
a  Hess charts.
n Orthoptic assessm ent reports.
Q Thyroid biochemistry results.
Plate 5.1 is a photograph of all the photocopied information.
5.2.5. ’Final’ assessment of patients:
Patients undergoing routine clinic visits were identified and examined by 
the author. Those not undergoing follow-up for whom inadequate ’final’ follow- 
up data were available were asked to return  for assessm ent by the author. Eighty 
six percent of 145 such patients attended.
The protocols of clinical examination and investigations are shown in 
Figures 5.1 and 5.2.
INITIAL ASSESSMENT
OCULAR MOTILITY
Diplopia Chart
Orthoptic assessment
Hess test
SYMPTOMS
DEMOGRAPHIC
INFORMATION
CLINICAL SIGNS
OTHER
INVESTIGATIONS
THYROID STATUS
Thyroid biochemistry {Table 5.1)
Duration of thyroid dysfunction
Clinical assessment
100-Hue colour vision test
Results of orbital imaging
Fluorescein angiography
Histopathology reports
Field of vision
Age at onset of ophthalmopathy
Consultant in charge
Name of the patient
Hospital number
Sex
Fundus examination (Disc oedema, Choroidal folds)
Lid signs (Lid oedema, Ud lag, Lid retraction)
Intraocular pressure (Straight Up-gaze)
Exophthalmometry (Luedde)
Visual acuity
Chemosis
Figure 5.1 Data examined at presentation (for all 
cases).
’FINAL’ ASSESSMENT
SYMPTOMS
CLINICAL SIGNS
OTHER
INVESTIGATIONS
TREATMENT
THYROID STATUS
Treatment of thyroid dysfunction
Treatment of ophthalmopathy
Change h  tfiyrcid stabs durng Mow-up
Thyroid biochemistry (Table 5.1)
CTf)ical assessment
OCULAR MOTILITY
Orthoptic assessment
Diplopia Chart
Hess test
100-Hue colour vision test
Results of orbital imaging
Histopathology reports
Reid of vision
Fundus examination (Disc oedema, Choroidal folds)
Lid signs (Ud oedema, Ud lag, Ud retraction)
Intraocular pressure (Straight, Up-gaze)
Exophthalmometry (Luedde)
Visual acuity 
Chemosis
Figure 5.2 Data examined at ’final' assessm ent for all cases.
*  Features examined on 'final' assessment for patients demonstrating disturbance of ocular motility
Examination techniques: 
Visual acuity:
The Snellen internally illuminated chart was used to assess the visual 
acuities of all patients.
Eyelid signs:
Lid lag, lid retraction, lid oedema chemosis and ptosis were qualitatively 
evaluated and coded into two categories, present or absent (Appendix Cl). No at­
tem pt a t quantification of these parameters was made because this was the only 
classification used a t the time of initial assessm ent of patients.
Cornea:
Slit lamp examination, for fluorescein and Rose Bengal staining were 
used to assess the corneal condition and to detect exposure keratitis.
Intraocular pressure:
The Goldmann applanation tonometer m ounted on a Haag-Streit slit 
lamp was used to measure the intraocular pressure. The intraocular pressure 
was recorded while the patient was looking straight ahead and in extreme up- 
gaze. Applanation of the central part of the cornea on upgaze was ensured by 
manipulating the patient’s head accordingly.
Exophthalmometry:
The Luedde exophthalmometer had been used for initial assessm ent of 
the vast majority of patients and therefore was also used for the ’final’ examin­
ation in  order to provide comparable data.
Extraocular muscle function:
A simple diplopia chart was used to document the direction of gaze in 
which diplopia could be elicited in the clinic. A full orthoptic assessm ent was also 
carried out and included the Hess screen test on those patients with detectable 
motility disorders.
Thyroid function tests:
- Protein-bound iodine.
- Radio-active iodine uptake ratio.
- T3 Resin uptake ratio.
- TSH radio-immuno assay.
- TRH stimulation test.
- Total and free serum T4.
- Total and free serum T3.
- T3 suppression test.
- Thyroid scan.
Table 5.1
Thyroid function tests used in this series. The trend for using individual tests 
changed with time (e.g., Protein-bound iodine which was the most frequently 
used test at the outset of the study was gradually replaced by other tests.)
Field of vision:
Kinetic perimetry of the central visual field was carried out using the 
Tubingen perimeter. Copies of all the field charts were kept for subsequent quan­
tification and analysis (Chapter 7).
Colour vision testing:
The Famsworth-M unsell 100-Hue test had been used both initially and 
a t follow-up visits. Most of the results were recorded in chart form without the 
original figures. Photocopies of these charts were also made in preparation for 
defining the axis and calculating the error score of colour vision impairment 
(Chapter 7).
Fluorescein angiography:
Fluorescein angiography and orbital venography had been performed 
upon 20 patients in this series as part of a  study of ocular and orbital circula­
tions in ’infiltrative’ dysthyroid eye disease by Cant and Wilson (1974). (Thirteen 
patients showed a delayed arm-retina circulation. Six patients had bilateral and 
one unilateral papilloedema. One patient had bilateral optic nerve atrophy. Seven 
patients showed pronounced chorio-retinal folds. The angiograms were repeated 
2 months after starting treatm ent by which time the arm-retina circulation times 
had returned to the normal range and the optic disc oedema had subsided. Des­
pite the rapid disappearance of optic disc oedema, the chorio-retinal folds were 
still present 6 m onths after starting therapy and they resolved only very slowly 
after this. The study demonstrated that interference with orbital and then, later, 
ocular circulation occurs as a  result of orbital infiltration). It had been decided 
after the end of the study that fluorescein angiography need not be repeated be­
cause little information had been obtained relevant to the management of the pa­
tients.
Thyroid status:
For the majority of cases clinical and biochemical assessm ent (Table 5.1) 
of thyroid function had been carried out in the endocrinology department a t the 
Gardiner Institute, Glasgow.
Plate 5.2
Table of coded patient data stratified and stored on the computer hard disk.
5.2.6. Data coding:
One hundred and forty param eters of ocular and systemic sta tus were 
identified for each patient. A coding system was devised to allow all this data to 
be entered into the computer system and manipulated (Appendix Cl).
5.2.7. Data stratification:
Coded data were entered into an  IBM/AT microcomputer and stored on 
its hard  disk using SPSS/PC+ V2.00 DATA ENTRY II programme (Appendix C2). 
This programme allows for conversion of the data file into different file formats 
suitable for handling by various spread sheet programmes and statistical pack­
ages which are capable of running on both mainframe and microcomputers. Plate 
5.2 shows the table containing the coded data stored on the computer hard disk.
5.2.8. Data handling: 
Statistical Package:
SPSS/PC+ V 2.00 BASE module was the m ain statistical package for per­
forming descriptive statistics and cross tabulation. SPSS/PC+ADVANCED STAT­
ISTICS was used to implement discriminant function analysis statistics. All the 
statistical tables were produced using the SPSS/PC+ TABLES module (Appendix 
C2).
Patient groups:
In this study attention will be focused on the aspects which are directly 
relevant to making the diagnosis and planning the management of thyroid oph­
thalm opathy patients. Therefore, the patients were grouped into the following 
major subcategories:
n ’Mild disease’. This group includes those cases whose management had 
required only conservative m easures and did not involve systemic ste­
roids, orbital radiotherapy or orbital surgical decompression.
Q ’Severe disease’. This group includes those cases who had been deemed 
to be severe enough to necessitate systemic steroids, orbital radiother­
apy or orbital surgical decompression or any combination of them.
Plate 5.3
Demonstrating the large size of cross-tabulation results.
During the follow-up period surgical orbital decompression was per­
formed for sight threatening conditions and not for cosmetic reasons in all bu t 
one patient.
Statistical techniques:
Sum m aiy statistics of all groups were first completed followed by cross 
tabulation of each possible combination of variables. The printed results came 
out as a large file of more than  eight thousand pages (Plate 5.3). These tables 
were examined and the most relevant and interesting ones have been included 
in Appendix C3. Examples of these results are discussed in the following sec­
tions.
No significant difference was found between the right and  left eyes for 
any of the 32 param eters studied in this series. Many of these param eters are re­
lated to functions which in spite of being performed by each eye individually, are 
finally dependent on one and the same visual processing system. For such  par­
ameter statistical analyses performed apply only to the data appertaining to the 
right eyes. Right and left eye data were not pooled for any statistical test.
The independent t-test was used to compare m eans of numeric variables. 
The linear discriminant function analysis was used for the calculation of risk  pre­
diction equations.
5.3. RESULTS:
5.3.1. Population characteristics:
During the time allocated for data collection (12 months) 258 case notes 
from! a total o f408 identified patients were available for examination. Two hundred 
and twenty four (86.8%) of these patients met with the inclusion criteria (Sec­
tion 5.2.2).
The population of our series consisted of 174 (78%) females and 50 (22%) 
males. The distribution of sex in the original list which contains 408 nam es is 
295 (72%) females and 113 (28%) males which does not vary significantly from 
the overall study group.
Summary of the studied sample:________________________ _____
Total num ber of p a tien ts  identified 408
- Fem ales 295
-M ales 113
N um ber of c a s e  n o te s  available 258
- Appointments sent for re-assessm ent 179
Dead 7
Moved 3
Did not attend 24
• N um ber of c a s e s  en tered  into th e  s tu d y  224
Males 50
Females 174
Routine follow-up 49
Patients attended for re-assessm ent 145
Dead (adequate data) 9
Moved (adequate data) 21
Table 5.2
General information and summary of the studied series of patients.
Of the 224 patients, a t presentation, the youngest was a 17 year-old girl 
and the oldest an  86 year-old man. The different age groups at presentation were 
normally distributed with the mean being 49 years (Figure 5.3). Table 5.2 sum ­
marises the m ain characteristics and findings in this population.
Figure 5.4 shows the distribution of the duration of thyroid dysfunction 
prior to the onset of ophthalmopathy a t the time of presentation (excluding the 
49 patients who were euthyroid). The m ean duration of thyroid dysfunction was 
ju s t over 52 m onths while the mode was 12.
The m ean follow-up time for this study is ju s t over 10 years with a  stand­
ard deviation of 6.
5.3.2. Systemic findings: 
Thyroid status:
As expected the largest proportion of patients were hyperthyroid a t pres­
entation (46%). However, ju s t over half were either hypothyroid (32%) or euthy­
roid (22%). All the patients who presented initially as being euthyroid developed 
thyroid dysfunction during the follow-up period (as this was one of the inclusion 
criteria). Eventually 15% of patients became hypothyroid and 85% euthyroid with 
or without thyroid hormone replacement therapy a t the time of’final’ assessm ent.
Treatment of thyroid dysfunction:
In our series 38% had received radioiodine treatm ent and 43% had had 
the antithyroid drug carbimazole. Only 19% had undergone partial thyroidec­
tomy prior to presentation with ophthalmopathy.
5.3.3. Severe and mild groups: 
Population details:
Of the 224 patients, 167 (75%) were included in  the mild group while 57 
(25%) met with the criteria for inclusion in the severe group. In the mild group 
34 (20.4%) were males with a mean age of 47.7 years and 133 (79.6%) were fe­
males with a  m ean age of 49.1 years. The num ber of males in the severe group 
was 16 (28.1%), which constitutes a larger proportion than  the mild group and
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the m ean age of the males was also about one decade higher at 53.3 years. The 
num ber of females was 41 (71.9%) and the mean age was 45.9 years.
Duration of thyroid dysfunction:
In this series the m ean time from the date of diagnosis of thyroid dys­
function to the onset of ophthalmopathy for females was 59.4 and 43.3 months 
for the mild and severe groups respectively (p<0.314). The mean duration for 
males was 21.4 months in the mild and 26.8 months in the severe group (p<0.727) 
These values are not significant, however, the difference between males and fe­
males is significant and means tha t fewer males develop ophthalmopathy b u t if 
they do this tend to occur more quickly than in females.
Follow-up period:
The m ean follow-up periods for the mild and severe groups were 10.8 and 
9.7 years respectively. However, the m ean follow-up period for the females (10.5 
years) was two years more than that for males (8.2 years). In the mild group the 
m ean follow-up period was 10.8 years for males and 10.6 years for females.
Systemic findings: 
Thyroid status:
About a quarter of each of the ’thyroid sta tu s’ groups (at onset) developed 
severe ophthalmopathy. Twenty six (25%) of the hyperthyroid patients, 20 
(28.2%) of the hypothyroid patients and 11 (22.4%) of the euthyroid patients de­
veloped severe disease.
Goitre:
The presence of goitre was documented in,77'(42%) of the 185 patients 
for whom this sign was sought. Of these, 16 (20.8%) patients developed severe 
disease. Of the 108 patients who did not have goitre at presentation, 32 (29.6%) 
patients developed severe disease. On the other hand, one third of the severe dis­
ease group and 44.5% of the mild group had had goitre.
On ’final’ assessm ent only 14 (10.9%) patients in the whole group still 
had goitre. Four of them were in the severe group and 10 in the mild group.
Pretibial dermopathy and thyroid acropachy:
Only 3 (5.9%) patients in the severe group and 4 (2.9%) in the mild group 
had had pretibial dermopathy, while thyroid acropachy was documented in only 
one patient who was eventually classified into the severe group.
Thyroid myopathy:
None of the severe group patients had had thyroid myopathy a t onset, 
the two reported cases were among the mild group. However, during the follow- 
up period, one patient in the severe group developed thyroid myopathy.
Treatment of thyroid dysfunction: 
Antithyroid drugs:
At presentation, 87 (43%) patients had had carbimazole treatm ent for 
hyperthyroidism. Of these 24 (27.6%) patients developed severe disease. Of the 
111 patients who were treated by other means 27 (24.3%) patients developed 
severe ophthalmopathy.
Radioactive iodine:
Of the 78 patients who were treated with radioactive iodine, 23 (29.5%) 
developed severe disease while out of 126 patients who did not have this treat­
m ent 28 (22.2%) developed severe ophthalmopathy.
Partial thyroidectomy:
Partial thyroidectomy had been carried out for 40 patients before the 
onset of ophthalmopathy. Of these 11 (27.5%) were eventually placed in the severe 
group. Out of the 166 patients who did not have surgery, 41 (24.7%) were in the 
severe group.
Ocular conditions: 
Eyelid and conjunctiva:
Fifty (98%) patients in the severe group had lid lag compared to 135 
(88.2%) in the mild group. Only one case (2%) of the severe group had no detect­
able lid lag. Lid retraction was detected in 187 patients of whom 52 (27.8%) were
Mild and severe groups
Severity of 
Disease
Row
total
mild severe
Cornea R. 
Normal cornea
138
76.7%
85.7%
4 2 
23.3% 
73.7%
180 
100.0% 
82 . 6%
Punctate keratitis
21 
63 . 6% 
13'. 0%
12
36.4%
21.1%
33 
100.0% 
15.1%
Corneal ulceration
1
25.0% 
. 6%
3
75.0%
5.3%
4
100.0% 
1.8%
Corneal scarring
1
100.0% 
. 6%
1
100.0% 
.5%
Column total
161 
73 .9% 
100.0%
57 
26.1% 
100.0%
218 
100.0% 
100.0%
TABLE 5.3 
The condition of the cornea at onset 
in mild and severe groups.
in the severe group. On the other hand only one case in the severe group had no 
lid retraction.
Lid oedema was documented in 58.8% (30) of the severe group of patients 
and in  only 30.6% (45) of the mild group. Also 40% of those who presented with 
lid oedema developed severe disease in contrast to 17.1% of those who did not 
present with lid oedema. Similarly 74.4% of patients who presented with che- 
mosis were in the severe group while only 20.9% of those without chemosis were 
in this group. Finally, one case only in the mild group presented with ptosis rather 
than  lid retraction.
Cornea:
Table 5.3 shows that 26.4% [n= 15] of the severe group presented with 
comeal involvement while only 14.2% [n=23] of the mild group had comeal ab­
normalities. Also it can be seen tha t 23.3% [n=42] of the patients presented with 
normal comeae developed severe ophthalmopathy later while 36.4% [n= 12] of the 
patients presented with superficial punctate keratopathy and 75% [n=3] of those 
who presented with comeal ulceration developed severe disease.
Fundus examination:
Five cases presented with disc oedema which obviously placed them into 
the severe disease group. Only three cases presented with choroidal folds, two of 
these progressed to severe ophthalmopathy.
Extraocular muscles:
Diplopia was one of the presenting symptoms in 90 patients. In 51 of 
them  diplopia was mild, in 28 patients diplopia was moderate and in  11 patients 
diplopia was severe (Appendix Cl). Table 5.4 demonstrates that 31% [n=16] of 
the mild diplopia patients, 46% In= 13] of the moderate diplopia patients and only 
18% [n=2] of the severe diplopia cases took the severe course. In contrast, only 
20% [n=26] of patients who did not have diplopia on presentation developed 
severe disease.
Tables 5.5 and 5.6, which show the relation between the course of the 
disease and diplopia a t presentation as detected by clinical examination and as 
assessed by Hess screen testing respectively, establish results which are com-
Mild and severe groups
Severity of 
Disease
Row
total
mild severe
Symptom of diplopia 
No diplopia
103 
79.8% 
63 . 6%
26 
20.2% 
4 5.6%
129 
100.0% 
58.9%
Mild diplopia
35 
68. 6% 
21. 6%
16 
31.4% 
28 .1%
51 
100.0% 
23.3%
Moderate diplopia
15 
53 . 6% 
9.3%
13
46.4%
22.8%
28 
100.0% 
12.8%
Severe diplopia
9
81.8%
5.6%
2
18.2%
3.5%
11 
100.0% 
5.0%
Column total
162 
74 . 0% 
100.0%
57
26.0%
100.0%
219 
100.0% 
100.0%
TABLE 5.4 
Diplopia as a presenting symptom 
in mild and severe ophthalmopauhy groups.
Mild and severe groups
Severity of 
Disease
ROW
total
mild severe
Diplopia on 
examination 
No diplopia
83 
83. 0% 
55.7%
18 
17. 0% 
31.6%
106 
100.0% 
49.3%
Up / down
6
54.5%
3.8%
5
45.5%
8.8%
11 
100.0% 
5.1%
Add / abd
12
48.0%
7.6%
13
52.0%
22.8%
25 
100.0% 
11.6%
Close to midline
17 
73 .9% 
10. 8%
6
26.1%
10.5%
23 
100.0% 
10.7%
Extreme gaze
35
70.0%
22.2%
15
30.0%
26.3%
50 
100.0% 
23.3%
Column total
158 
73.5% 
100.0%
57 
26.5% 
100.0%
215 
100.0% 
100.0%
TABLE 5.5
Diplopia elicited on initial examination 
in relation to mild and severe groups.
(Up/down = D i p l o p i a  on e l e v a t i o n  o r  d e p r e s s i o n .  
A d d / a b d  =  D i p l o p i a  on a d d u c t i o n  o r  a b d u c t i o n . )
Mild and severe groups
Severity of 
Disease
Row
total
mild severe
Ocular motility R. 
Normal
82 15 97
84.5% 15.5% 100.0%
52.9% 26.8% 46.0%
R. Up gaze
31 8 39
79.5% 20.5% 100.0%
20.0% 14.3% 18.5%
R. Down gaze
1 2 3
33.3% 66.7% 100.0%
. 6% 3 . 6% 1.4%
R. Up & Down
8 2 10
80.0% 20.0% 100.0%
5.2% 3 . 6% 4.7%
R. Add
1 1 2
50. 0% 50. 0% 100.0%
. 6% 1.8% .9%
R. Add & Abd
7 6 13
53 .8% 46.2% 100.0%
4.5% 10.7% . 6.2%
Combination
25 22 47
53.2% 46.8% 100.0%
16.1% 39.3% 22.3%
Column total
155 56 211
73.5% 26.5% 100.0%
100.0% 100.0% 100.0%
TABLE 5.6 
Ocular motility (orthoptic assessment) 
at onset in mild and severe groups.
(R. Up g a z e  = R e s t r i c t e d  up g a z e .
R. Down g a z e  -  R e s t r i c t e d  down g a z e .
R. Up £  Down =  R e s t r i c t e d  up and  down g a z e .  
R. A dd  = R e s t r i c t e d  a d d u c t i o n ■
R. A d d  £  A bd  = R e s t r i c t e d  a d d u c t i o n  and  
a b d u c t i o n ,  C o n ib in a t io n  =  C o m b in a t io n  o f  
r e s t r i c t i o n s . )
parable to Table 5.4. As expected, by clinical examination more cases of ocular 
motility disorders (109) were detectd.
The relationship between thyroid and ocular myopathy:
In this series both of the patients who presented initially with thyroid 
myopathy [n=2] and the patients who developed myopathy later [n=l] all de­
veloped extraocular muscle dysfunction.
Intraocular pressure:
The m ean intraocular pressure a t presentation of the mild group was
16.8 mm. Hg. and the standard deviation was 4, while in the severe group it was 
19 mm. Hg. and the standard deviation was also 4. This difference was statisti­
cally significant (p<0.002). On ’final’ assessm ent both the mild and the severe 
groups had identical m ean intraocular pressures of 16.2 mm. Hg. with standard 
deviations of 3 (p<0.937).
The m ean intraocular pressure on upgaze was 22.5 mm. Hg. for the mild 
group and the standard deviation was 6, while in the severe group it was 
25.6 mm. Hg. and the standard deviation was 5 (p<0.052). On the ’final’ assess­
m ent the mild group m ean pressure was 21 mm. Hg. and the standard deviation 
was 5 while in the severe group, the m ean was 19.2 mm. Hg. and the standard 
deviation was 4. This difference was not significant (p<0.200).
Furthermore, the num ber of cases diagnosed as having and who were 
treated for open angle glaucoma in the whole series was only 5 (2.2%).
Exophthalmometry:
The m ean exophthalmometric reading of the severe group (22.9 mm.) was 
significantly higher than that of the mild group (20.6 mm.)(p<0.0005). The ’final’ 
outcome for both groups was very close, with readings of 20.6 and 20.5 in mild 
and severe groups respectively (p<0.924).
MILD GROUP
CASE
NO.
INITIAL V. 
ACUITY
'FINAL'V. 
ACUITY
EXPLANATION OF LOW 
VISUAL ACUITY
028 2/60 3/60 Strabismic amblyopia
096 6/60 CF Myopic degeneration
203 CF CF Old retinal detachment
009 6/12 CF Senile cataract
062 6/12 6/60 Senile cataract
197 6/12 6/60 Marked glaucomatous cupping
Table 5.7 Explanation of visual loss in 
patients of the mild group whose visual acuity 
was 6/36 or less at presentation or at 'final' 
assessm ent.
Treatment of ophthalmopathy:
Of the 57 patients in the severe group 19 (33%) had been treated with 
systemic steroids only and 18 (32%) had undergone surgical decompression while 
20 patients (35%) required both.
Extraocular muscle surgery was carried out for 37% [n=21] of the severe 
group and for only 5% [n=12] of the patients in the mild group.
Perm anent tarsorrhaphy was required for 11% [n=6] of the severe group 
and for 5% [n=8] of the mild group.
5.3.4. Visual acuity:
Figure 5.5 shows the distribution of the various visual acuity levels of 
the whole series a t presentation. The majority of patients in either the severe or 
the mild groups had visual acuities of 6 /1 8  or better and the most frequently re­
corded acuity was 6 /6 . The same also applies to the distribution of visual acuity 
a t ’final’ assessm ent (Figure 5.6).
Figure 5.7 shows that the majority of patients had ’final’ visual acuities 
which, in general, did not differ from those a t the initial assessment. Both mild 
and severe groups behaved in a  similar m anner regarding the ’final’ visual acuity 
(Figure 5.8). However, the two cases with the worst ’final’ visual outcome were 
amongst the severe group.
The scattergram of Figure 5.9 shows tha t the overall visual outcome of 
patients who underwent orbital decompression and those who were treated with 
steroids only is nearly the same. However, two cases in the steroid treated sub­
group ended up  with the worst ’final’ visual acuity of the whole series.
Table 5.7 shows that amblyopia, myopic degeneration, and old retinal 
detachment were the causes of reduced visual acuity at presentation in three pa­
tients in the mild group. The ’final’ visual acuities of the other three patients were 
reduced because of senile cataract in two and advanced glaucoma in the third 
patient.
ro
o
03
o
.o.
o
cn
o
03
o
-sj
o
O
T 1
ro
03
o
"O
JDt ¥•
© a
Z J
C/5
c
3cr
CD
C/5c
SL
poc
crj
03
o
ZS C Q
Cl
CD00
X
Figure 
5.6
’F
inal’ visual acuity 
of the 
mild 
and 
severe 
groups.
(0ctt
fi>oc
(Overlapping 
points 
are 
represented 
by 
one 
m
ark)
O O O
0 5 CO O —A
II II II II II II
0 5 0 5 0 5 CO O z
0 5
CO
0 5
O
0 5
O
"11 * D
r
_ l _ k O O O
_ k 0 3 O l NO
11 II II II II II
0 5 0 5 0 5 1 3
0 5 CO 0 5 0 5 r
NO 0 5 O O
_ x O 0
CO O l NO CO 0 5
11 II II II II
0 5 0 5 0 5 c n r o
CO NO 0 5 0 5
0 0
IIX
CD
0 '  5 -  
cn ~
2 ,§L‘
SIor — o ^
—  03 O =r
X <
® CO
c5*g0  zL
T 1
CQ'c—I 
0
cn
CDro 05o00cnroo
o
05
v <  OD
o
ro
05
(/>
«a
3o
CL
o r''jo
3
_L —L o o
02 CO o -n|
II II II II II
cn 02 cn CO o
02 an 02 “TT03 o O
_JL _l O o o
-n4 ■t* —L 0 3 ai ro
II II II II ll ll
02 02 02 ”0
02 CO 02 02 r~
ro 02 O O
—L _L o o
00 cn ro to 02
II ll ii II II
02 02 02 02 ro
2* CO ro 02 02
4* O o
IIX
CD
o
c_
CO d2"! 5"
CD CD =;
*  - £ « ?—i “ 3  U 2
CD SU C  
CQ = r g _ 3
3 .  5 ‘ od
o  
c
T 3 __
co q . 5L
CD
Z3
a .
a .
00O ro oocoroo
o
ro
cn
o
ro
V  V  V
V  V
V  V02
V  V
00
(O
verlappingpoints 
are 
represented 
by 
one m
ark)
A
O
CDOO
3~o
COr  11 
0 —iO
CL 
0
CD O
CO L<"
o ’U
_JL _i. _L O  O  O
0  CO O  n J 4^ - 1
II II II II II II
3 )  ^  3 )  OV“TI “0  oo o  o  r~
§  S  P
Si ii ii H I' n35  C7) CD 4^ ^  i'
01 GO CD CD p -  
DO CD O  o
CD ro CD CD CO
00
II
CD II II II II 
CD CD CD r\o
cd r o  o5 cd 4^  O  o
S-co
o  «  -  o  E .g .
■ = 3  — - 
CD 03 13 0  —
0  o 05
0
0
ZJ
Q_
§ 0 =£
0 £  0 C 0  “
o  ^  <  
c q  E .  - -
3  ° - c
c  0
2  " "  0  Q .
ZD
c q 'c
—T 
0
CD
CD
ro 05 CD ro 05 CO
o
ro
<
0 *  "  C
0_
Q )  0 5 "
o
c _
CD - -
9 ■ 
*<
T3 o—*
0
0
00
A  A
A  A
05
A  A
A  A
SEVERE GROUP
CASE
NO.
INITIAL V. 
ACUITY
'FINAL'V. 
ACUITY
EXPLANATION OF LOW VISUAL ACUITY
t  052 6/12 H.M § Optic nerve atrophy
t  114 6/18 N. P .L § Comeal ulcer - graft - enucleation
t 132 6/36 6/12 Choroidal folds - increasing hypermetropia
t  181 6/12 6/36 § Rapid deterioration - emergency decompression
t 193 6/12 4/60 § Reduced vision after decompression
t 195 6/60 3/60 Myopic degeneration, aphakia since onset, glacoma- trabeculectomy later
*  164 6/12 6/36 § Reduced vision after decompression
Table 5.8 Explanation of visual loss in patients of the severe group whose 
visual acuity was 6/36 or less at presentation or at 'final' assessment
t  Patients treated with steroids.
$ Patients treated with orbital surgical decompression. 
§ Ophthalmopathy-related visual loss.
In the severe group (Table 5.8), two of the patients who were treated with 
systemic steroids, and who subsequently lost vision, presented with visual 
acuities of 6 /1 2  and 6 /18 . The ’final’ visual acuities were ’hand movements’ and 
’no perception of light’ respectively. Optic atrophy was the cause of reduction of 
vision in the first patient and comeal ulceration in the second.
Of the five patients who were treated with orbital decompression, one 
showed improvement from 6 /3 6  (accompanied with choroidal folds) a t presenta­
tion, to 6 /12  a t ’final’ assessm ent. Three had reduced visual acuity (by more than 
two lines) immediately following orbital decompression with no recovery after­
wards and only one had ocular problems which were not related to dysthyroid 
ophthalmopathy.
5.3.5. Extraocular muscle surgery:
Of the 33 patients who required extraocular muscle surgery in this series 
7 (21.2%) had had no diplopia on presentation, 9 (27.3%) presented with mild, 
12 (36.4%) with moderate and 5 (15.2%) with severe diplopia (Table 5.9).
At presentation there was no diplopia in 6 (31.6%) of the 19 patients who 
were treated with steroids only and in 20 (52.6%) of the 38 patients who required 
decompression (Table 5.10). Eventually, only 4 (22.2%) of the steroid subgroup 
and 17 (44.7%) of the decompression subgroup needed extraocular muscle 
surgery. On ’final’ assessm ent 53% of the patients who underwent orbital decom­
pression were free from diplopia in contrast to 75% for the steroid treated sub­
group.
5.3.6. Effect of decompression:
At presentation, the m ean intraocular pressures were 17.3 mm. Hg. and
19.8 mm. Hg. in the steroid and the decompression subgroups respectively 
(p<0.051). The ’final’ m ean pressure of the decompression (15.9 mm. Hg.) was 
lower than  tha t of the steroid subgroup (17.1 mm. Hg.), b u t the difference was 
not statistically significant (p<0.225).
The m ean exophthalmometric reading of the steroid subgroup was
20.8 mm. and the reading for the decompression subgroup was 23.6 mm a t pres-
-8 5 -
Muscle surgery
Symptom of diplopia Row
total
No
diplopia
Mild
diplopia
Moderate
diplopia
Severe
diplopia
Muscle surgery 
No
111 
68 .5% 
94.15
37 
22. 8% 
80.4%
9
5.6%
42.9%
5
3.1%
50.0%
162
100.0%
83.1%
Yes
7
21.25
5.9%
9
27.3%
19.6%
12 
3 6.4% 
57 .1%
5
15.2%
50.0%
33
100.0%
16.9%
Column total
118 
60.5% 
100.0% .
46 
23 . 6% 
100.0%
21 
10.8% 
100.0%
10 
5.1% 
100.0%
195
100.0%
100.0%
Table 5.9
The re la tionsh ip  betw een diploma a s  a p resen ting  sym ptom  and  the need  for
m uscle surgery.
Severe group
Symptom of diplopia Row
total
No
diplopia
Mild
diplopia
Moderate
diplopia
Severe
diplopia
Steroids only
6
31.6%
23.1%
6
31.6%
37.5%
6
31. 6% 
46.2%
1
5.3%
50.0%
19
100.0%
33.3%
Surgical decompression
20 
52. 6% 
76.9%
10
26.3%
62.5%
7
18.4%
53.8%
1
2.6%
50.0%
38
100.0%
66.7%
Column total
26
45.6%
100.0%
16
28.1%
100.0%
13
22.8%
100.0%
2
3.5%
100.0%
57
100.0%
100.0%
T able  5 .10
D ip lop ia  a t  p re se n ta tio n  in th e  s te ro id  a n d  th e  d e c o m p re s s io n  su b g ro u p s .
entation (p<0.016). Very close m ean readings were found on the ’final’ assess­
m ent of the steroid treated (20.0 mm) and the decompressed (20.8 mm) sub­
groups (p<0.681).
In the severe group 6 patients required perm anent tarsorrhaphy 4 of 
whom had had surgical decompression.
5.3.7. Diagnosis of optic nerve compression:
Optic nerve compression had been diagnosed in 25 of the 57 patients of 
the severe group. Figure 5.10 shows the relative importance of visual acuity, oph­
thalmoscopy, field of vision and colour vision testing in detecting patients with 
optic nerve compression. It also shows that the combination of field loss and col­
our vision deterioration was the most helpful param eter in making the diagnosis.
Indications for treatm ent in this group are shown in Figure 5.11. Cor­
neal exposure comes first (23 patients) then optic nerve compression (22 pa­
tients). Only one patient in this series was treated for cosmetic reasons as the 
m ain indication.
A larger proportion of the decompression subgroup suffered from optic 
nerve compression [n=15] and from comeal exposure [n=13] than  in the steroid 
subgroup where the num ber of patients with nerve compression and comeal ex­
posure were 7 and 10 respectively (Figure 5.11).
5.3.8. Efficiency of individual parameters at presentation for the 
prediction of outcome: 
Introduction:
The results presented in the previous sections provide background infor­
mation about the diagnosis and the ’final’ outcome in the various patient groups 
and subgroups. The efficiency of each individual clinical test or observation in 
predicting the ’final’ outcome will be calculated. This gives some indication as to 
the importance of each param eter based on the data of the present study. The 
efficiency (or accuracy) values are one of the essential requirements for building 
an  expert system (Chapter 8).
n
Geo
II CQII
O  Q -
<  CD 
co’ ^  
o  w
13 C - 0) 
o©i-Q .
3Jff
|| s0 9 .O 0) 
o  ^  
S  o
<8  0t - g f s
3 _
O  CD
P d 
m©
'^CD O 
CJI-Q‘ 0
03*
CO
. I—t
II ©
00 § 
o  3
8 -CD CDQ- 0 0 0
3  o '
03 33
< 5 ‘>  0 
II ©
5 :0
8 30_(Q
0  o o c c "O
00
o
oin
ii
S oW
30
O 23
o 0 3 -  
O  0
0 3 3 m ^  3
o ^
- - g  -  
cn o  cl 
—19! o II 0  0in 3o—H 13 2^ C W  c
05 m2 "n^
CQ-0 c —ic  X 0 O 0 
o  n g  cd  o
0-  ^  3  = :  0  - i .  0( 0 0 3  _l=? 0  r^ - «-+• 00 _ -j0
O - 3
n ©
o S  Eg
■§•.©5
°  0  0 X ©O CQT5
0
30
O
o g " Po
3“Q
0
0
0
O*
3
Accuracy of different observations:
Param eter Sensitiv ity Specificity Predictive value
Lid lag 0.93 0.00 0.28
Lid retraction 1 .°° 0.03 1.00
Table 5.11
Sensitivity, specificity and predictive values of lid lag and lid retraction at 
presentation in predicting patients who are likely to develop corneal problems.
Definitions and calculations:
The efficiency of any diagnostic test is assessed by determining the rates 
of true and false positive results and true and false negative results which are 
defined as follows (Chard, 1988):
□ True positive (TP): The result is positive in the presence of the clinical ab ­
normality.
a  True negative (TN): The result is negative in the absence of the clinical 
abnormality.
a  False positive (FP): The result is positive in the absence of the clinical ab­
normality.
Q False negative (FN): The result is negative in the presence of the clinical 
abnormality.
Sensitivity is an  index of the proportion of all cases of the clinical abnor­
mality correctly identified by the test. Specificity is an  index of the proportion of 
all patients in whom the absence of the condition is correctly identified. Predic­
tive value is an  index of the proportion of all patients who have the condition 
identified by the test and who actually have the condition (Chard, 1988). The for­
mulae for calculation of these efficiency indices are as follows:
Sensitivity =
Specificity =
Predictive Value=
TP
TP+FN
TN
TN+FP
TP
TP+FP
These values have been calculated from the contingency tables (Appen­
dix C3) for the param eters which are relevant to the detection of patients who de­
velop severe disease. This includes identification of patients who are likely to have 
comeal problems (Table 5.11), those who are likely to run  a  severe course 
(Table 5.12) and the prediction of patients who might require surgical orbital de­
compression or steroid treatm ent for severe disease (Table 5.13).
Accuracy of different observations:
P aram eter S ensitiv ity Specificity Predictive value
Lid lag 0.98 0.12 0.27
Lid retraction 0.98 0.14 0.28
Lid oedema 0.59 0.69 0.40
Chem osis 0.35 0.86 0.47
Ptosis 0.00 0.99 0.00
Cornea 0.26 0.87 0.40
Disc oedema 0.02 1.00 1.00*
Choroidal folds 0.04 0.99 0.67*
Symptom of diplopia 0.54 0.65 0.35
Diplopia on examination 0.68 0.56 0.36
Goitre 0.33 0.56 0.21
Pretibial dermopathy 0.06 0.97 0.43*
Thyroid acropachy 0.02 0.67 1.00*
Thyroid myopathy 0.00 0.99 0.00*
Cardiac failure 0.02 0.98 0.25*
Guanethidine 0.38 0.65 0.30
Carbimazole Rx 0.47 0.57 0.27
Propranolol Rx 0.20 0.89 0.28
T4 Rx 0.61 0.48 0.29
T3 Rx 0.18 0.76 0.21
Radioiodine Rx 0.45 0.64 0.29
Partial thyroidectomy 0.21 0.81 0.28
Diabetes 0.04 0.96 0.25*
Hypertension 0.11 0.90 0.29*
Table 5.12
Sensitivity, specificity and predictive values of various clinical parameters for 
assessm ent of the severity of thyroid ophthalmopathy (* Five cases or less).
Accuracy of different observations:
P aram eter Sensitiv ity Specificity P redictive value
Lid lag 1.00 0.05 0.66
Lid retraction 1.00 0.05 0.67
Lid oedema 0.64 0.50 0.70
Chem osis 0.39 0.72 0.72
Ptosis 0.00 1.00 0.00
Cornea 0.24 0.68 0.60
Symptom of diplopia 0.47 0.32 0.58
Diplopia on examination 0.63 0.61 0.63
Orthoptic assessm en t 0.16 0.68 0.89
Disc oedema 0.07 0.89 0.38 *
Choroidal folds 0.05 1.00 1.00*
Goitre 0.29 0.57 0.62
Pretibial dermopathy 0.05 0.94 0.67*
Thyroid acropachy 0.03 1.00 1.00*
Thyroid myopathy 0.00 1.00 0.00*
Cardiac failure 0.03 0.17 0.10*
Guanithidine treatment 0.70 0.61 0.67
Carbimazole Rx 0.43 0.44 0.63
Propranolol Rx 0.21 0.81 0.70
T4Rx 0.53 0.63 0.75
T3 Rx 0.09 0.63 0.34
Radioiodine Rx 0.46 0.56 0.70
Partial thyroidectomy 0.22 0.81 0.73
Diabetes 0.00 0.82 0.00*
Hypertension 0.11 0.88 0.67*
Table 5.13
Sensitivity, specificity and predictive values of various clinical parameters in 
predicting patients who are likely to require surgical orbital decompression 
amongst the severe group (* Five cases of less).
Discriminant analysis techniques:
1) Independence-based models for unordered categorical data.
2) Lancaster class model.
3) Lancaster first-order interaction models for unordered categorical data.
4) Kernel-based procedures for categorical data.
5)’Linear and quadratic’ discrimination based  on normality assumptions.
6) Linear logistic discrimination.
7) Loglinear models.
8) Non-parametric methods on orthogonal series.
9) Continuous kernel methods.
10) Location model.
11) Independent class model.
12) Latent class model.
Table 5.14
Various available discriminant analysis techniques summarised by Titterington
etal. (1981)
5.3.9. Risk prediction:
Introduction:
In the previous section the predictive value of each test or clinical obser­
vation was calculated individually and the interplay of other variables was not 
taken into account. It is impossible to make a complete mental picture using 
these individual efficiency indices and the statistical significance values to make 
predictions. A technique is required which shows the combined effects of a  set of 
independent variables and the separate effect of each independent variable in re­
lation to the others.
Statistical methods:
Several techniques for discriminant analysis can be applied on complex 
sets of data. Table 5.14 enumerates some of these techniques. The complexity of 
data sets in the present study was caused by the inclusion of data which could 
be regarded as being continuous, binary, or ordered categorical, and the occur­
rence of missing values.
The performance of six discriminant analysis techniques was compared 
by Titterington et aL (1981) using criteria of prognostic success and reliability. 
They concluded that, in general, performance varies more with the choice of the 
set of predictor variables than  with tha t of the discriminant rules. Linear dis­
crim inant function analysis was used in the present study.
Linear discriminant function analysis:
This is a  statistical technique for deciding into which category of a vari­
able a  case is most likely to fall. Individuals in the study are assum ed to belong 
to one or other ’outcome category’. A linear combination of the independent vari­
ables is formed and serves as the basis for assigning cases to groups. Thus in­
formation contained in multiple independent variables is summarised in a  single 
index.
A discriminant rule is set up to assign an  individual to one of the out­
come categories. A ’training data set’ of individuals whose outcome categories is 
known is used to construct the discriminant rule. A ’test data set’ of individuals
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whose outcome categories is also known, is required for the evaluation of the dis­
criminant rule used. Often the training set and the test set are the same. Less 
biased evaluation can be achieved if a  ’leaving-one out’ technique is used. This 
technique involves leaving out each of the cases in turn, calculating the function 
based on the remaining cases, and then classifying the left-out case. If the sample 
is large enough separate test and training sets are used (Norusis, 1988).
Variable selection methods:
The two methods used in this analysis are summarised as follows:
1. Stepwise selection:
In this method the first variable included in the analysis has the largest 
acceptable value for the selection criterion. After the first variable is entered, the 
value of the criterion is re-evaluated for all variables not in the model, and the 
variable with the largest acceptable criterion value is entered next. At this point, 
the variable entered first is re-evaluated to determine whether it meets the remo­
val criterion. If it does, it is removed from the model.
The next step is to examine the variables not in the equation for entry, 
followed by examination of the variables in the equation for removal. Variables 
are removed until none remains that meets the removal criterion. Variable selec­
tion is terminated when no more variables meet entry or removal criteria.
2. Forced entry method:
In this method all variables are entered simultaneously in the discrimi­
nan t analysis.
Variable selection criteria:
Several criteria for variable selection are available. This analysis uses 
minimisation of Wilk’s lambda which is the ratio of the within-groups sum  of 
squares to the total sum  of squares. Thus, in each step the variable th a t results 
in the smallest Wilk’s lambda for the discriminant function is selected for entry.
Predictorvariables:
1. Exophthalmometry (in mm.)
2. Age (In years)
3. Duration of thyroid dysfunction (in months)
4. Sex
5. Corneal condition
6. Thyroid status
7. Lid oedema
8. Chemosis
9. Ptosis
10. Cornea
11. Disc oedema
12. Choroidal folds
13. Symptom of diplopia
14. Diplopia on examination
15. Goitre
16. Pretibial dermopathy
17. Thyroid acropachy
18. Myopathy
19. Cardiac failure
20. Guanethidine Rx
21. Carbimazole Rx
22. Propranolol Rx
23.T4RX
24.T3RX
25. Radioiodine Rx
26. Partial thyroidectomy
27. Diabetes
28. Hypertension
Table 5.15
Variables entered for discriminant function analysis.
Outcome categories:
Two discriminant analysis models have been computed. The first pre­
dicts the severity of thyroid ophthalmopathy using a stepwise variable entry 
method. The outcome categories are ’severe disease’ and ’mild disease’. The sec­
ond model predicts the need for orbital surgical decompression using a forced 
entry method. The outcome categories are ’decompression’ and ’no decompress­
ion’.
Predictor variables:
The variables which had been judged as candidates for testing were first 
selected. The initial selection was based on statistical significance, indices of ef­
ficiency and clinical impression. Discriminant analysis was then used as an  ex­
ploratory tool in order to arrive a t the set of ’good’ predictor variables. Table 5.15 
shows the list of the predictor variables which had been finally selected for test- 
ing.
The linear discriminant equation:
To calculate the discriminant function score the following equation is
used:
D = Bo + B1X1 + B2X2 + ... + BpXp
The Xs are the values of the independent variables and the Bs are coef­
ficients estimated from the data. If a linear discriminant function is to distinguish 
between patients who develop severe disease from those who continue to have 
only mild disease, the two groups m ust differ in their D values.
The group centroid is the point corresponding to the m ean score of the 
group on each function. In classifying cases, the predicted group m embership is 
the one whose centroid is closest to the case’s discriminant function scores i.e. 
the D value.
Prediction of disease severity:
Four predictor variables were accepted in the model. These were exoph- 
thalmometric reading in millimeters, thyroid status  (Table 5.16), diplopia  
on examination; and duration o f thyroid dysfunction in months, ordered
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Discriminant function coefficients:
+ 0.2561361 = Exophthalmos in millimeters (Luedde).
+ 0.2493058 = Diplopia on examination .
+ 0.6831180 = Thyroid status .
- 0.0052511 = Duration of thyroid dysfunction (in months).
- 6.8772280 = Constant.
Table 5.16
The coefficients of the four predictor variables of the linear discriminant 
equation for classifying patients into severe or mild categories.
= diplopia on examination code: (0 = no diplopia, 2 = in extreme gaze, 3 =on elevation or depression, 4 = on adduction or 
abduction, 5 = close to midline). * *= thyroid status: (1 = hyperthyroidism, 2 = hypothyroidism, 3 = euthyroidism).
according to their relative importance in terms of contribution to the overall dis­
criminant function. Including additional variables did not substantially improve 
prediction. Table 5.16 shows the discriminant function coefficients. The group 
centroid of the mild cases is (- 0.37366) and of the severe cases is (+ 0.71929). 
The percent of cases which was correctly classified into mild or severe using this 
model was 74%.
Orbital decompression risk prediction:
The discriminant function coefficients of this model which predicts pa­
tients who are likely to require orbital surgical decompression are listed in 
Table 5.17. The forced entiy variable selection method was used in computing 
this model. Seventeen independent predictor variables were accepted. Using this 
model, a  correct classification rate  of 81% was achieved.
(Appendix C5 contains the full discriminant function analysis computer 
print out of the two models).
5.4. DISCUSSION:
5.4.1. Population characteristics:
In the present study which had been running for 22 years every effort 
was made to avoid introduction of any element of bias. The lapse of such  a long 
period would tend to eliminate already elderly patients who had been seen a t the 
outset of the study. Patients had either been discharged, recovered, moved or 
died. The inclusion criteria were carefully designed to cope with these potential 
sources of bias inherent in such a long-term prospective study. However, this 
series can represent only the population of patients typically referred to a  re­
search ophthalmic clinic in a teaching hospital.
The female to male ratio is in accordance with tha t presented in previous 
series of patients (Mulvany, 1944; Werner, 1971). The disease is four times more 
common among women than  m en b u t in older age groups the sex distribution is 
equal. The distribution of age among the males and females is alm ost the same. 
The rate of onset (in severe cases) is more rapid in males.
Discriminant function coefficients:
+ 0.5723660 = Sex of the patient (1 =MALE, 2=FEMALE).
- 0.0353433 = Age of the patient (in years).
- 0.2620977 = Visual acuity.*
+ 0.2562185 = Lid oedema (1=NO,2=YES).
+ 0.9450156 = Chemosis (1=NO, 2=YES).
- 0.0847337 = Cornea-”
+ 0.7151085 = Disc oedema (1=NO, 2=YES).
+ 1.0887400 = Choroidal folds (1 =NO, 2=YES).
+ 0.1239730 = IOP straight (mm. Hg.).
- 0.1581213 = Symptom of diplopia-
+ 0.0524721 = A ssessm ent of ocular motility by Hess t e s t . f  
+ 0.0388947 = Thyroidectomy (1 =NO, 2=YES).
+ 0.1326484 = Radioactive iodine treatment (1=NO, 2=YES). 
+ 0.1255362 = Exophthalmos (in millimeters).
+ 0.0014569 = Diplopia on examination. $
+ 0.1238457 = Thyroid status. §
+ 0.0025597 = Duration of thyroid dysfunction (in months). 
-3.8321760 = Constant.
Table 5.17
The coefficients of the predictor variables of the linear discriminant equation for 
identification of patients who are likely to require orbital decompression and
those who are not.
* = Visual acuity:
01=NPL
04=CF
07=3/60
10=6/60
13=6/18
16=6/6
** = C ornea:
1=NORMAL 2= SUPERFICIAL PUNCTATE KERATITIS 
4=NECROSIS/ PERFORATION 
*** = Sym ptom  of diplopia:
1=NONE
3=MODERATE
t  = H ess te s t:
1=NORMAL
3=RESTRICTED DOWN-GAZE 
5=RESTRICTED ADDUCTION 
7=RESTRICTED ADDUCTION & ABDUCTION 
9=FIXED EYE
t  = Diplopia on  exam ination:
1=ABSENT
3=ON ELEVATION/DEPRESSION 
5=IN EXTREME GAZE
§ = Thyroid s ta tu s :
1 = HYPERTHYROIDISM 
3 = EUTHYROIDISM
02=PL 03=HM
05=1/60 06=2/60
08=4/60 09=5/60
11=6/36 12=6/24
14=6/12 15=6/9
7=6/5 18=6/4
3=ULCER 
5= SCARRING
2=MILD
4=SEVERE
2=RESTRICTED UP-GAZE 
4=RESTRICTED UP & DOWN-GAZE 
6= RESTRICTED ABDUCTION 
8= COMBINATION OF RESTRICTIONS
2=IN EXTERME GAZE
4=ON ADDUCTION/ABDUCTION
2 = HYPOTHYROIDISM
The m ean duration of thyroid dysfunction before the onset of thyroid oph­
thalmopathy is 52 months, the standard deviation is 77 and the mode is 12 
months. This means that there were a  few patients in the group who had had 
thyroid dysfunction for many years prior to the onset of ophthalmopathy, which 
skews the data to the right.
5.4.2. Systemic findings:
Thyroid status:
In the present study 49 patients were euthyroid on presentation of whom 
69% became hyperthyroid and 31% became hypothyroid. They all did so within 
a mean period of 10 years. It can therefore be argued tha t all such patients should 
be subject to tests of thyroid function for up to 10 years from presentation. How­
ever, no valid comparison can be made between our series and other studies of 
’euthyroid Graves’ ophthalmopathy’ because CT scans were not available a t pres­
entation of our patients to make the diagnosis. Therefore, the development of ab­
normal thyroid sta tus a t onset or during follow-up was a criterion for inclusion 
in our study.
Treatment of hyperthyroidism:
It has been the clinical impression of a num ber of ophthalmologists tha t 
the administration of radioiodine treatm ent may be associated with the onset of 
dysthyroid eye disease and in particular its severe form. The series described 
here represents a  group of patients who had been referred from various hospi­
tals in the West of Scotland because of their ocular conditions. One cannot draw 
any conclusions regarding the incidence of ophthalmopathy in different treat­
ment groups from such a selected sample. A knowledge of the proportion of pa­
tients who had been offered a particular form of therapy i.e., radioactive iodine, 
partial thyroidectomy or medical treatm ent with antithyroid drugs is a  first re­
quirement. Furthermore, it is expected tha t these figures will vary in different en­
docrinology departm ents and may change in the same department over years.
However, for the series described, the proportion of patients presenting 
with severe dysthyroid eye disease following radioiodine treatm ent was similar 
to that which had received medical or surgical treatm ent. Recognising the ca­
veats outlined above, this fails to lend credibility to the popularly held belief th a t
radioiodine treatm ent is more liable to produce severe dysthyroid disease than  
the alternative treatments.
5.4.3. Severe and mild groups: 
Classification:
In the present study, patients were categroised into severe and mild out­
come groups because the emphasis was on the long-term effects of thyroid oph­
thalmopathy. Formal classifications (Section 3.5.2) were used only as a  guide for 
devising the coding system (Appendix Cl).
Population characteristics:
A quarter of the patients in our series ran  a severe course. This clearly 
demonstrates the potential seriousness of the condition which should be con­
sidered, along with chronicity, when discussing the disease and its complications 
with the patient.
The female to male ratio of the whole group was maintained in the mild 
group (i. e., 4:1), while in the severe group the ratio was ju s t  above 3 :1. This ratio 
is higher than  other studies by Mulvany (1944) and Werner (1971) who found an  
equal sex distribution in the severe group. This difference might be explained, a t 
least in part, by the difference in the classification criteria of patients into mild 
and severe adopted in different series.
5.4.4. Systemic conditions: 
Thyroid dysfunction:
Our results support the views of Gorman (1984) who reported tha t pre- 
tibial dermopathy is rarely seen in the absence of overt ophthalmopathy and that 
thyroid acropachy, the rarest expression of Graves’ disease, is found only in  pa­
tients who also have had the thyroid, eye, and skin manifestations of Graves’ dis­
ease. However, in the present study, the num ber of patients showing these signs 
is too small to reach definitive conclusions. This is also true for thyroid myopathy 
and cardiac failure as the presenting manifestation of hyperthyroidism.
Treatment of hyperthyroidism:
The receipt of antithyroid medication or radioactive iodine treatm ent or 
having undergone thyroidectomy did not seem to influence the course of the dis­
ease. Although, previous radioiodine therapy or thyroidectomy were associated 
with increased incidence of severe ophthalmopathy, this difference was not sta t­
istically significant.
Furthermore, patients whose management included receiving thyroxine 
or triiodothyronine developed the severe form of ophthalmopathy more frequent­
ly compared to those who did not receive hormonal therapy. This is more likely 
to be due to the endocrinologists tending to prescribe these hormones for pa­
tients showing evidence suggesting that their ophthalmopathy might be severe. 
The rationale is to suppress the production of excess thyrotropic hormone by the 
pituitary gland.
Ocular condition: 
Eyelids:
Lid lag and eyelid retraction are among the most characteristic signs of 
thyroid ophthalmopathy. Larger proportions of patients with these signs were in 
the severe group for whom only a very small num ber did not have them.
Comparing the mild and the severe groups, the sensitivity of both lid lag 
and lid retraction (at onset) is 0.98 while the specificity is 0.12 and 0.14 and the 
predictive value is 0.25 and 0.28 for lid lag and lid retraction respectively. These 
signs are therefore among the most useful clinical signs for making the diagnosis 
of thyroid ophthalmopathy. However, their value is limited in predicting its 
course. The present study confirms the observations of McLarty (1973) who re­
ported an  incidence of lid retraction of more than  90% in hyperthyroid patients.
Lid oedema (sensitivity 0.59) and chemosis (sensitivity 0.35), a t onset, 
are not as helpful in making the diagnosis as lid retraction and lid lag. However, 
lid oedema with a  specificity of 0.69 and a predictive value of 0.40 and chemosis 
(specificity 0.86 and predictive value 0.47) are more consistently associated with 
severe ophthalmopathy and are therefore better predictors of the severity of the 
disease. These signs give an  indication of the severity of soft tissue changes, the
presence of increased orbital pressure and vascular engorgement, which in tu rn  
reflect the severity of the condition.
Cornea:
In the present study, the degree of comeal involvement a t presentation 
closely paralleled the severity of ophthalmopathy. It is of course not surprising 
tha t severe comeal disease is correlated with the severity of ophthalmopathy be­
cause it is one of the indications for treating the patient with systemic steroids 
or orbital decompression. Our results indicate that comeal disturbances a t onset 
are indicative of the development of severe ophthalmopathy especially if the cor­
neal involvement is in the form of comeal ulceration.
Furthermore, comeal disturbance a t onset is not very helpful in making 
the diagnosis (sensitivity 0.26) bu t it is among the more specific param eters (spe­
cificity 0.87) in predicting the severity of the disease (predictive value 0.40).
The correlation between the degree of comeal disturbance and the se­
verity of the ophthalmopathy is understandable in view of the pathogenesis of 
comeal involvement in this disease. Five factors are thought to be associated with 
comeal exposure in thyroid ophthalmopathy, namely, upper lid retraction, 
exophthalmos, lagophthalmos, inability to elevate the eyes, and a decreased blink 
rate (Day, 1978; Werner, 1978; Sergott and Glaser, 1981).
Fundus examination:
Disc oedema is pathognomonic of optic nerve compression if the diag­
nosis of ophthalmopathy is not in question, this explains the high specificity and 
predictive value (both are 1.00). However, it occurs only in a  minority of cases 
(8.8% [n=5] of severe cases in this series), which also explains the very low sen­
sitivity (0.02).
Choroidal folds were seen in only three patients, two severe and one mild. 
This num ber is too small to draw firm conclusions regarding their predictive 
value.
Extraocular muscles:
Our results indicate tha t the severity of ocular motility disturbances (at 
onset) is correlated with the severity of the course of the disease. This is true for 
the symptom of diplopia (sensitivity 0.54, specificity 0.65, and predictive value 
0.35), ocular motility disorders detected on clinical examination (sensitivity 0.68, 
specificity 0.56, and predictive value 0.36) and orthoptic assessm ent, including 
Hess test, (sensitivity 0.73, specificity 0.53, and predictive value 0.53). These 
values indicate that the presence of ocular motility disturbance is one of the sen­
sitive param eters both in making the diagnosis of ophthalmopathy and in pre­
dicting that the disease is likely to follow a severe course.
These results are in full agreement with those of Trokel and Jakobiec 
(1981). They studied 200 orbits of patients with thyroid ophthalmopathy using 
high resolution CT scans and concluded that the extraocular muscles are the 
most consistently involved focus of disease in this disorder. They also concluded 
that, clinically and radiologically, the range of extraocular muscle abnormality 
varies from minimal enlargement of a few muscles in mild disease to enormous 
enlargement of multiple muscles in severe disease. These observations have been 
substantiated by histopathological evidence of both biopsy and autopsy tissue 
(Daicker, 1973).
The relation of thyroid and ocular myopathy:
Thyroid myopathy which was documented in 3 patients of this series was 
also associated with extraocular muscle dysfunction. Very little has been pub­
lished about thyroid myopathy. Perhaps the num ber of cases is so small tha t a 
satisfactory clinical study is virtually impossible.
Intraocular pressure:
It was established that only 2.2% of the whole series had open angle glau­
coma which is the same ratio in the general population (Perkins, 1974). This in­
dicates th a t intraocular pressure rise detected during the course of the disease 
probably does not result in an  increased incidence of glaucomatous visual loss 
(Section 3.8.7). These results are in accordance with a previous study by Cheng 
and Perkins (1967) who studied 155 patients with thyroid ophthalmopathy and 
found only 2 cases of glaucoma.
Exophthalmometry:
In the present series the severe ophthalmopathy group had a mean 
exophthalmometric reading of 22.9 mm, a t presentation, which is significantly 
higher than  the m ean reading of the mild group (p<0.0005). At ’final’ assessm ent 
there was no change in the m ean reading of the mild group while the reading of 
the severe group was 20.5 (STD 4). This is very close to the mild group value. 
W hether this was due to treatm ent or could have resulted from no treatm ent 
would require a  differently designed study which would probably be questionable 
from the ethical point of view.
Intraocular pressure and exophthalmometry after 
decompression:
The m ean intraocular pressures and exophthalmometric readings, a t 
presentation, were significantly higher in the decompression than in the steroid 
subgroup. At ’final’ assessment, no significant difference was found in intraocu­
lar pressure or in exophthalmometric readings between the two groups.
5.4.5. Visual acuity:
A valid statistical analysis is not possible for the present series in which 
there was a range of affected visual acuity before the onset of the disease or arose 
during the follow-up. However, it can be concluded that although the overall vis­
ual outcome is good, the disease represents a real threat to vision and can result 
in perm anent damage or even loss of the eye.
In this series, 4 patients had a reduction of vision (6/36 or less) due to 
optic nerve compression and one patient lost his eye due to comeal ulceration 
and perforation.
Three patients had reduced visual acuity following decompression. One 
might argue about the safety of surgical decompression. Certainly this procedure 
has its own risks, however, it can also be argued that reduction of visual acuity 
after decompression might be related to surgery being performed late in the 
course of the disease.
5.4.6. Extraocular muscle surgery:
In our series, the proportion of patients whose management required 
extraocular muscle surgery following orbital decompression was not significant­
ly different from that following systemic steroid treatment. The majority of pa­
tients who required extraocular muscle surgery presented initially with diplopia 
as compared with those who did not.
Ham er (1984) stated tha t "in orbital decompression there is a  consistent 
alleviation of certain problems, b u t other problems are created, i.e., extraocular 
muscle imbalance." In a  study of 200 patients who had transantral orbital de­
compression DeSanto (1984) reported that 70% of the total group required 
extraocular muscle surgery and tha t even if normal ocular motility existed be­
fore decompression, muscle dysfunction was still possible after surgery. How­
ever, in our series, there was no significant difference between the decompressed 
and the steroid treated subgroups in the ’final’ ocular motility nor in the propor­
tion of patients requiring extraocular muscle surgery.
5.4.7. Diagnosis of optic nerve compression:
Four param eters were used in making the diagnosis of optic nerve com­
pression in the 25 patients in this series who suffered from this condition. These 
comprised visual acuity, ophthalmoscopy, field of vision and colour vision test­
ing which were available for all the patients in this subgroup (Figure 5.10). In 12 
patients only one test was positive and the diagnosis was made on that basis 
(Visual acuity drop of more than  two lines [n=4], disc oedema [n=4], colour vision 
deterioration [n=l] and visual field changes [n=3]). In 13 patients the diagnosis 
was based on a  combination of two or more of these tests. The combination of 
visual field loss and colour vision deterioration was the most helpful amongst 
other tests.
No single sign or test was found to be positive in all of the patients with 
optic nerve compression. Furthermore, in 4 of the 5 patients who presented with 
disc oedema, visual acuity was normal and no changes were detected either in 
the visual field nor in the colour vision test results. This is in accordance with 
the findings of Sergott and Glaser (1981) who showed th a t the appearance of the
optic disc does not correlate with visual acuity nor does it predict the patient’s 
recovery of vision with treatm ent unless optic atrophy is severe.
Furthermore, the variability of visual acuity in patients with optic nerve 
compression in the present series is in agreement with previous studies (Werner, 
1969; Kennerdel etaL, 1981).
Changes in the field of vision were detected in 15 out of the 25 patients 
with optic nerve compression. This is the most consistent finding in  our series. 
This is also in accordance with the results of other investigators (Cant and Wil­
son, 1974; Trobe, 1981; Sergott and Glaser, 1981, Kennerdel etaL, 1981;Younge, 
1984). Further analysis of the field charts of this series in order to study the pat­
tern  of field loss will be carried out in the second stage of this project (Chapter 7).
5.4.8. Indications for treatment of patients in the severe group:
Comeal problems and optic nerve compression were on the top of the list 
of indications for treatment. A larger proportion of patients with optic nerve com­
pression was treated with orbital decompression than  with systemic steroids. 
This can be interpreted as reflecting the policy of the surgeons who tended to 
consider th a t decompression is more justifiable in patients with optic nerve com­
pression than  with other conditions. It may also indicate tha t optic nerve com­
pression is simply more steroid resistant because a large num ber (52.6% [n=20]) 
of patients who had undergone orbital decompression had a  preliminary trial of 
systemic steroids.
In this series the principal indication for surgical decompression was 
optic nerve compression whereas comeal pathology was deemed to w arrant 
surgery less frequently. It is recognised that optic nerve compression differs from 
other indications in the necessity for immediate relief of an  ostensibly ’m echan­
ical’ problem. It should also be recognised that the results reported are based on 
a  study which started over 20 years ago when current technical and technologi­
cal advances in orbital surgery and in general anaethesia were not available. How­
ever, comeal ulceration was the cause of a disastrous outcome in the only patient 
who lost his eye in this series despite orbital decompression. Therefore, it should 
be emphasised tha t comeal disturbances can be as serious as optic nerve com­
pression and may w arrant decompression, especially in the presence of marked 
exophthalmos.
5.4.9. Risk prediction:
Descriptive statistics and univariate tests of significance provide basic 
information about the distribution of the variables in this series and help ident­
ify some differences among the groups. However, any accurate prediction requires 
more than  such lists of separate prognostic variables. The interrelationships of 
these variables, and their combined predictive power need to be investigated. In 
discriminant analysis and other multivariate statistical procedures, the em­
phasis is on analysing the variables together, not one a t a time. By considering 
the variables simultaneously it is possible to incorporate im portant information 
about their relationships.
Linear discriminant function analysis does not require assumptioiis 
about the variance of the dependent variable. In fact, it is designed to work with 
nominal dependent variables. It is a  convenient technique for evaluation of the 
association between large sets of independent variables and a dependent vari­
able (Hedderson, 1987). One of the limitations of the linear discriminant func­
tion analysis, however, is that it cannot handle well a dependent variable with a 
large num ber of values. Interval variables m ust be re-coded into a small num ber 
of categories, which involves loss of some detailed information (Norusis, 1988).
The two models which have been computed were aimed at fulfilling two 
different requirements. The first model, which predicts the severity of the dis­
ease, needed to be based on the least possible amount of information that gives 
the best possible accuracy of prediction. This is the reason for the use of the step­
wise variable selection method which resulted in only 4 param eters being in­
cluded in the model.
The second model for prediction of the requirement for orbital decompress­
ion was intended for patients who had been first classified into the severe group 
using the first model. These cases require a  complete work-up (history, examin­
ation and investigation) before the second model can be used, therefore, reduc­
tion of the num ber of predictors was not as important as in the first model. The 
forced entry variable selection method was used in the computation of the sec­
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ond model to make use of the increase in the predictive value by inclusion of a 
large num ber of variables.
Both models were intended to be used in building a  thyroid eye disease 
expert system (Chapter 8) m aintaining the highest possible levels of accuracy. 
Therefore, no attem pt has been made to simplify these two models to be suitable 
for use by a clinician as a  kind of scoring system.
In the first model the analysis identified 4 risk factors for the prediction 
of outcome in terms of the severity of the course. Prediction is based on the clini­
cal findings a t the time of presentation of the patient with ophthalmopathy. 
Exophthalmometric reading was the most important predictor followed by thy­
roid sta tus then diplopia on examination. The duration of thyroid dysfunction 
was the fourth and the least important predictor in terms of discrimination be­
tween the mild and severe outcome categories. It can be concluded that, a t pres­
entation, the greater the exophthalmometric reading, the more likely is the 
development of severe disease. Euthyroid patients are more likely to run  a more 
severe course than  hypothyroid patients who are in tu rn  more a t risk than  pa­
tients who present with ophthalmopathy associated with thyrotoxicosis. Ocular 
motility disorders a t presentation as elicited by clinical examination is another 
risk factor whose magnitude is correlated with the severity of diplopia. Further­
more, the longer the period from the time of diagnosis of thyroid dysfunction to 
the onset of ophthalmopathy, the greater the risk of developing severe disease. 
These risk factors m ust be used in combination in order to accurately predict the 
likelihood of a particular patient being classified into the mild or the severe out­
come group.
The second model which achieves 81 % correct prediction was computed, 
based on the values of 17 param eters for the prediction of the necessity of su r­
gical orbital decompression. The percentage of cases classified correctly is often 
taken as an  index of the effectiveness of the discriminant function. When evalu­
ating this measure, it is im portant to compare the observed miss-classification 
rate to that expected by chance alone. If there are two groups with equal prior 
probabilities, the expected miss-classification rate is 50%. The rate of correct 
classification of the first and the second models (74% and 81% respectively) can 
be regarded as highly satisfactory considering that they are based on clinical par­
ameters only because the new advanced imaging techniques, with their high di-
agnostic value, were not available a t the outset of the study and therefore were 
not included in this series.
The medical literature contains reports of the successful application of 
discriminant analysis based on an  independent models for prediction of outcome 
in coma patients following head injury (Jennett, Pitts and Murray, 1980; Teas- 
dale et aL, 1976; 1981; Titterington et aL, 1981) and in prophylaxis of deep vein 
thrombosis (Crandon et aL, 1980), bu t to the author’s knowledge, these risk fac­
tors for the potential development of severe optic nerve pathology have not hither­
to been described.
5.5. SUMMARY:
The results of a  prospective review of the long-term effects of dysthyroid 
eye disease are presented. The study involved 224 patients (174 females and 50 
males) who presented to the Tennent Institute of Ophthalmology, Glasgow, be­
tween 1961 and 1983 who were traced and ’finally’ reassessed. The age of the 
patients ranged from 17 to 68 years with a  m ean of 49 years and the m ean fol­
low-up time was 10 years.
Patients were grouped into ’mild subgroup’, whose management had re­
quired only conservative measures, and ’severe subgroup’ who had been deemed 
to necessitate systemic steroids or orbital surgical decompression. The female to 
male ratio was 1:4 in the mild group and 1:3 in the severe group. Fewer males 
developed severe ophthalmopathy, bu t when they did this tended to occur more 
quickly than  in  females.
At presentation, the largest proportion of patients were hyperthyroid. The 
49 patients who initially presented with ophthalmopathy associated with norm al 
thyroid function developed thyroid dysfunction within 10 years. The treatm ent 
received for thyroid dysfunction did not seem to influence the course of the dis­
ease in our series. Thyroid acropachy and pretibial dermopathy were associated 
with severe disease, bu t the num ber of patients was small.
The diagnostic sensitivity of the presence of lid lag and lid retraction a t 
presentation was high bu t the specificity and the predictive value were low. Lid
oedema and chemosis were less sensitive in making the diagnosis of ophthalmo­
pathy b u t they were more consistently associated with severe disease (specificity: 
Lid lag 0.69, chemosis 0.86).
Patients who presented with comeal ulceration were more likely to de­
velop severe disease. Comeal disturbance at presentation was not particularly 
sensitive bu t was one of the more specific parameter in predicting severity of the 
disease (specificity 0.87).
The mean exophthalmometric reading (Luedde) a t presentation was 
22.9 mm in the severe group, which was significantly higher than  tha t of the mild 
group (20.6 mm). Similarly, the m ean intraocular pressures a t presentation both 
in the straight-ahead and in upgaze were significantly higher in the severe than 
in the mild group. At ’final’ assessm ent, no difference was found in the exoph­
thalmometric or the intraocular pressure readings of the two groups. Surgical 
orbital decompression was significantly more effective in reducing both the in­
traocular pressure and the exophthalmometric readings than  systemic steroids. 
Open angle glaucoma was found in 2.2% of patients a t ’final’ assessm ent which 
m atches the proportion in the general population.
The severity of extraocular muscle involvement a t the onset of ophthal­
m opathy was correlated with the severity of the course of the disease (diplopia: 
Sensitivity 0.54 and specificity 0.65). All the patients who developed thyroid 
myopathy were also suffering from ocular myopathy, bu t the num ber of patients 
was too small [n=3] to draw any firm conclusions. The majority of patients who 
required extraocular muscle surgeiy presented initially with diplopia. Decom­
pression was not associated with a  significant increase in the num ber of patients 
requiring extraocular muscle surgery; an  association which has been noted in 
other studies.
Reduction of visual acuity (2 or more lines), optic disc oedema, visual field 
loss, and colour vision deterioration were the param eters used to make the diag­
nosis in the 25 patients with optic nerve compression. No single test was suffi­
ciently sensitive to be positive in all of these cases. In 13 patients the diagnosis 
was based on a  combination of two or more of these parameters; the m ost im­
portant of which was field loss combined with colour vision deterioration. Disc 
oedema was reported in 5 patients and choroidal folds in only three.
Optic nerve compression was the most common indication for surgical 
decompression followed by comeal ulceration. Decompression was carried out 
for cosmetic reasons in only one patient in this series. More than  half of the pa­
tients in the decompression subgroup had a  trial of systemic steroids before the 
operation was contemplated.
The present study emphasises the potential sight threatening nature of 
thyroid ophthalmopathy. Two patients had marked reduction of visual acuity (to 
6 /3 6  or less) due to optic nerve compression and one patient lost his eye due to 
comeal ulceration and perforation.
A linear discriminant function equation has been computed. The ana­
lysis identified 4 risk factors for the prediction of outcome in term s of severity of 
the course of the disease. Prediction is based on the clinical findings a t the time 
of presentation of the patient with ophthalmopathy. Exophthalmometric reading 
was the most important predictor followed by thyroid sta tus then diplopia on 
examination. The duration of thyroid dysfunction was the fourth and the least 
im portant predictor in terms of discrimination between the mild and severe out­
come categories. It can be inferred that the greater the exophthalmometric read­
ing, a t presentation, the more likely is the development of severe disease. 
Euthyroid patients are more likely to ru n  a  severe course th an  hypothyroid pa­
tients who are in tu rn  more a t risk than  patients who present with ophthalmo­
pathy associated with thyrotoxicosis. Diplopia a t presentation as elicited by 
clinical examination is another risk factor whose severity is correlated with the 
severity of ophthalmopathy. Finally, the longer the period from the time of diag­
nosis of thyroid dysfunction to the onset of ophthalmopathy, the greater the risk 
of developing severe disease. These risk factors m ust be used in combination in 
order to accurately predict the likelihood of a particular patient being classified 
into the mild or the severe outcome group. This model gives a  74% correct classi­
fication rate.
A second model which achieves an  81% correct prediction has been com­
puted based on the values of 17 param eters for the prediction of the necessity of 
surgical orbital decompression.
Both models were intended to be used in building a  thyroid eye disease 
expert system (Chapter 8).
CHAPTER 6.
COMPUTER SYSTEMS FOR PATIENT ASSESSMENT
6.1. INTRODUCTION:
Microcomputers potentially provide a  means of assessing a  wide range 
of visual functions. This chapter outlines the development and preliminary as­
sessm ent of a  system which we have devised that imposes temporal constraints 
on the m easurem ent of visual acuity.
6.1.1. Snellen acuity:
The ability to discriminate the letters of the Snellen chart has provided 
the m ainstay of visual assessm ent since the last centuiy. This is because the test 
is accurately reproducible, quick to perform, and provides a relatively sensitive 
screening test for impairment of visual function. However, a ’normal’ visual acuity 
of 6 /6  can be achieved by a person who has extensive pathological damage of the 
visual apparatus. For example, in the present study of dysthyroid eye disease 
(Section 5.3), 17 of the 25 patients who had optic nerve compression demon­
strated normal visual acuities despite the nerve condition. A test is therefore re­
quired which can be rapidly performed, is repeatable and which has a high degree 
of sensitivity to facilitate the detection of such individuals.
6.1.2. Temporal assessment of visual acuity:
The reciprocal relationship between the luminous flux and the duration 
of a test flash for the threshold visual function is well known (Bloch, 1885); the 
longer the exposure, the lower the level of illumination required for detection of 
a test light as long as flash duration does not exceed a critical duration. The mag­
nitude of critical duration is significantly influenced by the level of adaptation. 
At higher levels of adaptation, critical duration tends to be shorter and temporal 
resolution is improved. When the eyes are in a  relatively dark adapted state, tem­
poral resolution is decreased b u t the system can respond to lower stim ulus le­
vels. It is suggested that this change in critical duration may reflect the transition 
from cone receptors in the light adapted state to rod receptors in the dark adapted 
state  (Brown, Phares and Fletcher, 1960; Brown and Black, 1976).
Kahneman and Norman (1964) showed that critical duration is in general 
shorter when the brightness criterion is employed than  when a criterion depend­
ent upon form discrimination is employed. Kahneman (1964) dem onstrated the 
possibility of obtaining rather longer integration times for the resolution of form.
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Nachmas (1967) has also reported evidence for longer temporal summation time 
with fine gratings as compared to coarse gratings.
In an  experiment concerned with the possible influence of eye movements 
on visual acuity Keesey (1960) demonstrated tha t for a  given level of illumina­
tion, grating visual acuity increases with increased duration of exposure up  to 
200 msec. The results were the same when the image was stabilised on the reti­
na  as when image movements could occur.
Baron and Westheimer (1973) have reached a  similar conclusion based 
on experiments involved a  Landolt C target under photopic conditions of adap­
tation. They also ruled out any role of pupillary or accommodative fluctuation by 
employing a  small artificial pupil and using a cycloplegic.
Researchers in both psychology and physiology are using an  experimen­
tal device called tachistoscope. Zusne (1970) reviewed the principle of the variety 
of available tachistoscopes. All operate on the same basic principle, namely, 
presenting a  visual display for a very brief period of time, usually some fraction 
of a  second. The exact control of time may be accomplished in a  num ber of ways: 
A gas discharge tube, a  specially wired neon lamp or a  mechanical device such 
as large photographic shutters.
No published work of which we are aware provide a  system for clinical 
assessm ent of temporal acuity based on the widely used Snellen optotypes.
6.2. GENERAL DESCRIPTION OF THE SYSTEM:
The test provides a temporal assessm ent of visual acuity and has been 
called TEMPRAC. TEMPRAC assesses the time taken to perceive each level of 
Snellen visual acuity. The Snellen visual acuity is a  m easure of the smallest angle 
which the individual components of a letter of the alphabet m ust subtend a t the 
eye for that letter to be discriminated when it is presented a t maximum contrast. 
The normal limit of resolution for the eye is 1 m inute of arc.
Individuals who have a relatively normal visual acuity in association with 
pathological damage of the visual system, whether it be the eye, optic nerve, chi-
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Plate 6.1
Shows the letter H surrounded by confusion bars displayed on a Black/White monitor 
which is placed 6  meters from the patient.
Plate 6.2
The examiner, the patient, the colour monitor and the keyboard.
asm  or optic radiations, may be subjectively aware of visual dysfunction despite 
a  ’normal’ acuity. One reason for this is that it takes longer to interpret a  visual 
image and tasks requiring vision thus become more time consuming.
A microcomputer system has been developed, as a prototype, which 
m easures the temporal as well as the spatial aspects of visual acuity. The hard­
ware configuration of the system comprises a  6MHz-IBM AT compatible com­
puter, two monitors, one of which is a  non-glare, black/white monitor (providing 
a maximum contrast black on white image), and a keyboard (Appendix E). The 
black/w hite monitor is placed a t 6 meters from the person being tested (Plate 6.1). 
The keyboard and the second monitor are placed on the desk beside the subject 
and are operated by the examiner (Plate 6.2). The examiner selects a  m anual or 
an  autom atic system.
6.2.1. Testing procedure:
After keying in the personal and administrative information about the 
patient, a  letter of the alphabet with the same dimensions of the 6 /6 0  Snellen 
optotype is presented on the monitor screen for a short period of time (current 
minimum 0.01 seconds). The individual being tested is asked to identify th a t let­
ter. If the letter is not identified, randomly selected letters of the sam e dimen­
sions are presented for sequentially longer periods, in 0.05 second steps, until a 
correct identification is made, for example on thee consecutive occasions.
The next letter to be presented corresponds to the ensuing line on a stand­
ard Snellen chart. This letter appears for the same maximum duration as the 
preceding letter, the time is again sequentially increased until accurate identifi­
cation is reached.
The ’crowding’ phenomenon is important in the m easurement of Snellen 
acuity. It is observed when acuity is poor and particularly in children with am- 
blyobia (Parr, 1981). The phenomenon results in easier recognition of letters when 
presented singly (angular acuity) than  when viewed in a  row. In tests such  as 
TEMPRAC, angular acuity is recorded and this could overestimate visual perfor­
m ance if confusion bars are not included (Parr, 1981). This has been taken into 
account and compensated for by surrounding each letter with such bars, the
H o s p i t a l  No,  1 2 3 4 2 2 a  h Age Code 6 D i a g ,  Code 1
8 ( 8 / 6 0 )  , , , 0 , 8 1  SECS
7 ( 6 / 3 6 )  , , ,  8 , 8 1  SECS
6 ( 6 / 2 4 )  , , , 8 , 0 1  SECS
5 ( 6 / 1 8 )  , , ,  0 , 0 5  SECS
4 ( 6 / 1 2 )  , , ,  8 , 1 5  SECS 
3 ( 6 / 9 )  , , , 0 , 3 5  SECS
2 ( 6 / 6 )  , , , 8 , 5 0  SECS 
1 ( 6 / 5 ) .  , , , 0 , 8 8  SECS
 ........................   i i i i i i i i i i i i i i ■ i i
8 ( 6 / 6 0 )  , , , 0 , 8 1  SECS
7 ( 6 / 3 6 )  , , , 0 , 0 1  SECS
6 ( 6 / 2 4 )  , , , 0 , 0 5  SECS
5 ( 6 / 1 8 )  , , ,  0 , 1 5  SECS
4 ( 6 / 1 2 )  , , ,  8 , 3 8  SECS 
3 ( 6 / 9 )  , , , 0 , 4 5  SECS
2 ( 6 / 6 )  , , , 0 , 9 5  SECS
A
S.OH
H .00
mi,
0 . 0 0
\ v
y ' o o  0 . 0 0  0 . i 7  0 . 2 5  0 , 3 3 0 . 1 2  0 . 5 0  0 . 5 8 - 0 . 5 5  0 . 7 5  0 . 8 3  0 . 3 1  1 . 0 0
. nasBas^acaHsssgffl
t0-00-jj
5 . 0 0  
1 . 00-1
2 . 0 0  
0.00
LEFT EVE
T I I
O'!00 o !o3 0 !  17 0 ! i 5  0 !s 3 0 . 1 2  0 . 5 0  0 . 5 3  0 . 5 5  0 . 7 5  0 . 3 3  0 . 3 1  1 . 0 0
Figure 6.1
A typical print out of TEMPRAC test result in graphical form.
components and separation of which from the optotype, subtend the same angle 
as the letter components.
The test is terminated when either all the letters have been correctly 
identified, or when no further letters can be recognised even when shown con­
tinuously.
The data accrued from the test can be printed out in graphical or n u ­
merical tabular form and are stored on the computer hard disk. A typical print 
out is shown in Figures 6.1 and 6.2. The interactive screen text is given in Ap­
pendix B l.
6.2.2. Software design:
The programme has been written using a Turbo Pascal compiler and a 
Turbo graphics toolbox (Appendix B2).
Figure 6.3 illustrates the m ain structure of the software programme. 
There is a procedure to draw each letter (using DrawUne, DrawSquare proce­
dures). The size and the period of letter presentation are chosen either autom ati­
cally or manually by the user a t the beginning of each consultation session. The 
’letters’ procedures are invoked randomly using a  ’random  num ber generation’ 
procedure. Changing letter dimensions is achieved by using a ’window zoom-out’ 
subroutine. All these procedures and subroutines are facilities offered in the 
Turbo Pascal Graphics Toolbox (Appendix B2).
In the Turbo Pascal ’letters’ procedure, a  letter is drawn bit by bit. This 
is rather a  slow process, during which the part of the letter which first appears, 
"grows" up to full size. What is actually needed is a  complete letter tha t appears 
for the preset specific period of time. To achieve this, the letter is first drawn in 
the virtual RAM screen (i.e. in the computer memory). Thus it rem ains invisible 
until it is completely drawn a t which time the image of the whole letter is moved 
to the display screen.
* * * * *
H OS.N U M .: 3 3 3 4 3 3
AGE CODE: 3  ' SEX : m
DIAGNOSIS CODE : t l
VAR CODE : 2 VAL CODE : 4
RIGHT EYE TEST
S I Z E ! PERIOD RESULT
8  ( 6 / 6 0 ) ! 0 0 . 0 1 SECS CORRECT
7 ( 6 / 3 6 ) ! 0 0 . 0 1 SECS UNRECOGNIZED
7  ( 6 / 3 6 ) ! 0 0 . 0 5 SECS CORRECT
6 ~ 7 6 / 2 4 >
1 l I I I l
O
l
O
l
O
l cm " s e c s UNRECOGNIZED
6  ( 6 / 2 4 ) i 0 0 . 1 0 SECS UNRECOGNIZED
6  ( 6 / 2 4 ) ! 0 0 . 1 5 SECS CORRECT
5  ( 6 / 1 8 ) : 00.15 SECS UNRECOGNIZED
5  ( 6 / 1 8 ) ! 0 0 . 2 0 SECS UNRECOGNIZED
5 ( 6 / 1 8 ) ! 0 0 . 2 5 SECS UNRECOGNIZED
5 ( 6 / 1 8 ) ! 0 0 . 3 0 SECS UNRECOGNIZED
5 ( 6 / 1 8 ) ! 0 0 . 3 5 SECS CORRECT
4 ( 6 / 1 2 ) ! 0 0 . 3 5 SECS UNRECOGNIZED
4 ( 6 / 1 2 ) 1 0 0 . 4 0 SECS UNRECOGNIZED
4  ( 6 / 1 2 ) ! 0 0 . 4 5 SECS UNRECOGNIZED
4  ( 6 / 1 2 ) ! 0 0 . 5 0 SECS CORRECT
3  ( 6 / 9 ) ! 0 0 . 5 0 SECS UNRECOGNIZED
3  ( 6 / 9 ) ! 0 0 . 5 5 SECS UNRECOGNIZED
3  ( 6 / 9 ) ! 0 0 . 6 0 SECS UNRECOGNIZED
3  ( 6 / 9 ) i 0 0 . 6 5 SECS CORRECT
2  ( 6 / 6 ) ! 0 0 . 6 5 SECS UNRECOGNIZED
2  ( 6 / 6 ) ! 0 0 . 7 0 SECS UNRECOGNIZED
2 ( 6 / 6 ) 1 0 0 . 7 5 SECS UNRECOGNIZED
2  ( 6 / 6 ) ! 0 0 . 8 0 SECS UNRECOGNIZED
2 ( 6 / 6 ) : 0 0 . 8 5 SECS CORRECT
1 ( 6 / 5 ) i 0 0 . 8 5 SECS UNRECOGNIZED
1 ( 6 / 5 ) ! 0 0 . 9 0 SECS UNRECOGNIZED
Figure 6.2
A typical print out of TEMPRAC test result in numerical tabular form.
RIGHTLEFT
LEFT/RIGHT/END
END
AUTOMATIC
MANUAL
RECOGNISED UNRECi X3NISED
STOP
CONTINUE
STOP
STOP/
CONTINUE
EXIT
CONTINUE/STOP
RECORDRESULTS
MANUAL/AUTOMATIC
GENERATE RANDOM LETTER
GET PATIENT 
INFORMATION
DRAW LETTER IN VIRTUAL MEMORY
DISPLAY LETTER FOR THE 
SPECIFIED PERIOD
DRAW THE LETTER 
IN THE VIRTUAL 
MEMORY
RECORDRESULTS 
AND INCREASE 
PRESENTATION 
. TIME v
INITIALISE 
SIZE= MAXIMUM 
SIZE= MINIMUM
RECORDRESULTS 
AND DECREASE 
LETTER 
DIMENSIONS .
GETTHEUSER 
DEFINED 
PRESENTATION TIME 
AND LETTER SIZE
GENERATE RANDOM 
LETTER
Figure 6.3 Showing the main operations of the TEMPRAC software algorithm.
The control of presentation time is achieved by a ’control loop’, where the 
’control variable’ is the machine’s real time obtained using the ’DOS’ interrupt 
function (Appendix Al).
It is important to point out tha t two of the performance param eters of the 
system are hardware dependent. Firstly, the accuracy of the letter dimensions a t 
various sizes is related to the display graphics card resolution (pixel dimensions). 
High resolution cards enables the production of greater dimension accuracy. Sec­
ondly, the minimum letter presentation time and the tolerance of successively 
longer presentation periods are dependent on the speed of the machine used (i.e. 
the microprocessor type, the clock frequency, and the monitor specifications).
The data acquired from the test are printed in graphical form using the 
’polygon’ procedure of the Turbo Pascal Graphics Toolbox (Appendix B2). The nu ­
merical form is printed or saved as a  table and also as a  text file in ’comma-de­
limited’ format which ensures direct translation to most of the standard spread 
sheets, databases, and statistical packages.
A copy of the software program is enclosed on a floppy diskette which 
can ru n  under MS or PC DOS on any IBM or compatible computer with hard­
ware configuration of colour graphics card (CGA), black/white monochrome 
monitor and 512 KB RAM as a  minimum. Software adjustm ents are needed if a  
processor or a clock speed other than  Intel 80286-6 MHz is used.
The programme has been written, debugged and calibrated by the joint 
effort and close collaboration a t all stages between the author and Mr. A. W. 
Ahmed, (programme listing is found in Appendix B3 and programme diskettet in 
Volume 2, pocket).
6.3. CLINICAL USE OF TEMPRAC:
6.3.1. Patient and methods:
Aims and protocois:
1. Normal volunteers:
Aim:
To determine the range of normal results for different age groups.
Protocol:
100 normal volunteers were examined, they were chosen from: 
a  Colleagues.
Q Friends.
Q Patients’ relatives and friends.
Test for repeatability:
Aim:
To determine the intra-observer repeatability.
Protocol:
Ten individuals were tested on 8-10 occasions a t different times of the 
day and different days of the week to evaluate the reproducibility of the test re­
sults.
Effect of induced errors of refraction:
Aim:
To establish whether errors of refraction affect the results obtained.
Protocol:
Ten patients were tested with the best correction then with a  +1.00 diop­
ter sphere, and finally with -1.00 diopter sphere added to their correcting lenses.
2. The assessment of the test following the central retinal 
dysfunction caused by central serous retinopathy (CSR):
Aim:
To determine whether patients with subtle central pathology, namely, with 
healed CSR and ’normal’ or near-normal visual acuity still demonstrate im­
pairm ent of temporal processing of image data.
Protocol:
A group of 23 patients who had had central serous retinopathy (CSR) 
were assessed by Dr. J . Mutlak in a  separate study. Temporal visual acuity were 
tested amongst other investigations to evaluate the long term visual outcome of 
CSR
3. The assessment of the test following optic nerve dysfunction due to 
retrobulbar neuritis:
Aim:
To determine whether patients whose visual acuity returned to ’normal’ after 
they had had unilateral retrobulbar neuritis still demonstrate impairment 
of temporal processing of image data.
Protocol:
A group of 12 patients who had had unilateral retrobulbar neuritis had 
the visual function of both eyes assessed by Dr. G. Craig by m eans of TEMPRAC.
Method of testing:
a  Snellen visual acuity was determined using the standard printed test 
type used in the clinic for examination of all cases.
n Each eye was examined while the other eye was covered.
o Each letter was presented once. If the patient was able to recognise it 
the next smaller letter was presented for the same period of time.
n If the patient failed to recognise the letter, the test was repeated three 
times using the same size and time setting.
Q The presentation time was increased only if the patient failed to recog- . 
nise the displayed letters for the third time.
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Enter Patient Sex (M/F)
Diagnosis Codes
Normal ------ —  (N)
Amblyopia --- —  (A)
Cataract ---- - —  (C)
(Cl) —  Congenital
(C2) —  Nuclear Sclerosis
(C3) —  PSCLO
Diabetes ---- —  (D)
(DN) —  No retinopathy
(DB) —  Background; no visible maculopathy
(DP) —  Proliferative; no visible maculopathy
(DO) —  Macular oedema
(DI) —  Ischaemic maculopathy
(DE) —  Exudative maculopathy
Glaucoma (OA) —  (G)
(GO) —  Ocular hypertension
(Gl) —  Baring of Blind spot
(G2) —  Arcuate scotoma
(G3) —  Constriction of part of field to <10 deg
(G4) —  Constriction of all field to <10 deg
Press Any Key
Diagnosis Code (cont.)
Hypermetropia — (H)
(HI) 0-5 DS
(H 2) — 6-0 DS
(H3) — 9+ DS
L e b e r ---------- (L)
Myopia--------- (M)
(Ml) 0-5 DS
(M2) — 6-10 DS
(M3) — 11 + DS
Optic N / CNS — (0) (O+number) referring to card file
Retinitis pig — (R) 
S M D ------------ (S)
(SI) Dry
(S 2) — Exudative
Thyroid--------(T)
(TO) — — Normal nerve function
(Tl) - Evidence of optic neuropathy
Unclassified ---(U)
Enter Diagnosis Code :
Figure 6.4
Coding system  used for data entry to TEMPRAC system.
a The test was terminated if the optotype 6 /5  was recognised or if no rec­
ognition was possible even when the maximum display time was 
reached (current maximum 0.95 seconds).
Calibration:
n The screen background and room illumination were measured using a 
photometer and were kept constant all the time by regular m easure­
m ents and adjustm ents.
a  The test distance was 6 meters.
Diagnostic code:
The coding system which was included in the test to facilitate data entiy 
is shown in Figure 6.4.
Documentation:
The results of the tests were automatically saved onto the hard disk of 
the computer. Regular backups and hard copies were made for all the collected 
data.
6.4. RESULTS:
6.4.1. Normal individuals:
The temporal visual acuity was assessed for 118 normal individuals the 
majority of whom were examined by the author. Their ages ranged from 14 - 79 
years (mean age 37 years). Fifty four (45.8%) were females and 64 (54.2%) were 
males. Figure 6.5 shows the distribution of various age groups of this sample.
The majority (93) of this group were emmetropes, 15 were myopes and 
only 10 were hypermetropes as shown in Figure 6.6.
The best corrected visual acuity was 6 /5  in 92, 6 /6  in 17 and 6 /9  in 9 
individuals of this group.
Frequencies of age groups tested with TEMPRAC
Number 30
10-19y 20-29y 30-39y 40-49y 50-59y 60-69y 70-79y
Age group
Figure 6.5
6/5 all ages
Noma Is
v '  X ' S /'«*■*• * ''-  '**,.■<*/' A1* vw s s -v «. r sV O'- *£
Myopes < 6DS
Hypemetropes < 6 DS
I
0 10 20 30 48 50
Number of cases
—I------ 1
70 88
Figure 6.6
Distribution of errors of refraction in the normal group.
No significant statistical difference was found between right and left eyes 
when the temporal acuity values for each individual optotype were compared. 
The results from only one eye were randomly selected for statistical analysis for 
each individual.
A typical test result for a  normal individual who achieved 6 /6 0  in 0.010 
seconds and 6 /5  in 0.150 seconds is shown in Figure 6.7.
Table 6.1 shows the m ean temporal acuity values of the whole group of 
normal individuals. It also shows tha t the m ean time required to recognise the 
different optotypes steadily increased from 0.010 seconds for the 6 /36  to 0.354 
for the 6 /5  letter. The standard deviation also increased correspondingly. All the 
values for the 6 /6 0  and 6 /36  optotypes were identical.
The frequency distributions of presentation times of the 6 /6  and 6 /  9 op­
totypes are shown in Figures 6.8 and 6.9 respectively. Table 6.2 shows details of 
the temporal acuity values for different age groups.
6.4.2. Test repeatability:
Ten normal volunteers were examined repeatedly to assess the reprodu­
cibility of the test. The test values were identical for the 6 /60 , 6 /36 , 6 /2 4  and 
6 /1 8  optotypes. The variability of the test values was within 1% for the 6 /1 2  op­
totype, 5% for the 6 /9  optotype 10% for 6 /6  optotype and 18% for the 6 /5  opto­
type. Figure 6.10 shows the 8 test results for one normal volunteer.
6.4.3. Effect of errors of refraction:
Snellen visual acuity did not deteriorate in any individual on adding 
-1 .0 0  diopter sphere lens. Creating myopia by placing + 1.00  diopter sphere in 
front of the eye resulted in deterioration of vision by one line in four out of the 
10 tested patients. However, the TEMPRAC test showed that the time required 
to achieve the same visual acuity was a t least doubled when a concave lens is 
added and more than  doubled when the lens was convex (Figure 6.11).
I j  
8.9-- 
8 .8 - -  
8.7- 
8.6--  
Iin 8.5-- 
8.4-• 
8.3-- 
8.2 - 
8 . 1 -■
SDH) SIX36 SD24 SIX1B SD02 SK3 SDCB SK5
Optolafc
Figure 6.7
A typical te s t result for a normal individual.
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TEM PO R A L VISUAL ACUITY
OPTOTYPE TEMPORAL STANDARD MIMIMUM 
ACUITY DEVIATION VALUE
MAXIMUM
VALUE
6 /6 0 0.010 0.000 0.010 0.010
6 /3 6 0.010 0.000 0.010 0.010
6 /2 4 0.012 0.012 0.010 0.100
6 /1 8 0.014 0.033 0.010 0.350
6 /1 2 0.031 0.101 0.010 0.900
6 /9 0.080 0.141 0.010 0.900
6 /6 0.235 0.224 0.010 0.950
6 /5 0.354 0.247 0.050 0.950
TABLE 6.1 T he tem poral acuity , s ta n d a rd  dev ia tion , 
mimim um an d  m axim um  va lues  for th e  w ho le  g ro u p  
of norm al indiv iduals a s s e s s e d  by TEMPRAC.
Tempral Visual Acuity
AGE GROUP 6 /5 6 /6 6 /9 6/12 6/18 6 174
10- - 19 years 0.238 (0.250) 0.134 (0.250) 0.026 (0.022) 0.010 (0.000) 0.010(0.000) 0.010 (0.000)
20 - 29 years 0.282 (0.208) 0.180 (0.189) 0.040 (0.054) 0.031 (0.125) 0.017(0.047) 0.012 (0.012)
30 - 39 years 0.412 (0.267) 0.239. (0.211) 0.052 (0.072) 0.016 (0.014) 0.011 (0.007) 0.011 (0.007)
40 - 49 years 0.441 (0.246) 0.284 (0.254) 0.090 (0.173) 0.042 (0.113) 0.019 (0.022) 0.016 (0.020)
50 - 59 years 0.489 (0.257) 0.259 (0.134) 0.132 (0.122) 0.090 (0.151) 0.029 (0.028) 0.019 (0.018)
60 - 69 years 0.350 (0.071) 0.460 (0.272) 0.240 (0.297) 0.038 (0.049) 0.010 (0.000) 0.010 (0.000)
70 - 79 years 0.350 (0.000) 0.200 (0.000) 0.317 (0.225) 0.103 (0.081) 0.010 (0.000) 0.010 (0.000)
TABLE 6.2 The m ean  tim e (In s e c o n d s )  req u ired  to ach ieve  
v e rio u s  levels of visual acu ity  in d ifferen t a g e  g ro u p s  of 
norm al indiv iduals.
S tan d ard  deviation  is show n  b e tw een  b rack e ts .
6/S fill age groups 
6/6 Optotype
Frequency
Figure 6.8
Number of normal individuals who achieved 6/5 Snellen acuity in each 
presentation time category required to recognise 6/6 optotypes.
0.25
6/5 011 age groups 
6/3 Optotype
0.15
line
0.1
0.01
60503010 200
Frequency
Figure 6.9
Number of normal individuals who achieved 6/5 Snellen acuity in each 
presentation time category required to recognise 6/9 optotypes.
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Figure 6.10
Test results of one normal volunteer repeated at 8 different occasions.
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Figure 6.11
The typical effect of induced erro r of refraction on tem poral acuity .
6.4.4. CSR patients:
Twenty three patients who had had CSR were examined. Twenty were 
m en (87%) and three women (15%). The ages of these patients ranged between 
26 - 65 years with a  mean age of 49 years. The follow-up time ranged between 2 
- 14 years with a  m ean of 7 years.
The ’temporal’ visual acuities were compared with those of the control 
unaffected eyes. Furthermore, findings were compared with age matched normal 
controls.
Statistical analysis:
Data were analysed by Dr. D. Allan using the facilities of the MINITAB 
package on the University of Glasgow ICL3980 mainframe computer. Paired com­
parisons were made between the performance of the affected eye and its unaf­
fected fellow for temporal visual acuity. The Mann-Whitney confidence interval 
and Mann-Whitney test were used.
Results:
Temporal acuity curves of all the affected eyes were overlaid as shown in 
Figure 6.12 and those of the control eyes in Figure 6.13. The overall similarity of 
these two graphs was confirmed by statistical analysis.
The affected eyes were compared with the unaffected fellow eyes together 
with 52 norm al age matched subjects. No statistical difference was found be­
tween eyes with (resolved) CSR and the unaffected eyes of the same patients. Fur­
thermore, the eyes with CSR and the unaffected eyes were compared with age 
matched norm al subjects. However, on individual analysis of each patient, there 
was a  clear difference between the unaffected eye and the eye with CSR (the u n ­
affected eyes did better than the affected eyes) in nine patients.
In a  further 6 patients the eye with CSR showed the better performance 
and in 5 patients there were no clear difference between both eyes. The rem ain­
ing three patients had had bilateral CSR, in two of them  there was no difference 
between both eyes and in the third there was a clear difference between both
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Figure 6.12
Temporal acuities of all eyes affected with CSR.
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Figure 6.13
Temporal acuities of all the control fellow eyes.
eyes. In th is particular case the eye with recurrent attacks of CSR had poorer 
performances than the other eye which had had no recurrence of the disease.
6.4.5. Retrobulbar neuritis:
The temporal acuities of 12 patients who had had retrobulbar neuritis 
followed by recovery of their Snellen visual acuity were assessed. In all of these 
patients the temporal acuity was m uch worse in  the affected eyes compared with 
the fellow unaffected eyes of the sam e individual. The time required to recognise 
even the larger optotypes is increased in the affected eyes although in the ma­
jority of these patients (n=10) 6 /6  vision was achieved with each eye. The curves 
shown in Figure 6.14 with the higher curve for the affected eye was characteris­
tic for all cases.
6.5. DISCUSSION:
6.5.1. Normal group:
It can be seen from Table 6.2 that individuals of younger age groups re­
quire a  shorter time to recognise letters than  those of the older age group except 
for the two oldest age groups. However, the num ber of patients in these old age 
groups was small.
The results indicate that, probably the best way to present the test values 
is by displaying the graph which comprises the values of all the recognised op­
totypes rather than  concentrating on the time needed to achieve the best visual 
acuity. The system automatically provides this on the screen a t the end of the 
test and the user can choose to print it as well.
Test repeatability:
It can be concluded from the results of assessm ent of repeatability of the 
test tha t the 6 /9  optotype is the m ost accurately repeatable optotype for normal 
individuals. It is also possible to suggest tha t the most appropriate optotype for 
assessing the temporal acuity is two lines before the best achievable Snellen 
acuity. However, investigation of a  larger groups of patients with known visual 
function disturbances is required to confirm this conclusion.
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Figure 6.14
A typical result of the test in a patient with left optic neuritis who achieved 6/5 
with each eye. The left eye ’temporal acuity’ is much worse than the unaffected
right eye.
Effect of errors of refraction:
It was of interest to find that one diopter of ametropia resulted in a  marked 
increase in the time required to recognise the optotypes even though it did not 
affect the Snellen visual acuity. The effect of making the patient myopic was 
greater perhaps because there is no mechanism to compensate for myopia, in 
contrast to hypermetropia which can be compensated for by exerting accommo­
dation.
6.5.2. CSR group:
No overall significant difference was found in the temporal acuity of eyes 
with CSR and the unaffected eyes and between those of age matched controls.
The affected eyes of these patients were found to have decreased m acu­
lar sensitivity. Failure to demonstrate an  abnormality implies th a t the spatial 
resolution was not sufficiently impaired to necessitate compensation by m eans 
of temporal summation of the data.
The temporal visual acuity of patients with acute CSR may be assessed 
to be compared later with the temporal acuity after resolution of the disease.
6.5.3. Retrobulbar neuritis group:
The temporal acuity has been found to be affected in eyes with retrobul­
bar neuritis compared with the fellow unaffected eye although each eye can 
achieve the same Snellen visual acuity level. This might be of value in making 
the diagnosis of multiple sclerosis. Further investigation of larger num ber of pa­
tients with both retrobulbar neuritis and other optic nerve conditions is necess­
ary before final conclusions can be made about the value of the test.
6.6. GENERAL DISCUSSION AND FUTURE RESEARCH:
It is recognised that the apparatus described above is custom  built with 
appropriate computer components. Moreover, a  similar system could be built in 
which the translucent component of Snellen chart is transiently illum inated for
specific progressively longer periods in a m anner analogous to that provided by 
the computer programme. Other similar modifications can also be envisaged.
It was expected that some letters can be missed because of lapses in  the 
patient’s concentration. The operator can then display another randomly selected 
letter of the sam e size and presentation time. Another way that helps the patient 
to concentrate are two sharp audible beeps which are sent to the computer loud­
speaker shortly before each letter is displayed.
The non-linearity of the steps between the different sizes of Snellen chart 
rows and the error it may introduce in statistical analysis has been discussed by 
Ridley (1959). Despite this, no attem pt was made to change the sizes of the let­
ters used by TEMPRAC. Our intention was to design a  system based on the same 
principles of Snellen chart which has gained world-wide acceptance as the stand­
ard visual acuity test. We believe that, by utilising an  existing accepted test prin­
ciple the operator can easily familiarise himself with the new test and the 
interpretation of the results with the added test param eter is more straightfor­
ward to understand. This test fulfils both these requirements and the others men­
tioned in the introduction to this chapter. It provides a new approach to the study 
of visual function, particularly in those patients who have apparently normal or 
mildly impaired visual acuity. It is expected to be more sensitive than  Snellen 
acuity in detecting patients whose visual system compensates for the impairment 
in spatial analyses by temporal summation of the input data.
It was noted that some of the 14 letters which are presented randomly 
during the test are easier to recognise while others are more difficult. Sloan (1951) 
revised the selection of the m ost suitable type of test object, the specification of 
the range and gradation of the size of test object required, and standardisation 
of the brightness of the test object and background and of other variable factors 
in the test procedures using Snellen optotypes. He concluded th a t the ideal test 
object should contain horizontal, oblique, vertical and curved contours such  that 
it can be recognised only when clearly focused.
Hartridge and Owen (1922), Bainster (1927) offered experimental evi­
dence showing that the letters of the Snellen chart are not equal in difficulty. The 
alphabet and num erals were arranged as follows: (1) Easily recognised - A C L D 
Y O U  7 1 4; (2) intermediate - T P Z I  G E F K N W R 6  2 3; and (3) difficult - H
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M Y X S Q B 5 8  9. The question of which are best letters to use has given rise 
to considerable controversy. Hay (1919) suggested tha t the easiest letter to re­
solve should be used; Sheard (1921) following the recommendations of the Oph- 
thalmological Section of the American Medical Association, and advised letters 
of different degrees of difficulty; Hartridge and Owen (1922) recommended letters 
of medium difficulty, and Bainster (1927) advocated the use of confusion letters 
such  as C D G O Q and H K M N W. Further investigations are required to estab­
lish the optimum letters which have the greatest similarity.
This test is based on the Snellen visual acuity test and by adding the 
temporal dimension it should be more sensitive. Therefore, one of its potential 
uses is screening which requires high sensitivity although the specificity may be 
low.
It is clear from the results of the effect of induced errors of refraction that 
TEMPRAC can only be used on patients who have been correctly refracted. This 
detracts from the potential use as a  screening test as refraction is time consum­
ing. By contrast, however, the results obtained for ametropia indicate th a t the 
test may prove very useful as a final subjective guide to optimal refraction.
The results obtained from testing the group of patients with retrobulbar 
neuritis indicate the potential usefulness of this test in the detection of other 
optic nerve diseases.
The frequency distribution of the values related to each optotype is shown 
as half of a  normal distribution curve (Figure 6.8 and 6.9). This can be explained 
by the fact tha t the current minimum time of presentation is 0.01 seconds. If this 
time were shorter the curve would be expected to adopt the characteristic nor­
mal distribution shape. The sensitivity would also be increased by shorter time 
presentations for the larger optotypes.
Resolved CSR and retrobulbar neuritis were chosen for the study to 
evaluate the sensitivity of the test in the detection of both mild retinal and  optic 
nerve pathology. Groups of patients with known minor dysfunction which had 
not affected Snellen visual acuity were chosen and tested. Thus making compari­
son of the two groups of results reasonably valid.
CHAPTER 7.
COMPUTER SYSTEMS FOR DATA INTERPRETATION
Figure 7.1
The Tubingen kinetic central visual field chart.
Figure 7.2 
The 100-Hue colour vision test chart.
7.1. INTRODUCTION:
A wide range of charts is used in ophthalmic practice in order to docu­
m ent various forms of eye disorder. Those which are relevant to the follow-up of 
the thyroid ophthalmopathy patient are also the most commonly employed, and 
comprise the field of vision chart (Figure 7.1) and the 100-Hue colour vision test 
chart (Figure 7.2). At present, the interpretation of the data presented in these 
charts is carried out by a skilled clinician who assesses them in a  qualitative 
m anner on the basis of his previous experience. This is a  time consuming, ex­
pensive and unreliable procedure, and one which is clearly a candidate for some 
form of automation.
There have been some attem pts a t ’computerising’ the data from these 
charts to allow more detailed and reproducible interpretation (Hart and Becker, 
1977; Pe’er, Zajicek and Barzel, 1983; Sponsel et aL, 1984; Weleber and Tobler, 
1986). However, these methods have required m anual digitising techniques for 
which an  operator traces the key features of the chart using a digitising tablet or 
a mouse device. This process is slow, and prone to errors. Moreover, the m anual 
entry of chart data becomes difficult and sometimes impractical when employed 
with crowded charts containing many important features.
A technique is required which allows automatic digitisation of the above 
forms of chart. I t  m ust be fast and reliable and provide a system in which the di­
gitised image can be processed by a  microcomputer to extract and quantify the 
information presented.
Such a system is currently being developed as part of an  ophthalmic 
clinic autom ation proj ect which is running in collaboration with Mr. A. W. Ahmed, 
who is currently a research fellow at the Signal Processing Division of the Elec­
tric and Electronic Department of Strathclyde University.
In this chapter the m ain features of the system are presented. In this 
early stage of the project details can only be presented in relation to the steps 
taken for quantification of the central 30 degree visual field charts plotted by the 
Tubingen perimeter.
7.1.1. Definitions:
Image: As used in this thesis, the term image refers to the series of values 
representing the brightness and colour a t every given point. These points are 
called picture elements or pixels (Sheldon, 1987).
Digital image: Is a  matrix whose coordinates (row and column indices) 
identify points in the image and the corresponding m atrix element value ident­
ifies the grey level or colour at tha t point (Dawson, 1987).
Image processing: Is the science of modifying and analysing pictures.
Image processing algorithms: Are step by step procedures for performing 
image processing operations (Sheldon, 1987).
Digitisers: A digitiser is an  input device which converts an  image into a 
numerical representation suitable for processing by a digital computer. Among 
the commonly used digitising devices are, graphics tablets, flat bed automatic 
scanners, and television cameras.
7.1.2. Field quantification methods:
Sponsel (1985) reviewed visual field scoring methods and suggested a 
scoring system on a 0-100 scale regardless of the technique of m easurem ent or 
quantification. This method is easily intelligible by the clinician and is the method 
adopted in our system.
A comprehensive appraisal of the various quantification approaches has 
also been given by Sponsel (1985). Three of these methods which are employed 
in our system are summarised as follows:
Simple area calculation:
’Simple area’ is the area enclosed by a given isopter. Hart and Becker 
(1977) were the first to employ electronic digitising graphics tablet for quantifying
visual fields. They expressed their results in terms of ’degree squared’. Williams 
(1983) used a similar method, expressing area in terms o f’square millimeters’ on 
the perimetric paper. This technique is applicable to recorded charts of all sizes. 
However, its major disadvantage is the absence of any central or functional 
weighting. In our system the field is quantified by calculation of this area as a 
percentage of normal maximum using a scale of 0-100.
Radial summation system:
The field score calculated in  ’radial units’ is the sum  of the lengths of the 
twenty four 15 degree radial lines which transect the centre of the visual field 
(Sponsel et aL, 1983)
The length of lines passing through a scotoma or indentation in the field 
is therefore easily subtracted from the length of each line a t its outermost limits. 
A scotoma near the macula will be crossed by more radial lines than  an  equival­
ently sized defect near the periphery, and this difference is reflected in the scor­
ing, which can therefore be considered to be relatively ’functionally weighted’ to 
central vision. This approach allows all the recorded perimetric information to be 
used (i.e., points on the 15 degree radial lines) without interpolation of lines or 
areas. A further characteristic of this system is tha t it can be applied to charts 
of any size, since the concentric isopter grid with its 5 degree intervals is used 
as the basis for determining the ’length’ of each radial line recorded.
Esterman grid:
The Esterm an grid is a  plastic overlay which when placed over a  Gold- 
m ann visual field chart divides it into 100 unequal areas (Esterman, 1968), each 
of which represents approximately 1% of the functional visual area (as deduced 
by its designer). In general, the central field is deemed more important (and there­
fore has smaller grid sections) than  the periphery, and the inferior field of greater 
functional value than  the superior field. This scoring system was designed as a 
general tool for quantifying the extent of visual disability in medicolegal terms. 
The classical grid is designed for a 0.5 degree white target and this has to be 
taken into account to derive equivalent grids in relation to smaller and dimmer 
or larger and brighter targets.
Plate 7.1
The hardware of the Image processing system  used for the development of the chart
reading programme.
The ’Solid angle’ approach:
Another approach suggested by Weleber and Tobler (1986), converts the 
field area into the solid angle subtended by the seeing region of the visual field 
m inus the solid angle of any scotomata with the sam e test target within that isop­
ter. The m ost commonly applied m easure of solid angle is the steradian, which 
is the three-dimensional counterpart of the two-dimensional degree. The stera­
dian is that solid angle where the surface area on the sphere equals the square 
of the radius. They also suggested a method for determining the solid angle of 
the kinetic perimetric visual field by transferring the sampling points for an  isop­
ter of a  given test size and brightness onto the surface of a sphere and determin­
ing the area of the polygon so created. The solid angle in steradians, is then 
proportional to this area and is calculated using the following formula:
Solid angle = Surface area / (radius)2.
This method gives a better estimation of the visual field as mapped on 
the inner surface of the perimeter bu t there still exist distortions in the repre­
sentation of the visual field with regard to retinal eccentricity and functional 
weighting.
7.2. SYSTEMS AND METHODS:
7.2.1. Hardware configuration:
A simple image processing system (Plate 7.1) (which consisted of an 
image acquisition device [digitiser], an  image memory [Display card], a  micro­
computer and a  display device [monitor] was assembled (Figure 7.3). The details 
of these components are shown in Table 7.1.
A Cannon scanner was used for image acquisition. Various scanning 
techniques may be employed in different scanner designs. The method used in 
the Cannon scanner is based on focusing the ’flood-illuminated’ chart by a  sys­
tem of mirrors and lenses onto a linear photosensitive silicon device called a 
’Charge coupled device’. Charges accumulate in proportion with the light flux 
while light is incident on this device. These charges are transm itted, amplified 
and eventually converted from analogue to digital form (Stamps, 1982). The Can­
non flat bed scanner takes only 12 seconds to digitize an  A4 page a t maximum
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Automatic Chart Reader:
Digitiser
Cannon IX 12 Scanner 
Cannon IX Scanner Interface
Computer:
IBM P C /a t Microcomputer 
640 KB RAM 
84 Hard Disk Storage
Display device:
NEC Multiscan Colour Monitor (Resolution 800X560)
ATI EGA-Wonder Automatic switching Display Card with 256 KB image Memory
Table 7.1
Hardware configuration of the image processing system.
IMAGE
DIGITISER
t
DIGITAL
COMPUTER
DSPLAY
Figure 7.3
Hardware configuration of the chart reading system.
KEYBOARD
resolution of 300 DPI (Dots Per Inch) which is equal to 90,000 dot per square 
inch (Dallas, 1988).
The computer processes the pixel data in the image memory and makes 
the required calculations. The function of the display unit in this system is to 
convert the numerical arrays stored in the computer memory back into spatially 
organised image intensities, i.e., a  from suitable for simple interpretation.
7.2.2. Software design:
Software tools:
1. Turbo C, Version 2.0: This is a version of the C programming language 
which is a powerful structured language characterised by having the flexi­
bility required to write graphics and image processing subroutines.
2- Halo-88 Graphics developers toolbox: Is a  graphics library which is written 
in the C language. The use of such tools saves time by offering ready­
m ade sub-routines which can be included into a computer programme.
Major features of the algorithm:
Figure 7.4 sum m arises the procedures tha t make up the software algo­
rithm, which is described as follows:
1. Scanning:
The scanning or ’image capturing’ procedure is software controlled and 
is fully autom ated in this system. Software device drivers and subroutine which 
are supplied with the scanner and those which are included in the Halo-88 li­
brary, control the mechanical operation and select one of the three grey level 
choices provided by the Cannon scanner. These drivers have been integrated into 
bur system.
2. Re-sizing:
The scanned image which is sent to the computer is so highly magnified 
that one typed letter fills the whole screen. The first step is to reduce its size and 
to adjust the aspect ratio (which is the ratio between the num ber of pixels in  the 
vertical and the horizontal axes) according to the display device characteristics 
so that the image fits the screen keeping its original proportions.
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IMAGE SCANNING
A
ZOOMING AND CORRECTING THE ASPECTRATIO
RECOGNITION OF THE TYPE OF CHART
DETECTION OF THE OUTER BOUNDARY OF THE BLANK CHART
DETECTION OF THE 
BOUNDARIES OF 
EACH SUCCESIVE 
ISOPTER
USE OF THE FILL' 
PROCEDURE TO FILL 
AREAS IN THE SAME 
SEQUENCE
6
DISPLAY THE FIELD SCORE
SIMPLE AREA CALCULATION 
RADIAL SUMMATION CALCULATION 
SOLID ANGLE COMPUTA TION 
ESTERMAN GRID EQUATION
STORE THE IMAGE AND THE RESULTS ON THE HARD DISK
!)
Figure 7.4 Algorithm for visual field chart reading and scoring using the image 
processing system based on Cannon automatic scanner.
3. Recognition:
The programme then detects the external general features of the image 
which characterises the type of chart. This process will be completed a t the final 
stages of the development when an  expert system is linked to this programme for 
pattern matching processes to be carried out (high level image processing algo­
rithm).
4. Orientation:
A ’paint’ with a  certain colour value then ’floods’ the whole chart area 
outside the outer circular boundary of the blank chart. A ’fast area-fill’ subrou­
tine is used for this purpose. The system then defines the centre of this circle 
which is also the centre of the field chart /
5. Information extraction:
The chart is divided into four equal areas by horizontal and vertical lines 
passing through its centre. The foreground of the lower left area is then given a 
colour value which is different from the rest of the chart. This area is then ro­
tated through 180 degrees and overlaid onto a copy of the upper right area. All 
symmetrical overlapping pixels (e.g., grid lines, scale markings) are cancelled. 
This subtraction procedure leaves the plotted information and some other scat­
tered ’asymmetrical’ m arks and numbers. Another algorithms has been written 
which removes any group of pixels which are not in continuity with a  plotted line. 
An extrapolation algorithm fills any gap and completes any missing sections of 
the plotted information. Finally, what rem ains is the plotted data with no back­
ground noise constituting the ’output image’. Information vectors describing the 
output image are then saved on the computer hard disk for storage and further 
processing. This process is repeated for the other three sectors using the odd 
symmetry principle (Section 7.4). This allows subtraction of one fourth of any cir­
cular area from any of the other three quarters maintaining full symmetry pro­
vided that it is rotated through the correct angle.
6. Calculations:
Area calculation and application of the scoring systems are applied on 
the information vectors of the output image using the four quantification ap­
proaches described in Section 7.1.2.
Plate 7.2
The first stage in the process of scanning.
Plate 7.3
Showing the screen half-way through the final stage of digitisation.
7.3. RESULTS:
Five of the six steps of the algorithm described above have been com­
pleted a t the time of writing; namely, scanning, re-sizing, recognition, orienta­
tion and information extraction. These processes take place in the computer and 
the graphics memories. During normal operation, they are invisible to the user. 
Screen displays (Plates 7.2 through 7.8) are presented to demonstrate the prin­
cipal operations of the algorithm and the progress made so far in this project. A 
demonstration disk is enclosed (Volume 2, pocket) which more effectively shows 
the dynamics of the described steps (Programme listing is found in Appendix B4).
7.4. DISCUSSION:
Several methods have been described for using a digitising tablet and a 
computer in quantification and scoring of charted information (Hart and Becker, 
1977; Sponsel etaL, 1984; Sponsel, 1985; Weleber and Tobler, 1986). The dis­
advantages of these methods of data entiy are that they are time consuming and 
tha t there is a  high risk of error. Moreover, these techniques are only suitable for 
entry of data concerning the visual field and it is not practicable to enter all the 
points of a  100-Hue chart as the likelihood of error is too great.
The new approach described overcomes this problem by using low level 
and high level image processing algorithms to directly process the raw chart 
image. These new techniques operate on the binary image of the medical chart 
obtained from a  scanning device.
Direct digital image subtraction:
The m ost straightforward approach to the extraction of information 
plotted on a  chart is by using the conventional ’digital subtraction technique’ 
which is used in diagnostic, radiology. In essence, a  stored image of the blank 
chart is superimposed on the image of the plotted chart allowing the overlapping 
pixels to cancel each other leaving only the plotted information. There are how­
ever several disadvantages which make this approach inappropriate for applica­
tion on microcomputers. The major difficulties and disadvantages are:
1- The computer m ust deal with three complete images simultaneously.
These are the image of the blank chart, the image of the plotted chart and 
the output image (after subtraction is completed). This requires large
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Plate 7.4
The monitor screen at completion of digitisation.
Plate 7.5
Showing the ’flooding’ of the areas outside the circular chart using blue ’paint’.
Plate 7.6
Showing a copy of the upper right quadrant of the chart which is to be subtracted
from the lower left quadrant.
Plate 7.7
This display shows that subtraction is completed, the circular chart grid has been 
removed and only some marks are left in addition to the charted information.
Plate 7.8
Demonstrates various stages of information extraction and background noise 
removal. The arrow points to a sector containing the charted information only.
graphics and working computer memories to accommodate the high resol­
ution images of such crowded charts. Sufficient memory space is only 
available in dedicated expensive high resolution image processing work 
stations.
2- Perfect alignment of the blank and plotted chart images is essential for 
successful subtraction. This can not be guaranteed in an  autom ated sys­
tem.
3- The sizes of the blank and plotted charts m ust be exactly the same for the 
technique to be successful. This m eans that photocopied charts will not be 
suitable if there is even a  small reduction or enlargement of the original 
size. Although image processing techniques (e.g. ’tie points spacial reloca­
tion’ and geometric transformation) may solve this problem by ’stretching’ 
or ’shrinking’ the plotted chart to m atch the size of the blank chart, these 
techniques require vast num ber of calculations and therefore are unac- 
ceptably slow (Green and van Nostrand, 1983).
Odd symmetry subtraction:
This technique is based on the fact that the majority of medical b lank 
charts are circular and symmetrical around the horizontal axis. Biological data 
plotted on these charts is unlikely to be completely symmetrical and even more 
unlikely if comparisons are made on the basis of ’odd symmetry’, i.e., the lower 
left quarter is compared with the upper right area of the chart. Subtraction of the 
upper lower data from the upper data effectively removes the blank chart data 
and leaves the plotted data for analysis and interpretation.
This approach had been devised and employed in our system because it 
has many advantages over the conventional direct method which can be outlined 
as follows:
1- Only the image of the plotted chart is required to be loaded into the mem­
ory which m akes it possible to use any of the popular, reasonably priced 
EGA-based general purpose microcomputers connected to a suitable scan­
ner to ru n  the programme.
2- Problems regarding alignment, orientation or centering are completely 
avoided when this approach is employed.
3- By applying this technique it was possible to write a universal chart read­
ing algorithm which extracts the plotted information from a wide range of
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charts. The size of the chart, which is taken into account when applying 
the calculations regarding quantification and scoring, has no influence on 
the effectiviiy of the algorithm in extracting the plotted data as long as the 
chart does not exceed the dimensions of the scanner. It is therefore 
possible to use photocopies or charts plotted using different types of equip­
ment.
However, there are some difficulties and limitations of the odd symmetry 
digital subtraction approach which can be summarised as follows:
(1) Subtraction m ay be applied on some sectors of the plotted information if 
they fall on one of the b lank chart grid lines. A separate interpolation algo­
rithm  had to be written to fill in any gaps found between plotted line ends. 
This can fill a  gap as large as half of a  circle.
(2) Some unwanted asymmetric information remains after subtraction (e.g., 
num bers and marks). These are removed using another algorithm which 
removes any collection of pixels which is not in continuity with a  line.
(3) The only limitations which are yet to be overcome arise when the plotted 
data is in the  form of a  perfect circle concentric with the chart grid or 
when larger than  half of a  circle overlaps one of the circular grid lines. 
However, it is highly unlikely to come across such a  chart in practice.
With such  a  system it will be possible to cany  out automatic, accurate 
and fast digitisation and analysis of the kinetic visual field and 100-Hue charts. 
In addition the facilities will be available to digitise any other charts and diag­
ram s related to the ophthalmic patient such as the field of binocular single vi­
sion, and the autoclave tem perature and pressure charts. Furthermore, a  wide 
range of charts used outside the medical field such as barometer, tachometer, 
and refrigerator circular charts may also be read using the sam e principle. This 
in tu rn  will allow immediate storage and retrieval of information, and analysis 
and quantification of the complex data presented in such two dimensional charts.
To the best of our knowledge no autom ated chart reading devices are cur­
rently available and this is the first such system to be designed exploiting the 
concept of odd symmetry in processing a  circular image.
This work, which took five and half months to reach this stage, has re­
sulted in the development of a novel class of efficient segmentation algorithm that
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employs a  fast area-1111 method to detect object boundaries. The first stage in­
volves a  noise removal and thresholding operation to clean the image for the sub­
sequent algorithms. These algorithms are the key to the diagnostic process and 
provide a  m eans of extracting the desired features from the background noise 
(e.g., patient nam e and data, grid lines and scale marks)
This programme will allow a meaningful scoring system to be accorded 
to the charts which will, in  the long-term, improve the management of patients 
who require repeated evaluation in order to detect whether significant change in 
visual function has taken place. This would include, for example, patients with 
primary open angle glaucoma and those with chronic dysthyroid eye disease. 
Moreover, this technique will greatly facilitate the conduction of studies in which 
the effects of treatm ent are being evaluated.
CHAPTER 8.
EXPERT SYSTEM FOR THE MANAGEMENT OF 
DYSTHYROID EYE DISEASE
8.1. INTRODUCTION:
An expert system has been defined as the "embodiment within a com­
puter, of knowledge from an  expert skill in  such a form that the system can offer 
intelligent advice or take an  intelligent decision" (Chard, 1988). It can be distin­
guished from other kinds of artificial intelligence techniques in tha t it deals with 
subject m atters with realistic complexity tha t normally require a considerable 
am ount of hum an expertise. It m ust exhibit high performance in term s of speed 
and reliability in order to be a  useful tool. It m ust also be capable of explaining 
and justifying solutions and recommendations in order to convince the user that 
its reasoning is correct.
H um an experts in any field are frequently in great demand and are there­
fore, usually in  short supply. An expert system contains the knowledge about a 
particular field thus assisting hum an experts in providing information to people 
who do not have direct access to an  expert in that particular field.
The m ost obvious reasons for building an  expert system are dissemina­
tion of rare and  costly expertise, and the more effective use of the hum an expert. 
Other reasons go beyond these productivity considerations. From a scientific 
point of view, the most important reason is the formalization and clarification of 
knowledge th a t results from having the hum an expert make his reasoning ex­
plicit.
Medical expert systems take in  diverse areas such as patient-monitoring 
systems, x-ray and ultrasound imaging systems, and prosthetic devices. The 
present thesis restricts the topic to systems concerned primarily with diagnosis 
and therapy.
8.2. OVERVIEW:
In the early 1960s researchers in artificial intelligence had  focused on 
problem solving in game playing, image recognition, speech understanding, and 
language understanding (Feigenbaum and Fieldman, 1963). During this period 
some general problem solving principles were formalised. However, it was dis­
covered th a t m ost of the difficulty in achieving intelligent computer performance 
was in collecting and storing a  large knowledge base of facts specific to the prob­
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lem area. This result was confirmed by the success of a  few large programmes in 
scientific and mathematical areas. At that time, the explosion in medical knowl­
edge was forcing physicians to specialise increasingly. Medicine was therefore an  
appropriate field in which to apply the developing knowledge-based techniques 
(Clancey and Shortliffe, 1984).
Large domain-specific problem solving systems came to be known as 
’consultation programs’, because they fitted the image of an  expert specialist who 
is asked to provide advice about a difficult problem. In medicine, the ’problem’ 
would typically be a  patient with an  illness to be diagnosed. By the late 1970s 
these programs became known as ’expert systems’.
The early efforts in developing the major systems in the late 1970s nam e­
ly, PIP, CASNET, MYCIN, and INTERNIST (Section 8.5) resulted in the produc­
tion of prototypes directed a t two research areas: Firstly, the issues involved in 
designing consultation programmes (e.g., acceptability to the end user) and sec­
ondly, the natu re  of expertise to be formalised (e.g., integration of factual and 
judgem ental knowledge).
Over the past 10 years various research groups in artificial intelligence 
have built highly specialised systems containing the expertise needed to solve 
such problems as medical diagnosis and treatm ent, chemical structure analysis, 
geological exploration, computer configuration selection, and computer fault di­
agnosis. Such systems have been comprehensively reviewed by Duda, Gasching 
and Hart (1979), Barra and Feigenbaum (1981), Weiss and Kulikowski (1984), 
Engelbrecht and Rothemund (1987) and Ellis (1987).
8.3. MOTIVATION FOR BUILDING A MEDICAL EXPERT SYSTEM:
The primary care physician who first sees the patient has m any tests 
available with a  wide range of costs (both financial and physical) and potential 
benefits (i.e., arrival a t a  correct diagnosis or optimal therapeutic management). 
Even the experts in a  specialised field may reach veiy different decisions regard­
ing the m anagem ent of a  specific case. Furthermore, medical students usually 
learn about decision making in an  unstructured way, largely through observing 
and emulating the thought process they perceive to be used by their clinical
supervisors (Kassirerand Gorry, 1978). Clancey and Shortliffe (1984) have sum ­
m arised the reasons for introducing medical expert systems as follows:
1. To improve the accuracy of clinical diagnosis through approaches which 
are systematic, complete, and able to integrate data from diverse sources.
2. To improve the reliability of clinical decisions by avoiding unwanted in­
fluences of similar b u t not identical cases and by making the criteria for 
decision explicit and hence reproducible.
3. To improve the cost efficiency of tests and  therapies by balancing the ex­
penses of time, inconvenience, or funds against benefits and risks of defini­
tive actions.
4. To improve understanding of the structure of medical knowledge.
5. To improve understanding of clinical decision making, in order to improve 
medical teaching and to make computer programmes more effective and 
easier to understand.
6. To disseminate rare and costly expertise.
8.4. COMPUTER-BASED CLINICAL DECISION AIDS:
The applications of formal methods of decision making have concentrated 
on problems of diagnostic reasoning, whilst decision-analysis techniques have 
been applied to treatment-selection problems. Table 8.1 sum m arises the se­
quence in which different techniques have been introduced.
An exhaustive review of computer-aided diagnosis will not be attem pted 
because the field is vast and only representative examples based on simplified 
classification of the topic are presented (Table 8.2).
8.4.1. Clinical algorithms:
Clinical algorithms, or protocols, are flow charts to which a diagnostician 
or therapist can refer when deciding how to manage a patient with a  specific clini­
cal problem. Such protocols usually allow decisions to be made by carefully fol­
lowing a  simple branching logic. They contain built-in safeguards whereby 
referral to experts is recommended if a  case is unusually complex. The value of 
such a  protocol depends on the infrequency with which such referrals are made,
Medical decision making:
Mid-1940s Statistical hypothesis-testing methods: Mostly for screening and Yerushalmy, 1947
radiology, computations by calculator.
1954 Logic schem e: For matching, symptoms to diagnoses, slide rule or Nash, 1954
Cards used for sorting and matching.
1958 Statistical and logical techniques combined: Computers introduced. Lipkin & Hardy, 1958
1960 Bayesian and discriminant methods Ledley & Lusted, 1959
1968 Sequential Bayesian methods and decision-theory approaches: McNeil etal., 1975
Applied to treatment selection.
1970 Information-processing models for diagnosis. Wortman, 1972
1971 Knowledge-based artificial intelligence system s Kulikowski & W eiss, 1971;
Pople etal., 1975; 
Shortliffe, 1976
Table 8.1
Evolution of methods of medical decision making
Computer-based medical decision aids:
(1) Clinical algorithms.
(2) Data bank analysis.
(3) Mathematical models.
(4) Statistical pattern recognition.
(5) Bayesian statistical approaches.
(6) Decision theory approaches.
(7) Symbolic reasoning approaches.
Table 8.2
A simplified classification of the computer-based medical decision making
approaches.
so it is im portant to design algorithms that reflect an  appropriate balance be­
tween safety and efficiency (Weiss and Kulikowski, 1984; Shortliffe, Buchanan 
and Feigenbaum, 1984; Chard, 1988). The systematic approach to eyelid surgery 
(Collin, 1983) and the work of Khir (1985) who presented an  algorithm which es­
tablishes a  functional and setiological diagnosis and gives brief notes on the ap­
propriate treatm ent of thyrotoxicosis, represent examples of this approach.
However, the role of the computer in  such applications has been limited. 
Since algorithmic logic is generally simple and can often be represented on a 
single sheet of paper, the advantage of an  automated approach over a  m anual 
system has not been clearly demonstrated (Vickery, 1974).
Although clinical algorithms are. amongst the most widespread and ac­
cepted method of the decision aids described in this section, the simplicity of 
their logic makes it clear why the technique cannot be effectively applied in most 
medical domains. Decision points in the algorithms are generally binary. Thus 
the difficult decision tasks are left to experts, and there is generally no formal al­
gorithms for managing the case from that point on.
There are two other major problems with clinical algorithms. Firstly, each 
binary decision depends on the sensitivity of the test which brought about tha t 
decision being 100% - no such test exists, therefore the wrong pathway may be 
followed especially when there are multiple steps. Secondly, the determination 
of the sequence of an algorithm is to a  certain extent arbitrary. Ideally tests of 
high sensitivity are used first and those of high specificity last. If the sequence 
is chosen inappropriately, inaccuracies will ensue.
8.4.2. Data bank analysis:
There have been several recent attem pts to create programmes th a t could 
provide analyses of the information stored in a computer data bank. Some early 
systems had retrieval modules tha t identified all patient records m atching a 
Boolean combination of description (Boolean algebra proposed by George Boole 
(1854) for describing logic in mathematical terms). However, further analysis of 
these records for decision-making purposes was left to the investigator.
Systems for data bank analysis depend on the development of a complete 
and accurate medical record system. Once such a system is developed, a  num ­
ber of additional capabilities can be provided: Correlation amongst variables can 
be calculated, prognostic indicators can be measured and the responses to vari­
ous therapies can be compared.
Physicians faced with a  complex management decision can look to such 
a system  for assistance in identifying patients who had similar clinical problems 
in the past and can then see how those patients responded to various therapies. 
A clinical investigator who keeps the records of his study patients on such a  sys­
tem  can use the programme’s statistical capabilities for data analysis.
The HELP system (Warner, Olmsted and Rutherford, 1972a; W arner 
et ol, 1974; Warner, 1978) is an  example of one of the most successful projects 
in th is category.
Data bank analysis systems have powerful capabilities to offer to indi­
vidual clinical decision makers. Furthermore, medical computing researchers 
recognise the potential value of large data banks in supporting many of the other 
decision-making approaches discussed in  subsequent sections. The following are 
im portant additional issues regarding data bank systems (Shortliffe, Buchanan 
and Feigenbaum, 1979):
1. Data acquisition remains a  major problem. Many systems have avoided di­
rect physician-computer interaction bu t have then  been faced with the ex­
pense and errors of transcription.
2. Analysis of data in the system can be complicated by missing values, out­
lying values, and poor reproducibility of data over time and amongst physi­
cians. Conversely, the system can itself be used to identify questionable 
values of tests or observations.
3. The space requirements for data storage can be large since the decision 
aids require a comprehensive medical record system as a basic component.
Slamecka et oL (1977) have distinguished between structured and em­
pirical approaches to clinical consulting systems, pointing out th a t data banks 
provide a  largely empirical basis for advice whereas structured approaches rely 
on judgem ental knowledge elicited from literature or from experts. However, it is
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im portant to note that judgemental knowledge is itself based on empirical infor­
mation. Even an  expert’s intuitions are based on observations and ’data collec­
tion’ over years of experience. Thus one might argue that large, complete, and 
flexible data banks could form the basis for large am ounts of judgem ental knowl­
edge th a t we currently have to obtain from other sources.
8.4.3. Mathematical models:
Pathophysiological processes can be well described by mathematical for­
mulae in a  limited num ber of clinical problem areas. Such domains have lent 
themselves readily to the development of computer-based decision aids since the 
issues are generally well defined. The techniques used by such programmes tend 
to reflect the details of individual applications, the most distinguished of which 
have been in pharmacokinetics (Jellifie et al, 1970) and acid-base/electrolyte 
disorders (M ennetaL, 1973).
The major strength of mathematical models is their ability to capture 
mathematically sound relationships in concise and efficient computer pro­
grammes. However, the major limitation is that few areas of medicine are am en­
able to firm, quantitative description. Mathematical models have limited 
applicability a t present because the accuracy of the results depends on correct 
identification of relevant parameters, the precision and certainty of the relation­
ships among them, and the appropriateness of the techniques for m easuring 
them.
8.4.4. Statistical pattern-matching:
This general methodology includes a  variety of techniques used to extract 
characteristic m easurem ents (the features) and to find and refine the pattern  
classifier. Linear regression analysis, cluster analysis and discriminant function 
analysis are the most commonly employed techniques.
Pattern recognition techniques are used for determining prognosis or pre­
dicting disease duration and outcome. These techniques have been applied to a 
variety of medical domains, such as image processing and signal analysis, in  ad­
dition to computer-assisted diagnosis.
In order to find the diagnostic pattern, or discriminant function, the 
method requires a  ’training’ set of cases for which the correct classification (e.g., 
diagnosis or outcome category) is already known, as well as reliable values for 
their m easured features (Section 5.3.9).
The num ber of reported medical applications for pattem-recognition 
techniques is large, bu t there are also num erous problems associated with this 
approach. The m ost obvious difficulties are choosing the set of features in the 
first place, collecting reliable m easurements on a  large sample, and verifying the 
initial classification among the ’training’ set of data. Current techniques are in­
adequate for problems in which trends or movement of features are important 
characteristics of the categories.
Various forms of discriminant analysis approaches have been described 
(Section 5.3.9) and the topic can be confusing for the non-mathematician (No- 
rusis, 1988). However, the choice of approach has been shown to m ake little dif­
ference to the eventual clinical results (Titterington et aL, 1981).
Pattern recognition techniques are often misapplied in medical domains 
in which the assum ptions essential for the validity of the chosen statistical tech­
niques are violated (Weiss and Kulikowski, 1984; Shortliffe etaL, 1984; Chard, 
1988).
8.4.5. Bayesian statistical approaches:
The theoretical basis of this approach was described by Thomas Bayes 
in the eighteenth centuiy. In essence Bayes’ theorem presents all the knowledge 
related to a  problem as a  set of probabilities and combines the prior probabilities 
of various input variables in order to reach a posterior probability or conclusion 
(Weiss and Kulikowski, 1984; Shortliffe e ta l ,  1984).
Bayes’ theorem can be used to calculate the probability of various diag­
noses given the clinical features of a particular patient.
The equation for Bayes’ theorem can be described in various forms, one 
of which is as follows (Chard, 1988):
P(CF:D)P(D)
P(D:CF) = P(CF:D)P(D)+P(CF:notD)P(notD)
Where P is probability, D is diagnosis, and CF is a set of clinical features. 
Thus the expression on the left, P(D:CF), is equivalent to ’the probability P of di­
agnosis D given the set of features CF. On the right, P(D) and P(notD) represent 
the prior probabilities of the diagnosis and its alternatives.
In a  clinical situation there would be a  num ber of possible diagnoses and 
a  num ber of clinical features. A separate calculation is performed in respect of 
each diagnosis. In other words, with regard to its diagnostic application Bayes’ 
theorem requires three sets of data for each condition which may present, the 
comprehensive differential diagnosis, the order of likelihood of each diagnosis (or 
conditional probabilities) and the investigation (or set of investigations) which es­
tablishes each diagnosis. Exclusion of the first diagnosis on the list immediate­
ly updates the diagnostic likelihood of the next diagnosis. This constitutes the a 
priori probability. Negative investigation results for the common diagnosis there­
fore update the probability of the unusual diagnosis.
More work has been done on Bayesian approach to computer-based 
medical decision making than  on any of the other methodologies which have been 
discussed. The process of drawing conclusions of practical certainty from 
multiple pieces of information, each of which is uncertain in its own right, is an  
almost perfect description of m uch of clinical medicine (Macartney, 1987). In sev­
eral domains the technique has been shown to be exceedingly accurate, b u t there 
are also several limitations to the approach.
Among the most commonly recognised problems with the use of a  
Bayesian approach is the large am ount of data required to determine all the con­
ditional probabilities needed for the rigorous application of the formula. A var­
iety of additional assum ptions m ust be made, for example, the diseases under 
consideration are assum ed to be mutually exclusive and exhaustive (i.e., the pa­
tient is assum ed to have only one of the diseases listed); the clinical observations 
are assum ed to be conditionally independent for a  given disease; and the in­
cidence of a  symptom of a  disease is assum ed to be stationary (i.e., the model 
generally does not allow for change in a  disease pattern  over time).
During the study of deDombal’s abdominal pain programme (Section 
8.5.1), which is based on Bayesian probability theory, the computer generated 
diagnoses were simply saved and later compared with the diagnoses reached by 
the attending clinicians and with the ultimate diagnosis verified a t surgery or 
through appropriate tests. Although the clinicians reached the correct diagnosis 
in 65-80% of the 304 cases studied (with accuracy depending on the individual’s 
training and experience), the programme was correct in 91.8% of cases (deDom- 
bal et al, 1972).
Even when diagnostic performance is excellent, such as in  deDombal’s 
approach to abdominal pain evaluation, clinical implementation and system ac­
ceptance will generally be difficult (Shortliffe et al, 1984). So, in general, a  pure­
ly Bayesian approach can constrain problem formulation so as to m ake a 
particular application unrealistic and hence unworkable.
8.4.6. Decision theory approaches:
V
Decision analysis is a  process by which numerical values are assigned 
to choices and probabilities in order to break down the processes by which deci­
sions are made or should be made in the form of a  decision network. The follow­
ing topics are among the central issues in the field (Ginsberg, 1972; Shortliffe 
e ta l , 1984):
1. The decision tree: The decision-making process can bie seen as a  sequence 
of steps in  which the clinician selects a  path  through a network of p laus­
ible events and actions. Nodes in this tree-shaped network are of two 
kinds: decision nodes, where the clinician m ust choose from a  set of ac­
tions (e.g., choice to perform a  test), and chance nodes, where the outcome 
is not directly controlled by the clinician b u t is a  probabilistic response of 
the patient to some action taken (e.g., occurrence or non-occurrence of 
complications). By analysing a difficult decision process before taking any 
action, it may be possible to delineate in advance all relevant chance and 
decision nodes, all plausible outcomes and the paths by which these out­
comes might be reached. Data may exist to allow specific probabilities to 
be associated with each chance node in the tree.
2. Expected values of various outcomes: In actual practice physicians make 
sequential decisions based on more than  the probabilities associated with 
the chance nodes tha t follow. Thus anticipated ’cost’ (financial expendi­
ture, complications, discomfort or patient preference) can be associated
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with the decision nodes. Using the probabilities a t chance nodes, the cost 
a t decision nodes, and the values ’of the various outcomes’, and the ’ex­
pected values’ for each pathway through the tree (and in tu rn  each node) 
can be calculated.
3. Test evaluation: The tests tha t lie a t decision nodes are central to clinical 
decision analysis, therefore it is crucial to know the predictive value of 
tests th a t are available. This leads to considerations of test sensitivity, spe­
cificity (Section 5.3.8) and disease prevalence (McNeil and Adelstein, 1977; 
Komaroff, 1979).
Computer implementations of clinical decision analysis have appeared 
with increasing frequency since the mid-1960s. Gorry and associates developed 
one of the m ost successful programmes in this category for the m anagement of 
acute renal failure (Gorry and Burm et, 1968; Gony et at, 1973). The investiga­
tors recognised the need to incorporate a means of balancing the dangers and 
discomfort of a  procedure against the value of the information that can be gained.
Perhaps the most difficult problem with the decision theory approach is 
the assignm ent of numerical values to a  hum an life or for example a  day of health 
(Warner, 1978). Overlapping or coincident diseases are also not adequately con­
sidered, unless they are specifically included in the analysis, and the Bayesian 
foundation for many of the calculations still assum es mutually exclusive and ex­
haustive disease categories. The problem of symptom conditional dependence 
still remains, and there is no easy way to include knowledge regarding the time 
course of disease. Kassirer and Gony (1978) point out tha t the acute renal failure 
programme was incapable of recognising circumstances in which two or more 
actions should be carried out concurrently.
8.4.7. Symbolic reasoning approaches:
Computers originally were designed specifically to process num bers. Hu­
m ans however, tend to think symbolically rather than  numerically. Hum an in­
telligence seems to be based, in part, on the mental ability to m anipulate symbols 
rather than  ju s t  numbers.
Computer architecture readily lends itself to algorithmic approach. Many 
hum an reasoning processes however, tend to be non-algorithmic, i.e. hum an
m ental activities consist of more than  ju s t following logical step-by-step ap­
proach.
Large num ber of artificial intelligence research continues to be devoted 
to symbolic and non-algorithmic programming techniques in an  attem pt to emu­
late more closely hum an reasoning processes with a computer.
In contrast to numerical calculation programmes, whose power is derived 
from the analytical equations used, symbolic programmes gain their power from 
qualitative and experiential judgem ents codified in heuristics. A heuristic is a 
’rule of thum b’ which applies to a  certain situation to suggest how to proceed 
without the need to re-think the problem completely every time similar or anal­
ogous situation is encountered. Heuristics focus the attention of the reasoning 
programme on parts of the problem that appears most critical and parts of the 
knowledge base that seem most relevant. They also guide the application of the 
domain knowledge to an  individual case by deleting items from consideration as 
well as focusing on other items. The result is that these programmes pursue a 
line of reasoning, as opposed to following a sequence of steps in a calculation.
It was the landm ark paper by Gorry et aL (1973) tha t first critically ana­
lysed the hitherto conventional approaches to computer-based clinical decision 
making and outlined his reasons for turning to the newer symbolic techniques. 
He used the acute renal failure programme as an  example of the problems which 
arise when decision analysis is used alone (Gorry et aL, 1973). His conclusions 
from these observations include the following points:
1. Clinical judgem ent is based less on detailed knowledge of pathophysiology 
th an  it is on gross ’chunks’ of knowledge along with a good deal of detailed 
experience from which rules of thum b are derived.
2. Clinicians know facts, of course, b u t their knowledge is also largely 
judgem ental. The rules they learn allow them to focus attention and gener­
ate hypotheses quickly. Such heuristics permit them to avoid detailed re­
search through the entire problem aspects and to take ’short cu ts’ based 
on previous experience.
3. Clinicians recognise levels of belief or certainty associated with many of 
the rules they use bu t they do not routinely quantitate or use their cer­
tainty concepts in any formal statistical m anner.
Symbolic reasoning is therefore knowledge based bu t the ’chunks’ of 
knowledge are not ju s t  composed of factual data b u t comprise knowledge of pat­
terns, associations and sequences of events and actions for which the outcome 
may be predicted with reasonable accuracy based on previous experience.
Based on observations such as those above, Gorry identified a t least three 
important problems for investigation:
a. Medical concepts: Clinical decision aids traditionally had no true ’under­
standing’ of medicine. Although explicit decision trees have given the deci­
sion theory programmes a greater ’sense’ of the pertinent associations, 
medical knowledge and the heuristics for problem solving in the field had 
never been explicitly represented or used. So-called common sense, was 
often clearly lacking when the programmes failed and this was often what 
most alienated potential physician users.
b. Conversational capabilities: Gorry argued tha t further research in the de­
velopment of computer-based linguistic capabilities was crucial both for 
capturing knowledge from collaborating experts and for communication 
with physician users.
c. Explanation: Diagnostic programmes had seldom emphasised the import­
ance of the ability to explain the basis for their decisions in term s under­
standable to physicians. System acceptability was therefore inevitably 
limited; the physician would have no basis for deciding whether to accept 
the programme’s advice, and might therefore resent what could be per­
ceived as an  attem pt to dictate the practice of medicine.
It was perhaps inevitable that some medical researchers would tu rn  to 
the artificial intelligence field for new methodologies because of the limitations of 
the older techniques . Major research areas in artificial intelligence include 
knowledge representation, heuristic search, natural language understanding 
and generation, models of thought processes and neural computing (Wolfgram, 
Dear and Galbraith, 1987; Eckniller and Malsberg, 1988; Recce and Treleaven, 
1988) - all topics clearly relevant to the problems discussed above. For artificial
intelligence researchers the question of how best to manage uncertainty in medi­
cal reasoning remains a  central issue.
W hereas the computations used by the other approaches mostly involve 
straightforward application of well-developed computing techniques, artificial in­
telligence methods are largely experimental. New approaches to knowledge rep­
resentation, language understanding, heuristic search, and the other symbolic 
reasoning problems mentioned above are still needed.
The techniques of artificial intelligence provide a way to respond to many 
of Gorry’s observations regarding the three major inadequacies of earlier ap­
proaches described above: (1) medical artificial intelligence programmes all stress 
the representation of medical knowledge and an  ’understanding* of the under­
lying concepts; (2) many of them have conversational capabilities which are based 
on language processing research; and (3) explanation capabilities have been a 
primary focus of systems such as MYCIN (Section 8.5.5).
This overview of the computer-based clinical decision aids has shown 
tha t there are two recurring questions. Firstly, how can systems designed to reach 
better and more reliable decisions in a  broad range of applications? And second­
ly, how can we more effectively encourage the use of such systems by physicians 
or other intended users?
8.5. EXAMPLES OF MEDICAL EXPERT SYSTEMS:
8.5.1. The deDombal system for abdominal pain:
Since the late 1960s, deDombal and associates at the University of Leeds, 
England, had  been studying the diagnostic process and developing computer- 
based decision aids using Bayesian probability theory. Their area of investiga­
tion has been gastrointestinal diseases (deDombal et aL, 1972). The programme 
was designed for the evaluation of cases of abdominal pain of less th an  one week’s 
duration presenting a t a hospital emergency department. The information from 
each patient was compared, using a Bayesian probabilistic analysis, with ref­
erence data derived from 6000 patients in 13 countries, with the addition of a  
more recent analysis of dyspepsia (Horrock and deDombal, 1975) and gastric car­
cinoma (Zoltie etaL, 1977).
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The system was evaluated in eight centres with more than  250 partici­
pating doctors and 16,737 patients. Initial diagnostic accuracy rose from 45.6% 
to 65.3%. The rate  of negative laparotomies fell by half, as did the rate of perfor­
ation in  patients with appendicitis. Serious management errors fell from 0.9% to 
0.2%, and mortality by 22 percent (Adams et aL, 1986).
8.5.2. CASNET/GLAUCOMA:
CASNET/GLAUCOMA is a model-based expert system which has been 
developed during the mid 1970s. It gives advice on diagnosis and treatm ent of 
glaucoma.
This system is based on causal associational network (CASNET) models 
of disease. A CASNET model consists of three main components: Patient clinical 
features, pathophysiological states, and disease classification.
As observations are recorded, they are associated with causally related 
network that sum m arises the mechanism of disease.
Strategies of specific treatm ent selection are guided by the individual pat­
tern  of observations and diagnostic conclusions as well as by the disease classi­
fication itself.
CASNET/GLAUCOMA demonstrated that there are areas of medicine in 
which explicit model representations permit powerful reasoning strategies tha t 
go beyond simple matching of treatm ent with disease. The CASNET model of glau­
coma helped to provide consultation for complex clinical cases, including those 
involving long histories and multiple follow-up visits. For some situations it pro­
vided alternative opinions derived from different consultants. The programme 
was developed and tested jointly by a  national network of investigators linked to 
Stanford University computer in the USA (Kulikowski and Weiss, 1971; Weiss, 
1974).
8.5.3. INTERNIST:
INTERNIST is one of the best-known expert systems. It is an  experimen­
tal computer-based diagnostic consultant for general internal medicine de­
veloped by Pople, Myers and Miller (1975).
The investigators decided to consider the entire field of internal medicine 
ra ther than  selecting a  small subspeciality in medicine for the programme. This 
necessarily requires approaches that quickly narrow the search space for possible 
disease and also permit case analysis in which two or more diseases may coex­
ist and interact. It differs from other expert system programmes in the generality 
of its approach and in the size and diversity of its knowledge base. The knowl­
edge base was developed over several years. Major and minor manifestations and 
weights th a t link each finding with the diseases in which they can occur were 
identified. Knowledge concerning 575 diseases and more than  4000 individual 
m anifestations of disease (demographic, history, symptoms, physical signs and 
laboratory data) were included. The resulting scoring scheme proved to be ca­
pable of guiding effective diagnostic reasoning (Pople e ta l ,  1975; Pople, 1975; 
Oleson, 1977).
8.5.4. PIP (Present Illness Programme):
PIP is a  computer programme designed to investigate the present illness 
of a  patient with oedema. It has a goal-oriented control strategy. Its data base has 
been organised into associative memory in which clusters of closely related facts 
about disease and clinical states are stored in a fashion analogous to a  richly 
cross-referenced encyclopaedia. These groups of facts, called ’frames’, are further 
organised into a  network.
W hen the programme is presented with a clinical problem (i.e., chief com­
plaint) it generates hypotheses about the case by moving frames from the long­
term  (associative) memory into the short-term  memory where the frames interact 
with the patient data. The computer characterises each finding into details, seeks 
relevant advice from associative memory, and tests the hypotheses.
As new facts are obtained, additional hypotheses may be generated. As 
questioning proceeds, all hypotheses under consideration are repetitively tested 
and scored to m easure the ’goodness of fit’.
At the termination of questioning, the accepted hypotheses are listed and 
the other hypotheses are rank ordered on the basis of the final score calculated 
for each. The programme was initially tested with a  series of exemplary cases, 
and the ’present illness’ diagnosed by the computer was compared with those 
concluded by the clinicians in their group. Discrepant behaviour on the part of 
the programme was taken as a stim ulus for further refinement. Corresponding 
refinements were then made in the programme, and the process of testing and 
revision was repeated until the programme’s behaviour closely resembled that of 
the clinicians (Pauker etaL 1976).
8.5.5. MYCIN:
MYCIN is an  expert system developed to advise physicians and medical 
students on the appropriate treatm ent of infections. It selects antimicrobial ther­
apy for patients with severe infections. The programme uses knowledge obtained 
from infectious disease specialists. This knowledge was captured in the form of 
heuristics or (rules of thumb) tha t relate microbiological data and clinical signs 
and symptoms to possible pathogenetic organisms.
MYCIN knowledge is expressed principally in a num ber of rules of deduc­
tion in the form of:
IF condition (ANTECEDENT)
THEN conclusion (CONSEQUENT)
The deduction forms an  AND/OR tree with a  certainty factor assigned to 
each rule. This factor is a  num ber between 0 and 1. With each fact in the data 
base is a  ’m easure of belief and a ’m easure of disbelief, both of which are also 
num bers between 0 and 1 (Shortliffe and Buchanan, 1975).
Evaluation of the programme has shown that the performance of the sys­
tem approaches that of a specialist in the two areas of bacteraemia and mening­
itis for which the knowledge base had been developed (Yu et at, 1979a, 1979b).
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Figure 8.1 Expert System Components
8.6. COMPONENTS OF AN EXPERT SYSTEM:
In general, an  expert system consists of four major components: (a) a 
knowledge base on a  specific topic (domain-specific), (b) an  inference engine, (c) 
a communication interface; and (d) a  development engine. Figure 8.1 demon­
strates these components and their interrelations.
8.6.1. Knowledgebase:
The knowledge base is the stored collection of facts on a particular sub­
ject and the hundreds or thousands of if-then (situation/action) rules by which 
the facts relate. The base includes rules provided by a group of experts in tha t 
field and thousands of facts and heuristics, as well as judgments, intuitions, and 
experiences.
The knowledge base differs from a traditional data base. A data base is 
a collection of related or unrelated facts. A knowledge base, on the other hand, 
not only contains static data as in the data base, bu t also contains relational in­
formation.
Another component of the knowledge base is working memory. Working 
memory is used only during processing and is the resident space for information 
manipulation.
To create a knowledge base, special designers called knowledge engin­
eers, familiar with expert system methods, spend months working with the 
hum an experts to extract and structure the facts, rules, and knowledge. After 
the knowledge base is developed, the inference engine will be able to ’investigate’ 
tha t base.
8.6.2. Inference engine:
An inference engine is the programme that allows the computer to ’intel­
ligently’ apply the facts and information to a  particular problem. It retrieves and 
m anipulates the facts and rules, deciding in which order to make connections, 
associations, and inferences.
8.6.3. Communication interface:
Various forms of interface are used in the creation and operation of an 
expert system. Interfaces include terminals, graphical representations, multiple 
character windows, and multiple graphics windows. These interfaces operate in 
three situations. The first is where the user wants answers to problems. The sec­
ond situation is where the knowledge engineer wants to improve or increase the 
knowledge of the system. The third situation is where the user is a  student who 
needs to learn form the knowledge base.
8.6.4. Development engine:
The development engine, also called an editor or knowledge acquisition 
subsystem, is vital in the creation of the expert system in that it allows the knowl­
edge engineer to create, modify, add or delete information from the knowledge 
base.
8.7. THE PROCESS OF BUILDING MEDICAL EXPERT SYSTEMS:
8.7.1. Knowledge acquisition:
The general motivations for building expert systems discussed in Sec­
tion 8.3 apply to any system of this type, bu t when a specific model of reasoning 
is built, the reasons have to be m uch more precise. An expert model is constructed 
to solve a specific class of problems and to give advice on their solution.
A hum an expert has to provide the builder of an  expert reasoning model 
with different types of information. This includes personal experience of past 
problems solved, expertise of methods for solving the problems and knowledge 
about the reasons for choosing the methods used. The expert model designer 
groups knowledge of the right class and degree of specificity to solve the prob­
lem.
Expert knowledge is generally represented as a modular collection of 
rules with relatively well established and agreed-upon conclusions. This is a key
factor for the success of those expert systems in everyday use (Weiss and Kuli­
kowski, 1984; Quinlan et aL, 1987).
8.7.2. Choice of computer representation:
The choice of computer representation m ust be based upon two a t­
tributes: Power to express the expert knowledge and simplicity to describe, up­
date and explain the knowledge in the model.
There is often a compromise between the ease of representing knowledge 
in a  computer and the richness in the structure of possible semantic relations 
that may be described in an expert system’s framework. For instance, a  system 
which represents cause-and-effect relationship of certain events may be more 
powerful bu t it will generally be more difficult to encode.
Another im portant issue in choosing representation should be the ease 
with which knowledge can be changed and updated. Flexibility is essential, par­
ticularly in the early stages of building the model. In fact, lack of flexibility was 
one of the m ost im portant defects of many of the early artificial intelligence sys­
tems, which used complex descriptive frameworks (Weiss and Kulikowski, 1984).
An expert usually has many judgem ental or empirical rules according to 
which the evidence supports a conclusion or hypothesis, bu t with less than  ab­
solute certainty. In these cases, numerical values are associated with each rule 
to indicate the degree of confidence which can be placed in the hypothesis or con­
clusion which follows from the evidence provided.
8.7.3. Choice of control strategies:
The control strategy decides the order in which rules should be applied. 
One of the simplest strategies is to scan through the rules until one is found 
whose antecedents m atch assertions in the data base. When the rule is applied 
the knowledge base is updated and the scanning resumes. This process con­
tinues until either a  goal state is reached or no applicable rules are found. This 
is known as a data-driven control strategy because the behaviour of the system 
is a direct response to the facts about the problem which have been entered into
the data base. This strategy is also known as forward-chaining or antecedent rea­
soning.
Another strategy is to select a  goal to be achieved and to scan the rules 
to find those whose consequent actions can achieve the goal. Each such rule is 
tried in turn . If the antecedents for a  rule m atch existing facts in the data base, 
the rule is applied and the problem solved. If an  unm atched antecedent is en­
countered, arranging conditions to m atch that antecedent becomes a  new sub­
goal, and the same procedure is applied repeatedly. If there are no rules to 
establish the new subgoal, the programme asks the user for the necessary facts 
and enters them  in the data base. The behaviour of such a system is governed 
by the goals which the system is hying to achieve. This strategy is known as goal- 
driven, backward-chaining or consequent reasoning.
It is possible to use other control strategies tha t combine elements of 
data-driven and goal-driven techniques.
8.7.4. Expert systems building tools:
Various types of tools may be used for building expert systems. A true 
split between these types cannot be made since the borders between them  are 
vague and subjective.
Although it may be possible to write many expert system programmes in 
any programming language, certain languages are designed to execute certain 
kinds of programmes with maximum efficiency.
Representation languages:
Representation languages such as PROLOG and LISP are designed to 
deal with knowledge and to exploit the power of the computer in processing rules 
rather than  num bers. They offer less freedom to the user than  normal program­
ing languages. The largest disadvantage of these languages is the fixed control 
strategy. It is impossible to choose a control strategy depending on the problem. 
Also the methods to represent knowledge are less advanced. Since these lan­
guages can easily be extended they allow the programmer to build constructs tai­
lored to their specific needs. (General purpose programming languages such  as
BASIC, PASCAL and the C language (Section 1.4.1.), do not separate knowledge 
from the reasoning process, they represent knowledge inadequately except for 
the m ost simple kind of problems which practically do not require artificial intel­
ligence programming in the first place; and they produce programmes which are 
veiy inflexible, any modification means rewriting large parts if not all of the pro­
gramme. In general, the languages devised for other purposes have not proven 
to be especially effective for writing artificial intelligence programmes).
Expert systems shells:
One of the m ost important outcomes of research in expert systems has 
been the framework computer programmes which provide inference engine and 
syntaxes for knowledge, bu t which contain no problem-specific knowledge them ­
selves (Figure 8.2). Such fiamework programmes, now commercially available, 
are called expert system shells.
In empty shells there are a  limited num ber of knowledge representations 
available. The knowledge engineer is therefore not completely free in the way the 
knowledge is structured. However, a  num ber of facilities which are not available 
in other tools, are available in these shells. The most important advantage of 
using a shell is the considerable time saved in the process of building an  expert 
system because the inference engine and the control strategy mechanisms are 
built into it.
Environments:
Environments are powerful and flexible programmes designed to develop 
expert systems. They are usually running on specially designed computers (LISP 
machines) with fast processors and advanced, interactive, user-friendly graphics 
interfaces. Some of the latest environments ru n  on microcomputers. These envi­
ronm ents can probably succeed where shells cannot achieve the desired results.
Environments are generally more advanced than  shells and shells are 
more advanced than  representation languages (van Koppen, 1986; Grigoriu, 
1986; SAVOIR technical description booklet, 1986).
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Figure 8.2 Expert system  shell
8.8. PARAMETERS FOR ASSESSMENT OF EXPERT SYSTEMS:
The barriers to successful implementation of computer-based diagnostic 
systems have been analysed on several occasions (Starsman and Robenson, 
1972; Friedman and Gustafson, 1977). In assessing programmes from the point 
: of view of its intended user, it is pertinent to examine several param eters tha t af­
fect the success and scope of a  particular system. Unfortunately, the medical 
computing literature has few descriptions of systems for which all the following 
questions have been addressed;
1. How accurate is the expert system?
2. W hat is the nature of the knowledge in the system and how it is generated 
or acquired?
3. How is the clinical knowledge represented, and how does it facilitate the 
performance goals of the system described?
4. How are knowledge and clinical data used, and how does this impact on 
the system performance?
5. Is the system acceptable to the user for whom it is intended?
6. Is the interface with the user adequate?
7. Does the system function outside the research setting and is it suitable for 
dissemination?
8. What are the limitations of the approach?
The accuracy of any diagnostic expert system is assessed by determin­
ing the rate of both true and false positive, and true and false negative results. 
From these, the sensitivity, specificity, and predictive values are calculated (Sec­
tion 5.3.8). These values are calculated in relation to a given diagnosis and com­
pared with the figures derived from the conclusions reached by an  expert given 
the same information (Chard, 1988).
The system m ust demonstrate that it is useful and m ust confer some ad­
vantages not available from the hum an expert. Speed and cost are other practi­
cal factors which may be looked for in  the system. The system m ust also reflect 
widely accepted views on a topic, not the views of one particular designer. Trans-
ferability of the system should be considered in the design if it is intended to be 
used in an  environment other than  that where it has been developed.
Reggia and Tuhrim (1985) have reviewed the studies which compare the 
performance of medical expert systems with different knowledge representation 
techniques and concluded that they are similar. Their advice was that methods 
should be chosen according to the specific problem. For example, if there are sev­
eral well-documented groups of rules, a  knowledge base of a  production rule sys­
tem can be used with little modification of the original rules. Similarly, there are 
problems which demand probabilistic solution of the Bayesian type. Systems 
which combine a  num ber of different approaches probably provide the optimum 
solution.
8.9. REASONS FOR BUILDING A DYSTHYROID EYE DISEASE 
EXPERT SYSTEM:
Expert system building tools have reached an  acceptable stage of devel­
opment and many lessons have been learned from pioneering work over the last 
two decades. Building useful medical expert systems for use in the clinical envi­
ronm ent is now possible.
Further improvements in the techniques for developing medical expert 
systems are desirable. This can only be achieved if m any clinicians are encour­
aged to help design, to use and to criticise such systems.
Early expert systems were built to run  on mainframe, minicomputers or 
dedicated workstations. For obvious reasons this has limited their use. With the 
steady increase in the use of microcomputers in the medical profession, they can 
be seen as the most practical way to popularise expert system programmes 
amongst clinicians.
Dysthyroid eye disease is an  appropriate area for expert systems appli­
cation because:
1- The disorder is uncommon.
2- Its course is variable.
Specifications of TEDEX:
Comprehensive data base and coverage.
High quality.
Flexibility.
Reliability.
Modular design.
Low cost.
Run on microcomputer.
D isease specific.
Use multiple control strategies.
Multiple knowledge formalization techniques.
Provide explanations and justifications.
Based on:
- Long term study of thyroid ophthalmopathy.
- World literature.
User friendly interface.
Table 8.3
Specifications of the required thyroid eye disease expert system.
3- The outcome is unpredictable.
4- Management is uncertain.
5- There is a  large num ber of diagnostic and management parameters.
6- Treatm ent is currently empirical in most cases.
8.10, SYSTEMS AND METHODS:
8.10.1. Protocol:
System specifications:
The proposed expert system has been called TEDEX (Thyroid Eye Dis­
ease EXpert). It should be designed to satisfy the requirements summ arised in 
Table 8.3. It should cover all major aspects of the diagnosis and management 
problems of thyroid ophthalmopathy. The quality of advice should approach ex­
pert standards and the system should demonstrate stability and reliability under 
various consultation conditions.
The initial cost of expert system building as well as the cost of m ainten­
ance and updating in terms of hardware, software, development time, and m an­
power m ust be acceptable. Running the system on personal computers satisfies 
most of these requirements. In addition, it ensures the availability of the system 
to the large num ber of clinicians who have already been or are likely to become 
microcomputer users.
The system should be designed as a  ’disease specific expert system’ i.e., 
capable of dealing with a  specific group of patients who have been initially diag­
nosed as suffering from thyroid ophthalmopathy. It is not intended to handle 
other ophthalmic problems or to provide comprehensive lists of differential diag­
noses.
Powerful and flexible expert system building tools are required to design 
a  knowledge base in which combinations of different control strategies and vari­
ous knowledge form alisation techniques are possible. Forward chaining 
strategies may be used in one part of a module and backward chaining
strategies in another part, directed only by considerations related to the appro­
priateness of application of each strategy.
Explanation and amplification of questions and clarification of the re­
sponses required during the user/system  dialogue should be built into the sys­
tem. The system should also exhibit the capability of justifying its decisions and 
suggestions.
Although the user interface is not intended to be designed according to 
the commercial standards, it is necessaiy to be in agreement with the following 
conditions:
a  Sufficiently user-friendly to be acceptable by the clinician.
Q Questions and instructions m ust be short and clear.
n Phrasing and sequence of history taking dialogue m ust comply with the 
conventions adopted by ophthalmologists.
n A parsimonious balance should be achieved between the speed and com­
pleteness of consultation sessions.
The knowledge base for the system comprises the results of the long term 
study of thyroid ophthalmopathy (Chapter 5) and the world literature in the areas 
which have not been covered by our own study.
Testing procedure:
The performance of the programme is to be tested after validation of its 
rules. Testing should include:
a  Patient data  of exemplary cases (for whom the outcome was known) are 
to be entered into the system and the conclusions obtained are com­
pared with an  independently obtained expert opinion and the known 
outcome.
Q Questionnaire for a  panel of consultants is to be designed for evaluation 
of the performance of the system.
The system is considered to be a  prototype until repeated cycles of test­
ing and refinement are complete. This should be done while the system is being
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Figure 8.3 Stages of building an expert system
used by various intended users (e.g., ophthalmologists in orbital clinics, general 
ophthalmologists, endocrinologists and general practitioners). It takes several 
years of usage of the system before this final stage is reached.
TEDEX development team:
TEDEX development team comprised the author and Mr. A. Wail, who is 
currently a research fellow a t the Signal Processing Division of the Electrical and 
Electronic Department of Strathclyde University. The process essentially requires 
prolonged sessions for all of the stages of system development.
Stages of building TEDEX:
Figure 8.3 outlines the steps which have to be followed in the process of 
building the different modules of TEDEX. Basically the m ain stages comprise the 
definition and evaluation of the problem, the development of a  simplified proto­
type, the construction of the system and finally the testing and evaluation stages. 
Integration of the expert system into the clinical environment, documentation 
and coordination of user training are advanced stages. In addition, m aintenance 
of the system by improving or expanding its knowledge base takes years to be 
accomplished.
8.10.2. Preparatory phase: 
Programming courses:
The author attended a  six weeks course for programming in  BASIC and 
a similar course for ’Learning to programme in Pascal’ (Section 1.4.1) in order to 
become familiar with the concepts and techniques of microcomputer programm­
ing.
8.10.3. Problem identification and evaluation:
1- Our objective was to build a  disease specific expert system which gives ad­
vice about the diagnosis and management of dysthyroid eye disease pa­
tients and performs the following functions:
Q Confirmation of the diagnosis of dysthyroid eye disease, 
n Assessment of the severity of the condition, 
a  Identification of high risk patients.
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Hardware requirements:
Minimum configuration:
IBM PC AT or XT or compatible microcomputer. 
EGA or Hercules graphics adaptor.
Monochrome or EGA colour monitor.
Dot matrix printer.
512 KB RAM.
Two floppy disk drives (Hard disk is recommended).
Hardware used for system development:
IBM PC/AT (80286 processor/6.4 MHz).
EGA Wonder Display adaptor.
NEC Multisync colour monitor.
Fujitsu DPL-12 4 ,1 8-pin dot matrix printer.
640 KB RAM.
Math coprocessor (80287/6.4 MHz).
84 MB Hard disk storage.
Table 8.4
Minimum hardware configuration required to run TEDEX and details of the 
system used for its development.
Q Suggestion of a  suitable management plan.
n Evaluation of the significance of any change in the condition of the pa­
tient a t the time of follow-up visits.
Q Provide a  new management plan according to changes in patient condi­
tion.
n Provide an  explanation and justification of its conclusions whenever re­
quested by the user.
2- The problem is sufficiently well defined and reasonably circumscribed.
The potential sources of expertise are available.
3- The domain is representable, i.e. can be modelled in a computer knowl­
edge data structure.
4- The data required to be entered into the expert system for analysis are re­
liable, available, and complete.
5- The domain knowledge is: Heuristic, judgemental, i experiential, specific, 
or descriptive, i.e., it is symbolic and not data intensive.
6- The intended users of the system are general ophthalmologists, endocrino­
logists, general practitioners and perhaps, at a  later stage, medical stu ­
dents.
7- The project effort (duration, time and cost) is within the acceptable range 
allowed for our study.
8- Identification of appropriate hardware and software tools:
The microcomputer used to conduct this study and the minimum con­
figuration required to ru n  the expert system programme are listed in Table 8.4.
A list of the required software features was prepared. The SAVOIR expert 
system shell (Appendix Dl) was deemed to be the m ost appropriate tool to de­
velop TEDEX after careful consideration of the criteria sum m arised in Table 8.5.
Software tool requirements:
Run on IBM XT/AT or compatible under MS/DOS.
Consistent run time response/seconds.
Interfaced with local or integrated data base.
Interfaced to other application programmes.
U.K. support for software m aintenance.
Implemented knowledge base easily intelligible to the expert. 
Reasoning process easily explainable to the user.
Screen interface reasonably controllable by the developer. 
Report generation facility available.
Inference strategy controllable by the knowledge engineer.
Table 8.5
The required specifications of expert system development software tools.
Data requirement:
List of possible questions:
Administrative information 
Clinical history.
Investigations.
Choice of output device.
List of possible clinical findings:
Structure
List of possible requested investigations:
Visual field 
Extraocular muscles 
X-ray 
MRI
CT scan
List of possible diagnoses:
Not thyroid ophthalmopathy 
Normal eyelid 
Lid oedema
Superficial punctate keratopathy 
Corneal necrosis or perforation 
Extraocular muscle involvement 
Suspected optic nerve compression
List of possible treatment options:
Artificial tears 
Prisms
Extraocular muscle surgery 
Temporary tarsorrhaphy 
Systemic steroids 
Cyclosporin A 
Plasmapheresis
List of possible suggested actions:
Emergency admission 
Appointment in 3-5 months 
Refer to orbital surgeon
List of possible explanations.
Statistics:
Discriminant function analysis equations
Sensitivity, specificity and predictive value of various parameters.
List of rules:
The study of thyroid ophthalmopathy (Chapter5)
Personal data 
Clinical findings.
User choice of treatment options. 
Treatment contraindication.
Function
Optic nerve function 
100-Hue colour vision test 
Hess screen test 
Orbital ultrasound 
Thyroid function tests
Possible associated disease 
Eyelid retraction 
Normal cornea 
Comeal ulcer
Normal extraocular muscles 
No optic nerve involvement 
Definite optic nerve compression
Comeal ulcer treatment 
Occlusion
Lid lengthening procedure 
Permanent tarsorrhaphy 
Orbital radiotherapy 
Surgical orbital decompression 
Retrobulbar steroid injection
Appointment in 6-8 months 
Next appointment in two weeks 
Refer to Endocrinologist
Statistical significance
World literature.
Table 8.6
Selected examples of the data lists compiled for development of TEDEX knowledge base.
8.10.4. Development of TEDEX prototype:
Studying the Shell:
The first step after choosing SAVOIR was to study the technical m anual 
as well as to run, practice and experiment with the sample programmes supplied 
with the shell before starting to use it.
Conceptualistion and formalisation:
The delineation of the components of each problem with regard to essen­
tial data, the hypotheses employed and the intermediate measuring concepts (or 
scores) was first required. The m anner in which these concepts determine the 
implementation of the programme was then studied and defined.
Data requirements:
An outline of the m ain items of the lists of all the required data is shown 
in Table 8.6. This comprises questions, clinical findings, diagnoses, investiga­
tions, treatm ent options, suggested actions, error messages and various ques­
tion-related amplifications and explanations.
Knowledge acquisition:
Although knowledge acquisition is always a  formidable task, there has 
been no great difficulties in our case. The familiarity of the author with comput­
ing concepts and techniques considerably expanded the common area shared by 
the second member of the expert system building team. The author initially pre­
pared a written report delineating the m ain features of the problems and the ex­
pected solutions. This constituted the basis for the first simplified prototype of 
TEDEX. Subsequently, modifications, expansion and refinement of this proto­
type was achieved during repeated discussions of each individual module. These 
meetings constituted the principal knowledge acquisition technique and there 
was no practical need for any of the formal techniques such as ’structured’ or 
’unstructured’ interviews, ’verbal protocols’ or questionnaires which are usually 
necessary in this stage.
Preliminary knowledge:
The following initial objectives were achieved:
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Part of the TEDEX semantic network.
Q Identification of the basic terms and concepts.
d Identification of typical inputs and outputs of the system.
a  Identification of typical solutions or classes of solution.
n Identification of strategies for handling problems and of forming control 
strategies for initial implementation of the system.
Once sufficient information had been gathered and the team  had good 
understanding of the different aspects of the application and the problem-solving 
structure, a  short, preliminary prototype programme was written in SAVOIR code. 
Running and experimenting with the compiled programme was essential to deter­
mine the detailed knowledge required for building the complete prototype.
Semantic network design:
A semantic network representation of TEDEX was then designed. A se­
mantic network is a  collection of nodes linked together by various relationships 
which are shown graphically. The nodes represent concepts, situations or any 
other variable. This network had to be veiy detailed, showing the inputs, prob­
lem solving processes and outputs. A sample of this tree is shown in Plate 8.1.
Detailed knowledge acquisition:
The objective of detailed knowledge acquisition was to gain the specific 
information summ arised in Table 8.7. The detailed rules that represent the 
knowledge were gradually formulated and refined by combining and reorganis­
ing the knowledge within the preliminary prototype.
The results of the dysthyroid eye disease study (Chapter 5) constituted 
the major component of the knowledge base. This comprised all the tables in Ap­
pendix C3, efficiency values of the individual predictor variables (Tables 5.12 and 
5.13), the inferences based on the data of the study (Sections 5.4 and 5.5) and 
the linear discriminant function analysis equations (Tables 5.16 and 5.17).
Detailed knowledge acquisition.
□ Identification of relationships between various data and rules.
□ Identification of the hierarchy of rules, what rules are intermediate, and what rules lead directly to conclusions.
□  Judging the relative validity and importance of data.
□ Judging the certainty of data  and the relative probabilities regarding assum ptions, strategies and conclusions, 
a  Judging the priorities and order of performing different functions.
□ Determining how conflicts between rules and conclusions are resolved, 
a  Recognition of alternative paths and strategies for problem solving.
□ Determination of shortcuts in reasoning and the conditions under which they are used, 
n  Detailing responses to both expected and unexpected outcomes.
□ Determination of 'strength of belief in different rules, outcomes and data.
□ Understanding the input requirements of different goals and sub-goals.
Table 8.7
Objective of the detailed knowledge acquisition stage.
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Figure 8.4 TEDEX Components
Knowledge base design:
Modularity:
TEDEX is designed in a  modular form so that it meets with the above 
specifications (Section 8.10.1), it ensures easy expendability and maintainability 
and it facilitates testing and validation of each individual module before the final 
assembly of the programme. Figure 8.4 shows the principal components of 
TEDEX and Figure 8.5 shows the various modules of the system.
Data acquisition module:
When the data acquisition module (Figure 8.6) is activated, on-line data 
can be obtained by direct interaction with the user. The potential is available for 
direct data acquisition from an  external source. TEMPRAC (Chapter 6), compu­
terised visual field testing equipment, automatic chart reader (Chapter 7), auto­
mated 100-Hue colour vision test or laboratory computers are examples of the 
data sources which could be linked to the system. This option has been kept open 
by designing 50 empty slots into the system. Future addition of these facilities 
will be possible with a  minimal am ount of programming effort.
Another form of data acquisition occurs a t the beginning of a follow-up 
visit. All the data acquired during the previous consultation are automatically re­
trieved from the data base and loaded by this module into the computer RAM. 
The data can then be updated or amended.
Data validation and interpretation module:
Data validation and interpretation module (Figure 8.7) detects any data 
entry error, displays an  error message and prompts the user to retype his re­
sponse. This process is repeated until the correct response is entered. Only ap­
propriate responses will be interpreted (scored).
This module also monitors the change of data over time. It evaluates and 
scores the change before the information is used by the diagnosis module.
Diagnosis module:
The diagnosis module has four main goals: To confirm or refute the di­
agnosis of thyroid ophthalmopathy, to detect possible associated disease and to
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evaluate the risk of developing severe ophthalmopathy in a particular patient 
(Figure 8.8).
Components of Diagnosis module:
Six m ain components (Figure 8.9) comprise the core of the diagnosis mo­
dule. The structure and function of the eyelids, cornea, optic nerve and extraocu­
lar muscles and the degree of soft tissue involvement are evaluated in addition 
to the calculation of risk score.
Each component handles the validated relevant group of data (e.g., His­
tory data, clinical examination findings and test results). Intermediate diagnosis 
(or score) is determined. When the ’final’ diagnosis is accomplished the proper 
m anagement plan is chosen. After the appropriate report is displayed, the rele­
vant data and scores are stored into the database. Subsequently, the other com­
ponents are similarly investigated (Figure 8.10).
Diagnosis reasoning strategies:
In breaking down the various types of reasoning involved in building this 
module, we identified several kinds of reasoning sub-problems (Figure 8.11):
1. Given some pattern of symptoms, signs, and test results, infer the possible 
diagnosis (data driven reasoning strategy) and the degree of certainty 
which can be assigned to this diagnosis.
2. Given this same pattern of data, other findings should be obtained to im­
prove certainty about the diagnosis (goal driven reasoning strategy).
3. After a diagnosis is provisionally established, discrepant, unexpected or in­
compatible findings are detected and conflict (e.g., if more than  one rule is 
applicable to a  situation) is resolved.
4. Deciding how and when does the system move from a provisional diag­
nosis to a  more conclusive one based on results of further confirmatory in­
vestigations.
5. Given tha t a diagnosis has been established, how does the system proceed 
to choose a  treatm ent, and which treatm ent option is to be chosen in  u r­
gent situations without having to wait for test results?
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Coding and scoring systems:
The sam e system used for coding the data of dysthyroid eye disease study 
(Appendix C 1) was applied on the corresponding param eters included in this pro­
gramme. A uniform simple grading system which assigns one value (score) to 
each division on the scales of severity and certainty was devised as follows:
This scoring scheme has been adapted from the scheme used in INTER­
NIST (Section 8.5.3) which proved to be capable of guiding effective diagnostic 
reasoning (Pople, 1975; Pople etoL, 1975: Oleson, 1977).
In situations where the user is required to answer any question using 
such grading system, explanation of the scores and any of its modifications are 
displayed in  association with the question.
The above grading system is applied so that the intermediate diagnosis 
of a  particular patient is represented as a pattern composed of a  combination of 
the scores of the condition of soft tissue (S), the cornea (C), the extraocular m us­
cles (M), the optic nerve (N), the eye lid (L) and the degree of proptosis (P). The 
risk score (R) is expressed as probability which ranges from 0 to 100. The pat­
tern  might be as follows:
Which m eans tha t this patient has mild soft tissue changes (S2), comeal 
ulceration (C3), no extraocular muscle imbalance (Ml), suspected optic nerve 
compression with a  certainty between 25 and 50 % (N2), mild lid retraction (L2), 
and severe proptosis of 6mm or more above the average normal value ’conside­
ring the  race and refraction of the patient’ (P4). The risk of running a severe course 
is 85% (R85). This diagnosis is considered as ’final’ when all the questions re­
garding confirmatory investigations are completed.
1 = Normal or 
2= Mild or 
3= Moderate or 
4= Severe or
(=/< 0.25 certainty value)
(0.25-0.50 certainty value)
(0.50-0.75 certainty value)
(>0.75 certainty value)
S 2, C 3, M 1, N 2, L 2, P 4, (R 85)
Diagnosis module Data
acquisition
module
noyes
Data BaseDisplayUsers’ Option
Check Treatment Selection Parameters
Check For Contraindications
Select Provisional Treatment Option
Ask More 
Questions Or 
Request More 
Tests
Select Next 
Treatment 
Option
TREATMENT MODULE
Figure 8.12 Treatment Module Strategy
Treatment module strategies:
On reaching a  ’final’ diagnosis, the treatm ent module (Figure 8.12) is ac­
tivated. This module examines the treatm ent option selection parameters. These 
are sets of rules relating treatm ent options to the following variables:
(a) personal information,
(b) structure and function of different ocular tissues,
(c) thyroid status,
(d) treatm ent history,
(e) combination of diagnoses (i.e., pattern), and
(f) history of systemic diseases.
These rules predetermine the order of option selection and investigate 
the possibility of relative or absolute contra-indications for each treatm ent op­
tion.
Once an  option has been selected, the data acquisition module is reac­
tivated to ask  more questions or request more investigations relevant to possible 
contra-indications for this particular treatm ent option. If the selected option is 
found to be contraindicated, the second TDest’ option is chosen and another set 
of questions m ay be asked. A selected option is considered to be ’final’ if no con­
tra-indications are found and the user accepts the choice, or if the user accepts 
a  choice despite the presence of contra-indications (overriding the system).
A hybrid of four knowledge representation approaches was used to de­
velop the knowledge base. Firstly, the semantic network (Plate 8.1), which is the 
most general representational structure, served as the basis for other knowledge 
representations. Secondly, the production rules approach, which is the technique 
used most extensively in  the system. The following is an  example of one of the 
rules used in TEDEX:
Knowledge representation
"IF
AND
THEN
there is evidence of optic nerve compression
the patient has had orbital radiotherapy in the past
the option of orbital radiotherapy should not be offered.'
The rule is ’activated’ when all of the conditions (antecedents) are satis­
fied by the current situation. The production rule is ’fired’ or executed when the 
action (consequent) is performed. The inference engine is responsible for control­
ling the activity of the production rules through cycles of matching, conflict res­
olution and action.
The third knowledge representation approach is ’Predicate Calculus’ (or 
logic programming). Predicates describe the relationship or make a statement 
about the variables under consideration. They produce a  simple way of determin­
ing the tru th  or fallacy of a statement. Some of the predicates which are com­
monly used in TEDEX are:
AND, OR, NOT, IMPLIES, EQUIVALENT, BESTOF, WORSEOF
The fourth representation comprises a  pattern matching approach where 
each of the various combinations of clinical features of thyroid ophthalmopathy 
forms a particular pattern which requires a specific m anagement plan.
Problem solving strategies: 
Search strategies:
TEDEX follows a  ’Breadth-First Blind Search’ strategy in the first part of 
the consultation session which is concerned with the establishm ent of a  data 
base (e.g., personal information, history and clinical findings). This involves 
examining the first steps in all paths available. If an  answer is found, the next 
step is searched, if not, the appropriate question is displayed requesting the user 
to enter the answer.
A ’Hill-Climbing’ heuristic search strategy is followed in the other parts 
of the programme. A search is initiated downward along a given path  until an 
answer is found or a  dead end is reached. If a  dead end is reached, the search 
will backtrack to the first alternative path  and repeat the procedure.
Control strategies:
Once the search strategies had been established, it was realised th a t dif­
ferent situations require different control strategies for deciding which procedure 
to apply and where to apply it.
A ’Bidirectional’ reasoning strategy was chosen. This involves going both 
forward and backward through the knowledge base during a  session. To begin a 
session, the inference engine starts by following forward chaining strategy, i.e., 
driven by the acquired data. As the inference engine traverses through the knowl­
edge base, it has the choice of proceeding forward or backward a t each decision 
node. Heuristic algorithms have been implemented into the system in order to 
determine these choices a t various nodes.
’Monotonic reasoning*, which is straightforward, repetitive procedural 
technique has been applied to the histoiy taking part of the data acquisition mo­
dule.
The ’Certainty factors’ which have been associated with reasoning paths 
of TEDEX fall into one of the following categories:
1- Certainty: The proposition statem ent (question or variable) may be either 
true (a value of 1) or false (a value of 0). A value of zero will automatically 
halt the continuation of solving the problem along this solution path and 
will proceed to a  different path.
2- Confidence: This indicates a value ranging from -1 to +1. These factors do 
not imply absolute tru th  or falseness, bu t rather imply the strength or 
weakness of the proposition. A zero implies no tendency toward the re­
sponse being true or false, bu t maintains neutrality. A value of 1 indicates 
an  absolute truth, whereas a  value of -1 is indicative of absolute falseness.
3- Probability: The proposition may have a probability of occurrence which 
ranges from 0 to 100. A value of 100 implies the maximum probability 
th a t the proposition will be true or will occur. A value of 75 may imply a 
75% chance of the proposition occurring and a  25% chance of it not occur­
ring.
Another technique used to enhance the efficiency of the search is ’Ab­
straction’. The computer should abstract the information to a  higher level before 
deciding whether it is relevant or not. This is done by means of forward and back­
ward chaining. The goal of abstraction is to quickly and efficiently find a  solution 
path. For example in the diagnosis module this technique is employed to reduce 
the am ount of detailed information acquired by the system to 7 intermediate di­
agnoses or scores forming a diagnostic pattern.
FIRST VISIT
Establish database.
Request necessary investigations. 
Calculate risk score.
Suggest management plan.
Store information.
Display final report.
Figure 8.13 First visit objectives.
FOLLOW-UP VISIT
Retrieve final report of last visit. 
Update and amend old data.
Monitor change in various param eters. 
Request necessary investigations. 
Recalculate risk score.
Suggest management plan.
Store information.
Display final report.
Figure 8.14 Follow-up visit objectives.
Working patterns:
There are two main consultation modes, a  ’First visit mode* and a  ’Fol­
low up visit mode’. The goals of these modes are shown in Figure 8.13 and 
Figure 8.14.
At the beginning of a  consultation session for a  new patient a  new file is 
opened. All the data acquired or the intermediate values (scores) and the conclu­
sions (diagnoses or management plans) generated during the session are auto­
matically saved before ending the consultation.
For a  follow up visit, the TEDEX session starts by transferring all the 
available information from the hard disk into the working memory of the com­
puter. Routine questions about past history are not repeated. The rest of the ses­
sion is completed in a  m anner similar to that followed in the first visit. TEDEX 
compares all the answers and values entered during the current session with 
those acquired during the previous sessions. The change is evaluated and taken 
into account with regard to making inferences about the current condition of the 
patient. Again all the values, variables and conclusions are automatically stored 
in the data base a t the end of the session.
Communication interface:
Throughout a  consultation session the user has a  dialogue with the com­
munication interface. This interface shows uniform behaviour no m atter which 
of the components the user is using. Possible forms of dialogue include text 
m enus, flashing warning messages, questions and answers or written text. As 
part of the control mechanism, the communication interface supervises the dia­
logue and invokes other modules which are appropriate to the state of the con­
sultation. The communication interface itself is an  expert system in  its own right 
with knowledge about the hardware, the application, the ergonomic require­
m ents, the user, and the dialogue (Figure 8.15).
The computer keyboard is used to input the data during the dialogue 
with TEDEX. The output (Figure 8.16) is displayed on the computer screen or 
sent to a  printer if the user wishes.
rU S E R
U S E R  INTERFACE
a u t o m a t e d ,
i q u i p m e n yK e y b o a r d P r i n t o u tD i s p l a y
INPUTS O U T P U T S
V_________________________________________________ ;________ y
Figure 8.15 User Interface
Warnings
Clinical sum m ary
Final case report
D i s p l a y
P  rin t e r
Database
Figure 8.16 System Output
r \
ADMINISTRATIVE & PERSONAL DATA.
CLINICAL FINDINGS.
TEST RESULTS.
DIAGNOSIS.
MANAGEMENT PLAN. --------------------
-
- Actions.
- Treatment recommendations.
- Requested investigations.
^  - Next appointment. ^
V J
Figure 8.17 Contents of the final report.
Final reporting:
The final report which is displayed at the end of a  consultation session 
contains the items outlined in Figure 8.17. This report is also saved a t the con­
clusion of a  consultation session and the user has the choice of displaying or 
printing it a t the outset of the next session. H ie user might, on some occasions, 
want to consult TEDEX only to read the displayed or printed most recent report 
about a particular patient.
File creation and database:
Two files are opened for each new patient a t the commencement of a  ses­
sion. The first file contains 181 fields to store all the data acquired during con­
sultation. This file is the first step in  establishing the system’s data base which 
is also interfaced with the ’dBase-in+’ package which is currently the industry 
standard data base for IBM and compatible microcomputer. The second file is 
created to store the final report generated by the system.
8.11. PROTOCOL FOR TESTING AND EVALUATION OF TEDEX:
8.11.1. Rule validation:
After compilation of the system’s code, the completeness and correctness 
of rules were tested using the ’PV’ programme which is one of SAVOIR’s tools. 
The task  of this programme was to examine every item (variable, question, ac­
tion and group) in order to assign an  initial value to each one. It also performed 
consistency checks on the model, including searches for circular argum ents in 
the reasoning (e.g., A depends on B which depends on C which depends on A).
8.11.2. Testing - modification cycles:
The system was then tested using exemplary patient data. TEDEX con­
clusions were compared with the already known correct diagnosis and outcome. 
Guided by the test results, the system was then modified and adjusted. A loop of 
’testing - modification - testing’ will continue until the performance of TEDEX is 
deemed to be satisfactory.
8.11.3. Performance Assessment:
Protocol for performance evaluation: 
Testing procedure:
(1) Ten cases representing the whole range of complexity which the sys­
tem is likely to handle will be used to perform the following tests:
[a] Calculation of the average history taking time:
The time required to complete the history taking part of the user-system 
dialogue is calculated for each case. The average of the readings is then calcu­
lated.
[b] Calculation of the average consultation time:
The average time taken to complete a consultation will be calculated.
Ic] Calculation of the average system response time:
The average response time (i.e., the time from the entry of the last ques­
tion to the display of the final report) is calculated. This average will be calcu­
lated using an  IBM/AT 6 MHz and a faster computer, AMT/AT 10 MHz, which is 
an  IBM compatible machine.
(2) Evaluation of TEDEX advice accuracy in comparison with historical
cases:
50 case histories will be randomly selected from the data base which con­
tains the data of thyroid eye disease study (Chapter 5). The system’s diagnosis 
and management plan will then be compared with the already known diagnoses, 
management and outcome of each case.
8.12. RESULTS:
One of the chief differences between an  expert system model building 
project and other research projects is that the expert system itself represents the 
major part of the results. It is also worth mentioning tha t the only way to dem­
onstrate all the features of the system is by running it. A copy of the programme 
and an  instruction sheet are enclosed for this purpose in Volume 2 pocket, and 
a copy of the source code of the complete programme files is printed in Appen­
dix D2.
8.12.1. A session with TEDEX:
Case num ber (074) which has been selected from dysthyroid eye disease 
study (Chapter 5) is summ arised in Table 8.8. Plate 8.2 through 8.10 are screen 
photographs showing samples of user-system dialogue. Printout of samples of 
TEDEX m enus, questions, messages and reports of the sam e case are presented 
in Appendix D3.
8.12.2. Results of testing and validation 
Rule validation:
The compiled programme was tested by running the SAVOIR ’PV’ testing 
tool. No errors were found on checking all questions, variables, actions and 
groups. The complete output of th is testing procedure is printed in Appendix D4.
Model statistics:
The complete printed model sum m aiy (Appendix D5) is the of source 
Table 8.9 which shows the num ber of each of the model items. The programme 
code occupies about 22 KB and the total num ber of items is 726.
8.12.3. Performance assessment results:
Table 8.10 shows the average history taking time, the average consult­
ation time and the average system response time for new patients and for follow- 
up visits when the system was running on the IBM/AT and on the faster AMT 
machine.
Table 8.11 shows the accuracy of TEDEX in reaching the correct diag­
nosis and in predicting the ’final’ outcome for 50 historical cases whose diag­
noses and outcome were already known.
Case summary:
C ase  No. 074 Age in y ears 50
S ex  F C om plaint Lacrimation, photophobia & cosmetic appearance
Thyroid s ta tu s Hyperthyroidism
Duration o ph thalm opathy  (m onths) 1
Duration of thyroid  dysfunction  (m onths) 48
T reatm en t of thyro id  dysfunction Carbimazole
O cular treatm ent Artificial tears
S ystem ic d is e a se none
Right eye F irst v isit Follow-up visit
Diplopia None Mild
Diplopia on exam ination On elevation and depression Combination of restrictions
Exophthalm om etry  (mm) 25 28
Visual acuity 6/6 6/12
Lid lag Mild Mild
Lid retraction Mild Mild
Lid oedem a Mild Moderate
C hem osis Mild • Moderate
C ornea S.P.K. S.P.K.
Intraocular p re ssu re  s tra ig h t 18mm. Hg 20mm. Hg
Intraocular p re ss u re  up 24mm. Hg 28mm. Hg
Pupillary reac tio n s No afferent defect No afferent defect
O phthalm oscopy No papilloedema, No choroidal folds No papilloedema, No 
choroidal folds
Table 8.8
Clinical summary of the exemplary case used to demonstrate TEDEX operation.
(1) New patien t
(4) Teaching se ss io n
(1 to  4 , t i f  not known or an option)
Plate 8.2 
Opening menu.
Patient conplaint
1 -  L a c r in a t io n .
2 - Photophobia.
3 - Blurring of vision
4 - Double vision.
5 - Pain.
Does the patient suffer fron
( ¥ . . ? . . N or an option) V.
Plate 8.3
History taking.
No lid  re trac tion  -
The upper lid  nargin is  1 m  below the 1 inbus.
NiId lid  re trac tion  ■
The upper lid  nargin is  ju s t a t  the 1 inbus.
Noderate lid  re trac tio n  -
The upper lid  nargin is  1-2 nn above the 1 inbus.
Severe lid  re trac tio n  *
The upper lid  nargin is  3 nn or nore above the 
1 inbus.
tape <CR> to continue.
Plate 8.4 
Amplification.
lanation
(1) Nonpositional intraocular pressure 
thyroid eye disease
ftraily and Eyre (1901) were the f ir s t  to 
report cases with hyperthyroidisn and 
exophthalnos who had evidence of glaucona by 
palpation. The studies during the f ir s t  half of 
the twentieth century were reviewed by 
Pbhjanpelto (1968), who enphasized the lack of 
agreenent on the question of the link between 
intraocular pressure and thyroid dysfunction. 
However, tononetry was poorly developed during 
r)orwards or S)top CF,SD_
Plate 8.5
Expansion.
Provisional Diagnosis
Optic Nerve:
Fron the a v a i lab le  data  the re  is  no evidence to  suggest 
optic  nerve conpression. (confidence = 0.21)
Nornally no fu r th e r  inves tiga t ions  of the visual 
functions are  req u ired .  However, i t  is  reconnended to 
proceed with base l in e  t e s t s  fo r  fu tu re  reference.
Cornea:
Nornal cornea, (confidence = 0.18)
Fjorwards or S )top
Plate 8.6
Intermediate report.
fis reported before t h i s  p a t ie n t  is 
alnost d e f in i t ly  su ffe r in g  fron optic  
nerve conpression, t h i s  is  an eye 
energency. 81so p rop tos is  is severe
Systenic s te ro id s  is  con tra ind ica ted . 
Orbital radiotherapy is out of question 
My f i r s t  choice is su rg ica l  deconpression
Considering a v a i l a b i l i t y  and your 
preference, what is  your choice?
for deconpression.Enter 2
(1 to 3 ,  • i f  n o t known o r  nn o p tio n )  _
Plate 8.7 
System’s  advice.
I do not fu l ly  agree with you because 
there a r e :
conrta indications to  radiotherapy 
in th i s  p a r t ic u la r  p a t ie n t
Do you want me to  continue using 
your choice? (V)
Look for o ther  choices? (N)
Enter (V) fo r  Continue 
Enter (N) for  Other choices
(V or N or an option)
Plate 8.8 
User’s  choice.
The ava ilab le  da ta  provides a conclusive evidence of 
extraocular muscles dysfunction , (confidence = 0.74)
Management Plan
Suggested Action
Review in one month.
Treatment Recommendations
Any plans fo r  e x t rao cu la r  muscle surgery should be 
postponed.
No treatment i s  requ ired  fo r  the ocular m otil i ty  
disturbance a t  t h i s  s ta g e .
B)ackuards or S)top [ B , S J _______________
Plate 8.9 
Final report.
(1) - DISPLAY final report.
(2) - PRINT final report
(3) - RE-START new patient.
(4) - EXIT from TEDEX.
(1 to  4 , ! i f  not known or an option)
Plate 8.10 
Closing menu.
Statistics of the model.
Questions 121
Variables 414
Actions 178
D atabase fields 181
Groups 13
Table 8.9
The details of statistics of various com ponents of TEDEX.
Performance evaluation:
IBM/AT AMT/AT
H istory taking in m inu tes:
New patients 4.45 3.00
Follow-up visit 2.80 2.30
Mean history taking time 4.23 2.65
S y stem  re s p o n s e  tim e in s e c o n d s :
New patients 5.00 3.00
Follow-up visit 5.00 3.00
Mean response time 5.00 3.00
C om plete s e s s io n  in m inu tes:
New patient 5.45 4.00
Follow-up visit 3.25 2.80
Mean session  time 4.35 3.40
Table 8.10
Mean history taking, system response, and complete session  times using 10 
cases representing various degrees of complexity.
TEDEX Performance:
P ercen tag e  of co rre c t d ia g n o ses  96%
P ercen tag e  of co rrec t p red ictions of o u tco m e 71 %
Table 8.11
A ssessm ent of the performance of TEDEX using 50 historical dysthyroid eye
disease cases.
8.13. DISCUSSION:
8.13.1. Performance of TEDEX:
No m easure or group of values has been universally accepted as a  stand­
ard to evaluate expert system performance. An expert system can be measured 
against several criteria for analysis, b u t the analysis will always be subject to 
personal interpretation.
From the user point of view the system needs to have a  smooth, efficient, 
and ’natural’ interface which is ’user friendly’. An expert system’s advice m ust 
be useful. Explanations and justifications are needed to explain its decisions in 
case any questions should arise during the consultation session.
TEDEX takes an  average of 5.45 m inutes for completion of a  session when 
dealing with a  new patient and only 3.00 m inutes in subsequent follow-up visits 
when running on the slow AT machine, which means tha t in a clinical situation 
the consultation time will be increased only by this am ount of time which in­
cludes establishing a  complete data base as an  added advantage.
The average system response time is 5 seconds when running on the slo­
west IBM AT personal computer, which is rapid enough to m aintain the user’s 
attention. This can be further shortened if the system is ru n  on the faster m a­
chines which are currently becoming available. This aspect is im portant in order 
to enhance the acceptance of expert systems such as TEDEX by busy clinicians.
TEDEX accuracy in reaching the correct diagnosis was 96% and it was 
71% accurate in predicting the ’final’ outcome using the exemplary historical 
cases which are part of the study tha t constituted the foundations of the system. 
However, these results can only be interpreted as an  indication of the system ’s 
integrity and consistency. Evaluation of the performance of the system in general 
ophthalmic clinics, orbital clinics and in endocrinology clinics needs a  separate 
study and should be carried out using new cases. Such a  study should be pros­
pective, long-term, and perhaps multicentric in order to compensate for the rarity 
of this disorder.
There have been a num ber of studies in which the accuracy of computer 
diagnosis has been compared with that of a hum an presented with the same data 
(deDombal etaL, 1972; Adams etaL , 1986; Scherk etaL, 1986; Chard, 1987; 
Barlow et aL, 1987). Most of these studies show the computer to be more accur­
ate.
8.13.2. Difficulties:
No established methodology:
No standard methodology for designing and building medical expert sys­
tem models is available despite more than  two decades of research. Most of the 
published work focuses on presenting the method used in developing a particu­
lar system. One of our first tasks was to define the problem and sub-problems 
and decide on which approach was suitable for each individual sub-problem. 
Clear set of methodologies was then decided as appropriate.
Software tools for microcomputers:
Few shells for the development o f’real’ expert systems are able to ru n  on 
microcomputers (as opposed to ’toy’ expert systems with small num ber of rules). 
Moreover, most of the powerful tools have been designed with financial and busi­
ness applications in mind. A general purpose expert system shell, which had 
been tried and proved to be sufficiently powerful, was required for the develop­
m ent of TEDEX.
It was decided to use a  shell rather than  any of the other available tools 
for several reasons. In general, the expert system building team was immediate­
ly able to use a  shell for expert system development and is able to describe the 
knowledge processes using the shell syntax. Prototypes of application pro­
grammes can be built and tested when a  shell is used. In prototype development 
the feasibility for a particular application can be tested and the test results used 
in order to evaluate shell suitability for a  particular application. Moreover, a  su it­
able shell offers a considerable increase in programming productivity. Further­
more, new shell architectures can enable one application to ru n  identically in 
different computer environments. Shells available for IBM personal computers 
and compatibles are reasonable in price. In addition, developing an  expert sys­
tem application using a  shell has a m uch higher chance of success than  build­
ing it from scratch which is, unnecessarily, lengthy and expensive process. These 
requirements are m uch reduced if a  shell is used.
It was agreed tha t SAVOIR meets most of the requirements and is the 
best for our purpose a t the present time. Based on the above considerations, the 
m ain reasons for selecting SAVOIR were:
1. As a compiler, it has a  separate run-tim e programme with compiled code 
(as opposed to interpreted) which m eans that the run  time speed will be 
fast.
2. SAVOIR supports all the data types required.
3. As one of the m ain features of our system m ust be a good user interface, it 
is im portant that, as developers, we have control over it. SAVOIR allows 
for this.
4. SAVOIR has good facilities for debugging the knowledge base allowing 
error capture and fine tuning to be performed rapidly and easily.
5. Explanation and help facilities are essential features of our system. SA­
VOIR allows for implementation of context sensitive help, general help and 
justification.
Hardware limitations:
We have committed ourselves to develop the expert system on microcom­
puters in fulfillment of one of the aims of this study (Chapter 4). Dedicated work 
stations, such  as LISP machines are very powerful, flexible and effective b u t they 
are very expensive. Microcomputers have serious limitations regarding speed and 
graphical capabilities from the developer’s point of view. This adds to the devel­
opment difficulties, although the situation is changing with time.
The TEDEX hardware development system has been configured to mini­
mise the effect of these limitations (Table 8.4). This configuration combined with 
a powerful and flexible software shell constituted an  adequate development sys­
tem  for this particular project.
Expert system application categories:
Interpretation*
Identification*
Prediction*
Diagnosis*
Control*
Design
Planning*
Monitoring*
Debugging and testing 
Instruction and training
Table 8.12
Application categories which are suitable for expert system implementation.
'fulfilled by TEDEX
Transferability:
The deDombal system of abdominal pain has been used in different 
unites with similar degrees of efficacy (Adams et aL, 1986). On the other hand a 
system for diagnosis of jaundice which was developed a t a  specialised liver unit 
in Britain (Knill-Jones et aL, 1973) was shown to be inadequate for use in Sweden 
(Lindberg, 1982), whereas another system developed for use in Sweden was 
shown, in a  later study, to work satisfactorily (Lindberg et aL, 1987).
The TEDEX knowledge base has been developed with this potential prob­
lem in mind. However, the efficacy of the system elsewhere can be decided only 
after the system has been evaluated in the new environment. Further adjustm ent 
of the knowledge base could become necessary after such tests. It seems that 
there are two major factors which influence transferability. Firstly, the differen­
ces between the population which has been studied to build the expert system 
(training and testing sets of cases) and the population of patients in the new en­
vironment. Secondly, the nature of the knowledge base rules and how m uch they 
depend on values which are specific to the population under evaluation.
Further problems can arise if the system has been developed using one 
class of machine (e.g., IBM microcomputers) while the intended user has a  dif­
ferent system (e.g. an  Apple Macintosh). This problem is currently being solved 
with the introduction of tools which have been written in the C programming lan­
guage (e.g., NEXPERT, Appendix D6). Such tools enable the developer to use any 
of several classes of machine for system development and to deliver the finished 
programme in various formats which ensure compatibility with a  wide range of 
microcomputers. However, TEDEX has been designed to ru n  on the industry 
standard and the most widely used microcomputer system. The newer transfer­
able development tools have been introduced since the inception of the project 
and cannot be used for TEDEX.
8.13.3. System features:
Wolfgram et aL (1987) discussed various applications categories which 
are appropriate for expert systems. Table 8.12 lists ten of the major categories. 
TEDEX has the facility to control external data acquisition equipment (e.g., Key­
board, TEMPRAC, Scanner, etc.) to obtain information about a  particular patient. 
It interprets and scores the data, identifies any error, inconsistency or discrep­
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ancy in them  and monitors the evolution of thyroid ophthalmopathy in time. It 
suggests a diagnosis, predicts the prognosis and provides a management plan. It 
therefore fulfils seven of the ten categories listed in Table 8.12.
Domain selection:
Diagnosis, prediction, monitoring and planning the management of a  
medical disorder are particularly suitable for the application of expert system 
techniques. The acceptance of such a system by clinicians contributes to the 
credibility of these techniques and, more importantly, will establish their efficacy 
and limitations in clinical practice.
The subject of thyroid ophthalmopathy is small enough tha t an  expert 
system could be developed as a  prototype in the designated project time. Fur­
thermore, the am ount of domain-specific knowledge involved in the diagnosis 
and m anagement of this disorder was limited enough to make it possible to ac­
quire, understand and represent that knowledge in the relatively short time avail­
able.
Development time:
The development of a functioning prototype of TEDEX required only 18 
m onth (3 man-years) which is considerably shorter than  the time taken to de­
velop comparable expert systems such as MYCIN (Section 8.5.5). Although both 
systems contain approximately 400 rules, MYCIN development required 20 man- 
years (Engelbrecht and Rothemund, 1987). A num ber of factors can explain this 
fact. Firstly, TEDEX has been developed using a  shell (Section 8.7.4) whilst 
MYCIN had been built from scratch; no shells were available a t the time of its de­
velopment. Secondly, enough lessons have been learned form the early work to 
enable us to avoid many pitfalls which were inevitable in the early nineteen seven­
ties. The growing experience of expert system developers gained during the last 
two decades is constantly decreasing the development time (Engelbrecht and Ro­
them und, 1987). Finally, the author as a  computer enthusiast and Mr. A. Wail 
as an  artificial intelligence expert (who had ju s t successfully finished a  ’Com­
puter fault diagnosis expert system’ project for his Master’s degree), were able to 
work in harmony forming a unique expert system building team. This consider­
ably shortened m any of the development stages, particularly that of knowledge 
acquisition which is usually lengthy and difficult.
Large systems running on microcomputers:
TEDEX, which is considered a  large system (with a num ber of rules equi­
valent to MYCIN) runs on IBM and compatible microcomputers. To the best of 
our knowledge no such system have hitherto been developed to deal with clini­
cal ophthalmic problems.
Methodology chosen:
The steps outlines in Section 8.10 were chosen as being most appropri­
ate b u t they should not be considered the only possible course for developing an 
expert system. However, this project is based on a  methodology which led to the 
achievement of the desired goals in the time available and which could be fol­
lowed in the development of similar systems for use in other areas. The charac­
terisation of such a  methodology in evolving an  artificial intelligence system is 
one of the major aims of this study.
Communicating knowledge:
TEDEX and other medical expert systems exemplify a  new concept in 
communicating and spreading knowledge. They demonstrate th a t medical expert 
systems can be used as a  medium which contain both the facts and  figures (i.e., 
standard textbook information), in addition to the decision making process itself.
Although textbooks and expert systems are both knowledge repositories, 
expert systems have some additional potential advantages. A given knowledge 
base can be used for multiple applications because knowledge can be represented 
independently from its use. A knowledge base typically contains procedures for 
making a diagnosis, for teaching and for learning. A textbook generally adopts 
one view point whilst an  expert system can integrate various sources of knowl­
edge and may contain various view points. Textbooks however are more conveni­
ent to use and more portable.
The development of an  expert system is currently very costly in term s of 
time needed to build the system, the expertise required and the development 
tools.
TEDEX versus scoring systems:
Various classifications and scoring systems have been employed to evalu­
ate patients with dysthyroid eye disease (Section 3.5.2). One of the major aims 
of such  systems is to assess disease severity in order to plan management. These 
systems are generally inflexible and thus inadequate for this purpose.
TEDEX diagnostic and management decisions are based on the structu­
ral and functional changes of the individual ocular tissues, and the patterns re­
sulting from the combination of these changes in conjunction with the general 
condition, and the previous medical and therapeutic history of the patient (Sec­
tion 8.10.4). In effect, tailor made advice is provided when TEDEX is used which 
contrasts with the application of a rigid scoring system. Furthermore, computers 
are superior to hum an in dealing with situations in which large num ber of par­
ameters m ust be simultaneously considered in order to make a decision (Elstein 
etaL, 1972; Macartney, 1987). No scoring system is currently available which 
gives predictions regarding the course and outcome of the disease.
8.13.4. Similarities and distinctions from other systems:
Knowledge base design :
Part of the routine developed by clinicians is an  appropriate order for ac­
quiring clinical information systematically. TEDEX complies with such conven­
tion in the history taking part of the data acquisition dialogue. However, the rest 
of the dialogue is guided by a  backward chaining strategy and depends on the 
line of reasoning selected by the inference engine (Section 8.10.4). Other de­
signers tend to enforce such an  order either strictly (e.g., MYCIN, Section 8.5.5) 
or not a t all (e.g., INTERNIST, Section 8.5.3).
Both TEDEX and the deDombal’s abdominal pain expert systems (Sec­
tion 8.5.1) deal with a circumscribed domain. The essential difference between 
the two systems is that thyroid ophthalmopathy is an  uncommon disorder while 
abdominal pain is very common. Therefore, it was possible to build abdominal 
pain programme purely on a Bayesian probability approach (Section 8.4.5) which 
requires a  veiy large num ber of patients. Bayesian probabilities are used in some 
parts of the TEDEX knowledge base and represent one of several approaches 
used (Section 8.10.4).
The ideal expert system:
Expert system should:
(1) Provide the m eans for efficient transfer of knowiedge.t
(2) Have knowledge bases  that are expandable & modifiable.!
(3) Show improved competence with addition of new knowledge.!
(4) Interact in a  language natural to the expert and u se r .t
(5) Think in a  way that m atches the human expert.
(6) Leams from experience.
(7) Insulate the user from the underlying m echanics.!
(8) Have a  control strategy that is simple.!
(9) Be computationally fast.!
(10) Be comfortable to use.
(11) Be inexpensive to build and experiment w ith.!
(12) Have provision for ’help’ and dialogue.!
(13) Have displays that are informative to the u se r.!
(14) Explain reasoning and conclusions.!
(15) Be useful in practice.
Table 8.13
The characteristics of an ideal expert system summarised from Konopasek and 
Tayramanu (1984). " ! Criteria so far satisfied by TEDEX."
TEDEX has some similarities to the frame-based concept of PIP (Sec­
tion 8.5.4). Each of the diagnosis module components (Figure 8.9) represent one 
cluster of knowledge with distinct features (i.e., frame-like). However, the TEDEX 
inference engine m anipulates these clusters differently and considers them as 
one level of abstraction.
The concept of ’multilevel description of states’ which is the basis of the 
CASNET (Section 8.5.2) inference engine design has been modified and used in 
devising the TEDEX knowledge base. The original CASNET multilevel structure 
embodied a  clinical data level, a  pathophysiological level, a  diagnosis level and a 
treatm ent level. By comparison TEDEX contains a  clinical findings level, an  in­
termediate level (data interpreted into scores), a diagnosis level and a  treatm ent 
level.
Knowledge representation:
A hybrid of three knowledge representation approaches has been used 
to develop the knowledge base of TEDEX (Section 8.10.4), namely those of se­
mantic network (Plate 8.1), production rules and predicate calculus. Combining 
such a  num ber of various techniques ensures system flexibility and allows for 
the implementation of the most appropriate technique for the right situation. 
TEDEX is unique in making use of this kind of combination bu t it is in accord­
ance with the concepts of Reggia and Tuhrim (1985) who advised tha t knowledge 
representation methods should be chosen according to the specific problem in 
hand.
8.13.5. How does TEDEX compare to the ideal system:
It can be seen from the above discussion tha t TEDEX so far embraces 11 
of the 15 features of the ideal expert system listed in Table 8.13 (Konopasek and 
Tayramanu, 1984).
Learning from experience capabilities has yet to be improved and im­
plemented on microcomputers. The usefulness of TEDEX cannot be claimed be­
fore the test of time and prospective studies prove it. This is therefore a  future 
research project.
The development of the portable ’laptop’ microcomputer effectively ne­
gates the argum ent that computerised systems are impracticable because of their 
lack of portability.
Perhaps the major hindrance to the potential usage of this system is that 
it solely deals with one uncommon aspect of ophthalmology. This potentially dim­
inishes the expected level of usage at present. However, as further expert sys­
tems are devised and developed and computers become routinely used in the out­
patient clinics the use of such system is likely to gain in popularity.
CHAPTER 9.
SUGGESTIONS FOR FURTHER RESEARCH
9.1. INTRODUCTION:
Com puter applications to ophthalmic diagnosis and m anagem ent 
promise to optimise the existing empirical approaches, and improve patient as­
sessm ent and clinical data handling. Further research is required to make use 
of the currently available computer technology in solving clinical ophthalmic 
problems and to overcome the difficulties and limitations of computing ap­
proaches. On the other hand, dysthyroid ophthalmopathy rem ains to be an  enig­
ma. The present work raises new questions and leads to m any areas for future 
research.
9.2. DYSTHYROID OPHTHALMOPATHY:
A long-term study of dysthyroid eye disease using advanced imaging 
techniques and computerised data collection is required, TEDEX offers a means 
of starting such a study. Furthermore, the role of advanced and quantitative im­
aging techniques in the management of ophthalmopathy and in particular their 
value in determining the appropriate timing of surgical decompression deserve 
further evaluation.
There is a  need for a test which is sensitive and specific enough to detect 
optic nerve compression a t an  early stage before irreparable damage occurs. So 
far, the most sensitive clinical tests for detecting optic nerve compression are the 
field of vision and the 100-Hue colour vision test. A system for automatic read­
ing and quantification of the charts of these two tests is currently being investi­
gated (Chapter 7) in an  effort to improve their sensitivity. The value of this system 
in increasing the rate  of early detection of optic nerve compression has yet to be 
established.
The safety and effectiveness of orbital radiotherapy and imm unosup­
pressive drugs such as cyclosporin A as a  primary and definitive treatm ent of 
severe ophthalmopathy need to be investigated using controlled studies which 
perhaps should be multicentric to compensate for the small num ber of patients 
with this disease.
9.3. COMPUTER APPLICATIONS:
9.3.1. Temporal assessment of visual acuity:
Further assessm ent of the TEMPRAC test is required using larger num ­
ber of normal individuals in the older age groups.
Evaluation of the usefulness of the test in the diagnosis of optic neuritis 
patients comparing the results with other visual function test modalities has yet 
to be carried out. Furthermore, the usefulness of the test in the early detection 
of optic nerve compression in patients with dysthyroid eye disease requires a sep­
arate study.
The value of the test as a  screening tool for diseases such as glaucoma, 
its value in verification of spectacle correction of errors of refraction and the ap­
propriate choice of the optotype to be used in the test, in term s of difficulty of 
recognition, needs further elucidation.
9.3.2. Automatic chart reading system:
Quantification of other ophthalmic charts and the establishm ent of an  
image data base which may include advanced imaging techniques results, photo­
graphs, diagrams and histopathology photographs of ophthalmic patients are 
potential future research projects.
9.3.3. TEDEX
Easy m aintenance and updating of an  expert system programme can be 
enhanced by adopting a  m odular design. However, there is a real need for the de­
velopment of a  user interface with a  ’maintenance module’ which is intended for 
the user to readjust his programme by himself according to the changes in in­
vestigation techniques, therapeutic procedures, attitudes in social values, work­
ing environment or health care cost.
The keyboard is the principal input device of the TEDEX system. Every 
effort has been made to keep its use as limited and simple as possible. However, 
the keyboard remains a  major barrier to the effective use of microcomputers. The
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m an-machine interface in the context of medical applications, and voice syn­
thesis and recognition are interesting areas which require active research aimed 
a t providing easier, effective and more natural communication between the user 
and the computer.
Expert system development requires high software and hardware stand­
ards. This is not surprising in view of its attem pt to emulate hum an thought pro­
cess. Parallel processing is one advance which is well suited to the purpose of 
expert systems techniques. Neural computing, which is in effect a software emu­
lation of parallel processing has a  similar potential. Further research in  these as­
pects of artificial intelligence is needed in order to make the best use of the current 
technology to solve clinical problems.
One of the features of the ideal expert system (Table 8.13) which is par­
ticularly significant for medical applications is its ability to learn from ’experi­
ence’. This m eans tha t the expert system would be able to extract new rules or 
modify existing rules in its knowledge base when data of new cases are added to 
its data base. Unfortunately, the current induction software tools are still very 
primitive (Clancey, 1983; Ellis, 1987; Chard, 1988). Research is needed to de­
velop such tools and to integrate them into some of the successful expert system 
building tools. The capability of ’learning from experience’ when included in a  
medical expert system would enhance its acceptance, improve its transferability 
and ensure tha t its knowledge base is continuously updated.
The choice of a  problem area which is suitable for building a  medical ex­
pert system is critical. Practical problems for which expertise is in demand are 
appropriate for expert system applications. Experience has also shown that the 
domain should be reasonably well circumscribed. Research to define such areas 
in clinical ophthalmic practice is needed.
Dysthyroid ophthalmopathy and thyroid diseases are interrelated and 
together form one circumscribed area suitable for development of a comprehens­
ive thyroid expert system. It seems logical to extend the present work to include 
the systemic aspects of this disorder.
For future expert system building projects, it is recommended that the 
recently introduced expert systems development tool kits should be used because 
they are user friendly, powerful and provide transferability across a wide range 
of available microcomputers in common use. Computerisation of clinical records 
would guard against the loss of valuable patient data. This gives more accurate 
statistical results and a  better quality of decision rules which in tu rn  enhance 
the accuracy of future expert systems whose foundations would be based on such 
data. One of the advantages of using TEDEX is the discipline it imposes on the 
user which results in establishing a complete patient data base.
Expert systems capabilities open new fields in medical education. Using 
microcomputers, both interactive problem oriented teaching, and factual knowl­
edge combined with decision making procedures can be handled a t the same 
time. Furthermore, anatomical, physiological, pathophysiological and pathologi­
cal information can be effectively included in such a system.
The TEDEX development project will have to run  for a t least one more 
year during which its intended design features, user interface improvements and 
further refinements of the knowledge base will be completed. However, the major 
target during the next year is to link the system into the following equipment:
1-TEMPRAC (Chapter 6)
2- Automatic clinical chart reading equipment (Chapter 7)
3- Microcomputer-based visual field testing.
The completed project aims to act as a model for the demonstration of 
the concept of clinic automation. One expert system could control and communi­
cate with a wide range of, already computerised, sources of information. Contrast 
sensitivity testing equipment, visual field testing apparatus, laboratory computer 
or on-line data bases are bu t a few examples. Many other potential systems can 
be integrated in such a  clinic automation project, these include charting and 
graphical representation of knowledge (e.g., displaying chronological data of pa­
tients), as part of an  advanced reporting capability, simulation of surgical oper­
ations and three dimensional imaging of intraocular tum ours based on different 
parameters.
Further research can adapt TEDEX and combine it with other ophthal­
mic expert systems to constitute a  comprehensive ophthalmic advisor for General 
Practitioners, for the developing countries or for medical teams serving in remote 
areas.
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